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Proceedings of the British Thoracic Society, Scottish
Thoracic Society and Thoracic Society of Australia
The 1987 summer meeting held on 1-3 July in the University of Edinburgh.
Bronchoscopy in the elderly: helpful or hazardous?
AJ KNOX, BH MASCIE-TAYLOR, RL PAGE Respiratory
Medicine Unit, St. James's Hospital, Leeds Recently,
doubt has been cast on the safety and desirability of
fibreoptic bronchoscopy in the elderly (Grant IBW, Br Med
J 1986;293:286-7). To answer this question, we looked at
the safety and acceptability of the procedure in 60 patients,
aged 80-92 over the four year period May 1982-May 1986.
Thirty-four patients were male. Sedation was with atropine,
fentanyl, and diazepam, 2% lignocaine being instilled
locally over the cords. There was no serious morbidity and
no mortality. The diagnostic yield was similar to younger
age groups. Twenty-one patients had histologically proved
carcinoma of the bronchus, one a benign polyp, one
tuberculosis diagnosed from washings, two collapsed lobes
with re-expansion following removal of secretions. The
remainder either showed infective changes or were normal.
Where no tumour was seen active treatment resulted in
improvement in all but four. Of those with tumour, four
were treated with radiotherapy with symptomatic relief, the
remainder being treated conservatively. A positive
diagnosis of malignancy greatly helped the planning of
future care. We conclude that fibreoptic bronchoscopy is a
safe, useful procedure in this group of patients.
A randomised, double blind comparison of midazolam and
diazepam -(Diazemuls) as sedation for fibreoptic
bronchoscopy
RG TAYLOR, F JOHNSON, JCG COX, PJH POI, AG
ARNOLD Medical Chest Unit, Castle Hill Hospital,
Cottingham Having shown that bronchoscopy patients
dislike instrumentation of the nose and appreciate amnesia
(Morrison et al, Thorax 1987;42:223), we compared
intravenous diazepam (as Diazemuls) with midazolam,
which gives more amnesia at similiar sedation. One
hundred consecutive patients (median age 66.5 years) from
routine bronchoscopy lists were given atropine 0.6 mg
beforehand, oxygen 2 I/min throughout and lignocaine by
nasal spray and endobronchially (up to seven 2 ml 2%
aliquots allowed). The initial dose of midazolam 3.5 mg
given over 30 s or diazepam 7.5 mg (1.5 min) was reduced
by one third if the patient was small, frail or over 65 years.
Increments of midazolam 0.5 mg or diazepam 1.25 mg were
repeated after 2 minutes as required until the patient was
drowsy with slurred speech; only then was the nose sprayed.
The median (range) doses (and average ampoules/patient)
were: midazolam 4 (2.5-10) mg (one), diazepam 10 (5-30)
mg (two). Bronchoscopists completed questionnaires
immediately afterwards, and patients the next day,
returning them promptly by stamped addressed envelope.
After midazolam, fewer patients remembered the nasal
spray (15% vs 36%, p<0.05) or bronchoscope insertion
(9% vs 38%, p<0.01); complaints fell from 48%
previously to 7%o. Fewer patients were difficult to
bronchoscope or found it unpleasant after midazolam,
though more needed extra lignocaine; these differences
were not significant. Overall, the commonest complaint
(32%) was of apprehension about the procedure or results
but 97%to would have another bronchoscopy, and 74%o
found it better than expected, though 93% appreciated
being sedated.
Visual distraction of biofeedback?
A study of patients' tolerance of fibreoptic bronchoscopy
PJV HANSON, MJ PLANT, J GOLDMAN, JV COLLINS St.
Stephen's Hospital, London Anecdotal evidence suggests
that fibreoptic bronchoscopy is better tolerated by subjects
allowed to observe their bronchoscopy through a side
viewing attachment. We conducted a controlled clinical
trial on 73 patients undergoing bronchoscopy to assess the
value of visual stimulation during the procedure. Standard
premedication was given and patients randomised to three
groups: 23(S) looked at slides projected onto a screen;
25(V) looked through the side viewing attachment and 25
controls (C) had no visual stimulation. The procedure was
conducted by an experienced bronchoscopist who delivered
a standard commentary on the basic anatomy seen during
the procedure. The side piece was attached for all groups
and used by the patient (Gp.V) or by an attendant (Gps. C
and S). Patients in group C used a hand control to project
slides onto a screen in front of them. Patient tolerance was
assessed by recorded cough counts and operator and patient
questionnaires. Groups (S) and (V) coughed less than
controls (p<0.02; p<0.05 resp.). Group (V) found the
procedure more tolerable than (S) or (C) (p<0.05;< 0.001
resp.). Operator's assessment of patient tolerance related
inversely to degree of coughing in all groups. There was
generally no correlation between operator's and patient's
assessment of the procedure. Patients benefit subjectively,
and cough less when using the sidepiece, perhaps due to
biofeedback. Patients also cough less but do not benefit
subjectively from simple visual distraction as provided by
slides. The operator considered both measures beneficial,
perhaps because of reduced coughing.
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An assessment of fluid flux across the alveolar membrane
during bronchoalveolar lavage (BAL)
CA KELLY, J FENWICK, PA CORRIS, A FLEETWOOD, C WARD, DJ
HENDRICK, EH WALTERS Departments ofMedicine, Physics
and Biochemistry, Newcastle General Hospital, University
ofNewcastle on Tyne Two related studies were performed
to investigate and quantify the degree of fluid exchange that
might occur between the pulmonary circulation and the
lung segment during BAL. Using 0.005% methylene blue as
a marker, we calculated the median degree of dilution of
the aspirate in five subjects with normal pulmonary
function undergoing 180 (3 x 60) ml BAL to be 24/o (range
15-35%). Using 99mtechnetium colloid it was 25% (range
16-35%), i.e. a net fluid gain of about 45 ml within the lung
segment. In the same experiment, four MBq of tritiated
water were also added to the introduced fluid and the
degree of dilution of tritium in the aspirate was found to be
greater than that of the other two markers. This suggested
that a median of 57 ml (range 36-130 ml) of water had
effluxed from the lung during BAL. The total fluid gain by
the lung was thus about 100 ml. We performed 3 x 60 ml
BAL in a further five subjects 12 hours after an oral dose of
four MBq of tritiated water. A median of 39% (range
32-52%) of the 85 ml (range 63-124 ml) aspirated was
calculated to have come from the circulation by
simultaneously measuring the concentrations of tritium in
plasma and aspirate. The concentration of urea, an
'endogenous marker', was also assayed simultaneously in
plasma and aspirate, and fluid normally resident within the
lung segment was calculated to contribute only 2% of the
total aspirate. These studies offer a quantitative analysis of
the complex fluid dynamics of a standard BAL.
The early diagnosis of aspergilloma using computed
tomography
B STRICKLAND, KM CITRON, CM ROBERTS Departments of
Diagnostic Radiology and Thoracic Medicine, Brompton
Hospital, London The diagnosis of aspergilioma is made
from the chest radiograph and tomograph, which are
imperfect methods for imaging damaged and distorted lung
parenchyma in which aspergillomas usually lie. The
diagnosis may thus be missed. We examined the CT
appearances in 26 patients referred with the diagnosis of
aspergilloma made or suggested by serum precipitins and a
chest radiograph. Three millimetre narrow sections and a
bone algorithm (Strickland et al, Clin Radiol
1986;37:335-338) were used to improve definition. In nine
patients histological specimens became available for
comparison with the scans. There was absolute correlation
in diagnosis and number of aspergillomas when CT was
compared with histology. Forty-six per cent of patients had
multiple lesions, far more than reported in previous
radiological series, reflecting the increased resolution of
CT. The appearances of both the mature fungus ball and
the forming aspergilloma are described in detail. Lesions
not seen on chest radiograph are identified on CT and the
reason for this are elucidated. CT is an accurate method of
identifying both mature and forming aspergillomas and is
useful in cases where the diagnosis is suggested
Proceedings
immunologically or clinically but not confirmed using
conventional radiology. CT should also be performed
before surgical resection to localise all aspergillomas.
Correlation of lung CT density with respiratory function in
smokers and patients with bullous emphysema
GA GOULD, W MACNEE, AT REDPATH, MF SUDLOW, JJK BEST, DC
FLENLEY Rayne Laboratory, Departments of Respiratory
Medicine, Medical Physics, and Medical Radiology,
Edinburgh We have previously shown a strong
correlation between lung CT density and the severity of
microscopic emphysema, using precise morphometric
measurements of distal air space size to define emphysema
(Gould et al, Thorax 1986;41:717). Using the same method
of CT analysis we have recorded the EMI number of the
lowest 5th percentile of the CT density histograms (as a
measure of peripheral lung density) in 77 smokers (60M,
17F; 23-82 years; FEVY 15-125% predicted; Kco 15-139%
predicted) and 27 patients with bullous disease (25M, 2F;
31-69 years; FEVY 15-84% predicted; Kco 20-114%
predicted) correlating respiratory function with lung CT
density, excluding any bullous areas of the lung from
analysis. In both groups lung CT density correlated with
functional measurements thought to reflect the severity of
emphysema, such as air flow limitation (FEV/FVC%
predicted, r= -0.73) and impairment of gas transfer (CT
density vs Kco r= -0.76). The extent of bullous disease
was not a major determinant of respiratory function. We
conclude that 1) lung CT density correlates with functional
impairment and thus quantifies the severity of emphysema,
2) impairment of respiratory function in patients with
bullous disease relates mainly to the degree of emphysema
in the non-bullous area of lung, 3) the combination of lung
CT density and gas transfer (Kco) measurements is a
sensitive and specific method for non-invasively
quantifying the severity of pulmonary emphysema.
Analysis of QCT lumbar spine densitometry values in
patients with obstructive lung disease
WJH LECKIE, M ALCOCK, P BALDOCK, A MCALINDON, S BURDON-
JONES, JM ROWLANDS, SDR HOMAN Thoracic Medicine Unit,
The Queen Elizabeth Hospital, Woodville, South
Australia Vertebral fractures are common among older
patients with chronic obstructive lung disease with (COLD)
especially in thin smokers with exogenous hypercorticism.
Whether there is a threshold corticosteroid dose related
either to daily intake or to duration of treatment below
which it is no longer a significant risk factor in osteoporosis
remains in doubt. A survey of vertebral fractures and single
energy QCT spinal densitometry (Computed tomography
of the Body, ch 23; Saunders, 1984) of 153 patients
suffering from COLD has been undertaken and the
relationship of CT and fractures to some known risk
factors determined. Patients with other conditions causing
osteoporosis were excluded. There was a positive
correlation (see table) between number of patients with
fractures and QCT, and between number of fractures and
QCT. Only in postmenopausal women was there a
significant relationship between QCT and the annual
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(though not the total) prednisolone dose. Even in this
subgroup corticosteroids accounted for no more than 20%
of the osteoporosis found (men 63% and women 79% of
normal values of a North American series: C Cann 1985,
personal communication). Current activity was the only
other factor which independently correlated (positively)
with QCT, particularly in men. It seem likely that oral
corticosteroids have only a minor role in the osteopenia
found in COLD, particularly when a daily dose of >10 mg
is used, and then only in postmenopausal women.
QCT < 60 CT , 100
Total patients 42 38
No with fractures 25 6 p < 0.0005
No of fractures 58 10 p< 0.005
Factors influencing survival in lung cancer
S CAPEWELL ON BEHALF OF THE EDINBURGH LUNG CANCER
GROUP Department of Respiratory Medicine, City
Hospital, Edinburgh The Edinburgh Lung Cancer Group
has registered over 3,000 new patients presenting with lung
cancer since 1981. Only 57 of 651 patients registered in 1981
survived four years (9Gb). Survival was highest in 41 of the
116 (35%) selected for surgery and in this group was related
to cell type (p<0.01), to stage of disease (p<0.02) and
possibly to Karnofsky performance status (p=0.08). The
116 surgical patients differed from the "non-surgical"
patients in terms of age (34% vs 22% under 60), histology
(6% vs 25% small cell), stage of disease (86% vs 32% stage
I or II) and performance status (75% vs 26% Karnofsky>
90%) (all p<0.01). Forty-two of the 535 "non-surgical"
patients were given radical radiotherapy alone and eight
(191o) survived four years, whereas only eight of the
remaining 493 (2%) survived four years following
radiotherapy, chemotherapy (alone or in combination), or
symptomatic treatment only. Median survival (MS) varied
markedly with cell type (adenocarcinoma MS 2.6 months vs
squamous carcinoma MS 6.2 months), stage (stage I MS 8.5
months vs stage III MS 4.0 months) and performance status
(Karnofsky > 90 MS 9.3 months vs Karnofsky < 50 MS
1.2 months) (all p<0.001). Age had no independent
prognostic value in any group. Performance status was
highly correlated with stage (and age) and represents the
"best single prognostic factor" in clinical practice.
Smoking pattern, occupational risk, family history, and
dietary and alcohol intake in lung cancer: results of a case-
control study in males
RJ PIERCE, LF WATSON, GA KUNE, S KUNE, L VITTETTA, B FIELD, D
MERENSTEIN, A HEY, LB IRVING Department of Thoracic
Medicine and Melbourne University Department of
Surgery, Heidelberg Repatriation Hospital, Victoria,
Australia In a case-control study of 72 consecutive new
male cases of lung cancer and 73 male hospital control
patients, smoking pattern, occupational history, family
history of lung and other cancer, previous diet and alcohol
intake were investigated by univariate and multiple logistic
regression analyses using GLIM. The cases and controls
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were similar in age, country of origin, area of residency and
marital status. Smoking duration was longer for cases (44.3
(SEM 1.2) years) than for controls (34 (1.8) years) with a
relative risk (RR) of 1.06/years (X2 = 19.0, p<0.0001). For
ex-smokers time since cessation of smoking was shorter for
cases (4.5 (0.9) years) than for controls (13.4 (1.9) years),
giving RR=0.92/year (X2=21, p<0.0001). These two
factors showed a stronger association than pack years
(cases 50.8 (4.1), controls 33.6 (3.3), RR= 1.02/pack year,
X2= 10.4, p<0.001). The average number of cigarettes per
day (cases 23.3 (1.9), controls 19.2 (1.7), (RR= 1.03/cig,
X2 = 3.6, p = 0.06) and the prevalance of smoking (66
cases, 62 controls, RR = 3.4, X2 = 4.3, p = 0.04) were
weaker associations. Individual occupations, as assessed in
this study, were not associated with the risk. A priori
nominated at-risk occupations, were seen in 20 cases and 14
controls - RR smoking adjusted (RRs) =1.67 (p = 0.27).
Self-reported dust exposure was noted in 23 cases and 17
controls RRs = 1.72, p = 0.24). Of 28 cases and 22 controls
who reported a cancer in a first degree relative (RRs = 1.77,
p = 0.22), this was a lung cancer in four cases and in three
controls. Using a frequency assessment of previous dietary
intake, broad food groups were similar for cases and
controls. Examining individual food items showed that
cases had a higher intake of cream and lower intake of fruit
and fish than controls but only the association with fish
remained significant after smoking adjustment (RRs = 0.90,
X2 = 4.2, p = 0.04). Although serum levels of retinol and A
carotene were significantly lower in cases than controls, a
dietary difference for these was not detected by the
frequency method. Alcohol intake was similar in cases and
controls.
Lung cancer: survival, tumour size and kinetic data at
presentation
KM KERR, D LAMB Department of Pathology, University of
Edinburgh, Edinburgh In a series of 46 classical primary
bronchogenic carcinomas we have measured the thymidine
labelling index (TLI: a measure of cell proliferation) in all
cases and tumour volume doubling time (DTact) in 13
cases. These patients were followed up for five years and
these data compared with postoperative survival, tumour
volume at operation and pathological staging. Unlike
breast, lymphoid and brain malignancies we find a higher
TLI does not correlate with a more aggressive clinical
course for the tumour. Five year survivors had smaller
tumours than non-survivors (p=0.015) but no correlation
was found, in those dying of malignancy, between size of
tumour and length of postoperative survival. Larger
tumours have higher TLIs than smaller lesions (0.01 >
p>0.001). If this implies tumour progression with time
then cell loss would also have to increase in parallel with cell
production rate since tumour growth rate is relatively
constant. Tumour size at operation may predict likelihood
of cure but not postoperative survival. Tumour cell
proliferation, taken alone, is not useful in either context.
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Treatment duration in small cell lung cancer (SCLC): a
randomised comparison of four versus eight courses of
initial chemotherapy
SG SPIRO, HM EARL, RL SOUHAMI, CM ASH, DM GEDDES, PG
HARPER, JS TOBIAS, H QUINN Department of Respiratory
Medicine, University College Hospital, London Six
hundred and sixteen patients with SCLC were entered into a
randomised trial comparing different treatment durations
and the value of chemotherapy on relapse. Patients were
staged by isotope bone scan and liver ultrasound, and
stratified according to stage (limited or extensive). Patients
were then randomised to receive either four or eight courses
of chemotherapy (cyclophosphamide lg/m2 day 1,
vincristine 2 mg day 1, etoposide 100 mg t.d.s. days 1-3)
three weekly. At presentation patients were also
randomised for treatment at relapse, to receive either
further chemotherapy (adriamycin 50 mg/M2 and
methotrexate 50 mg/M2, every three weeks) or symptomatic
treatment alone. Response rates to short (S) and long (L)
initial chemotherapy were similar (S = 610o, L = 630o), as
were response rates to relapse chemotherapy (S =2507,
L = 1807). Overall median survival (MS) from course one
was analysed by intention to treat, and patients randomised
to eight courses of initial chemotherapy had a slightly
longer MS than those randomised to four courses (MS, 39
vs 32 weeks, p = 0.085). Progression free interval (PFI)
after initial chemotherapy was longer in patients receiving
eight rather than four courses (median, 31 vs 23 weeks,
p = 0.0002). Survival from relapse was longer for patients
receiving relapse chemotherapy than those receiving
symptomatic treatment alone (MS, 17 vs 12 weeks,
p = 0.0004). The only treatment strategy associated with a
significantly worse survival was short initial chemotherapy,
followed by symptomatic treatment on relapse.
A randomised trial of short course intravenous versus oral
chemotherapy for small cell lung cancer (SCLC)
PA CORRIS, B CANTWELL, J BOZZINO, D VEALE, AL
HARRIS North East Lung Cancer Group, Department of
Respiratory Medicine, Freeman Hospital, and University
Department of Clinical Oncology, Newcastle General
Hospital, Newcastle upon Tyne Conventional therapy for
small cell lung cancer (SCLC) includes hospital based
intravenous chemotherapy. Oral chemotherapy has been
shown to be effective treatment in other chemosensitive
malignancies such as Hodgkin's disease, and has
advantages in terms of expense and ease of administration.
We have carried out a randomised trial of hospital based
short course intravenous (IV) chemotherapy versus
outpatient based oral chemotherapy in two hundred
patients with small cell lung cancer. Randomisation was
stratified for extent of disease and all patients gave
informed consent. The initial course of IV chemotherapy
comprised adriamycin 40 mg/M2 vincristine 2 mg,
etoposide 100 mg/M2 on day one and etoposide 300 mg
orally on days two and three. Subsequent courses of IV
chemotherapy comprised adriamycin 30 mg/M2, vincristine
2 mg, etoposide 200 mg/M2 and 24 hour infusion of
ifosfamide 5 g/m2 plus MESNA. All courses of oral
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chemotherapy comprised chlorambucil 6 mg/M2,
procarbazine 150 mg, prednisolone 20 mg each day for 10
days and etoposide 300 mg daily for the first three days.
Each treatment was given every three weeks to a total of
four courses and good responders received prophylactic
cranial and consolidation mediastinal radiotherapy. The
results of survival up to a maximum of 32 months have
been compared in the first 150 patients, of whom 76
received IV and 74 oral chemotherapy. There were no
significant differences in survival between IV and orally
treated patients either when compared overall or when
subdivided by stage at presentation (log rank test). Overall
median survival for all patients from the first course of
therapy was eight months and nine months after oral and
IV drugs respectively. Oral chemotherapy was not only
easier to administer but also significantly cheaper than the
intravenous drugs. We conclude that oral outpatient
chemotherapy confers the same early survival benefit as
more expensive hospital based IV chemotherapy in patients
with small cell lung cancer.
Survival after radiotherapy for lung cancer
LM MATHESON, S CAPEWELL, MF SUDLOW, GA NEWAISHY ON
BEHALF OF THE EDINBURGH LUNG CANCER
GROUP Department of Clinical Oncology, Western
General Hospital, Edinburgh The Edinburgh Lung
Cancer Group (ELCG) registered 2586 new cases of lung
cancer prospectively during 1981-84. Thirty-one per cent of
patients were treated initially with radiotherapy compared
with 197o undergoing surgery, 12/o chemotherapy and
3807 considered suitable for symptomatic therapy only.
During 1981, 233 patients with non-small cell cancer
received radiotherapy as primary treatment; 41 (1707.)
received radical radiotherapy (radical RT: 42-57 Gy) and
192 palliative radiotherapy (palliative RT: 18-30 Gy).
Positive histology was available in 32/41 radical RT (78%)
and 156/192 (8107.) palliative RT patients. The radical RT
patients were more selected in terms of stage (6107 vs 2807.
stage I; p<0.001), age (760o vs 5707. < 70 years; p<0.02)
and performance status (Karnofsky index > 80 in 7907 vs
4907; p<0.001). Four years survival after radical RT was
12.507 (4/20) for patients with positive histology; 7/192
(3.70o) palliatively treated patients survived four years.
Pulmonary manifestations of prostatic adenocarcinoma
H MESTITZ, RJ PIERCE, PW HOLMES Department of Thoracic
Medicine, Repatriation General Hospital, Victoria,
Australia Of four patients with intrathoracic metastases
from primary prostatic adenocarcinoma, two presented
initially with pulmonary involvement, whereas the other two
patients had previously treated prostatic cancer. One repre-
sented with haemoptysis due to multiple pulmonary nodules,
which resolved after orchidectomy, and the other developed
asymptomatic hilar and mediastinal lymphadenopathy,
which partially responded to orchidectomy. These cases
demonstrate: 1) Pulmonary, pleural and mediastinal metas-
tases occur in advanced stages of this disease. 2) lntra-
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CASE 1: CASE 2:
Lymphangitis Isolated pleural
carcinomatosa effusion
Respiratory symptoms Dyspnoea. Cough None
Urinary symptoms None Frequency. Nocturia.
Prostate examination Hard. Fixed. Enlarged. "Benign"
Serum prostatic acid Markedly elevated Normal
phosphatase (S.P.A.P.)
Bone scan Positive Normal
Diagnosis Transbronch. biopsy Prostatic aspiration
Specific tissue stain Pleural aspirate Pleural aspirate
Orchidectomy response Rapid improvement Unchanged
thoracic metastases may be the presenting feature of
otherwise inapparent prostatic cancer. 3) Rectal examination
and 'a normal S.P.A.P. do not exclude the prostate as the
primary site. 4) Other causes of intrathoracic disseminated
adenocarcinoma respond poorly to any treatment whilst
secondary prostatic cancer responds radiologically and
symptomatically to orchidectomy. We recommend that
males with intrathoracic adenocarcinoma have prostatic as-
piration cytology and immunocytochemical stains for pros-
tatic specific antigen and prostatic acid phosphatase
performed on lung, pleural or mediastinal biopsy specimens.
Immunohistological investigation of bronchiectasis
J SILVA, P COLE, A IONES, LW POULTER Host Defence Unit,
Cardiothoracic Institute, Brompton Hospital, and the
Department of Immunology, Royal Free Hospital and
School of Medicine, London Mononuclear cells are
prominent in the histology of bronchiectasis (Whitwell,
Thorax 1952;7:213-39). This study was designed to
determine the contribution of acquired immunological
mechanisms to the inflammatory damage occurring in this
disease. Cryostat sections were prepared from
microscopically involved but non-ulcerated areas of the
resected bronchial tree (n=7) or from endoscopic biopsy
specimens obtained from segmental bronchi of affected
lobes' (n=2) in nine patients with proved bronchiectasis
without pan-hypoglobulinaemia. A panel of monoclonal
antibodies was used to identify the presence and
distribution of lymphocyte and macrophage subsets. Of the
lymphocytes present, 90% were T cells with the exception
that in 1/9 cases follicles of B cells were seen. The T cells
were predominantly found infiltrating the surface
epithelium and in some cases (6/9) the glandular epithelium
within the lamina propria. These T cells were mostly
CD8 +ve cells, although some CD4 +ve cells were found
(mostly in the lamina propria). Very few cells were seen to
express IL2 receptors (Tac + ve), but significant numbers
had high concentrations of CD7 antigen on their surface.
Macrophage-like cells were of two types: RFD1 +ve
dendritic cells predominantly found within T cell infiltrates
- including those adjacent to or in the epithelium;
RFD7 + ve macrophages were diffusely distributed
throughout the lamina propria. We conclude that the
inflammatory reaction in bronchiectasis is associated with a
T cell mediated immune response. This response appears in,
or associated with, the epithelial surface as well as the
lamina propria.
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Characterisation of the local immune response causing
pneumonitis in bone marrow transplant patients
HJ MILBURN, RM DU BOIS, LW POULTER Departments of
Immunology and Thoracic Medicine, Royal Free Hospital
and School of Medicine, London A previous report to
this society described an association between pneumonitis
in bone marrow transplant (BMTX) and a lymphocytosis in
bronchoalveolar (BAL) fluid resulting from increased
numbers of CD8 + (suppressor/cytotoxic) T cells.
Subsequent immunocytochemical studies (reported here)
characterise the full membrane antigen phenotype of these
BAL cells. The majority of CD8 + cells (60-80%) express
high concentrations of CD7 antigen and CD25 (IL2
receptors). 25% express HLA-DR molecules. Using McAbs
RFT1O (CD38), RFT1 (CD5) and Leu7, two major
populations of CD8 + cells, were found in lavage. One was
CD8 + CD5 - Leu7 - CD38 + while the other was
CD8 + CD5 + Leu7 + CD38 -. The latter cell phenotype
reflects that of the predominant circulating CD8 +
population in BMTX patients who develop graft versus
host disease (GVHD) and/or overwhelming viral
infections. It differs, however, from the CD8 + cells found
in the infiltrates of GVHD skin. These findings suggest that
the pneumonitis in these patients results from a local T cell
mediated immune response against viral infection which
possibly becomes uncontrolled, leading to a local GVHD
reaction in the lung.
Lymphocyte-macrophage interactions: peripolesis in
human lung cells
DJ LYONS, A GAUTAM, J CLARKE, JS MILLEDGE, MG HARRIES, BM
BALFOUR Departments of Immunological Medicine and
Anaesthesia, Clinical Research Centre, Harrow
Lymphocyte-macrophage interactions occur in a variety of
cell mediated immune responses. One such interaction is'
peripolesis, in which one or more lymphocytes bind to a
target cell and move rapidly over its surface in a purposeful
manner. This phenomenon has been associated with cell
mediated cytotoxicity. We report for the first time that
peripolesis occurs in cells recovered from the human lung.
Cells obtained by bronchoalveolar lavage were centrifuged,
washed twice and resuspended at a concentration of
5 x 105/ml in RPMI culture medium with penicillin,
streptomycin and 10%7o fetal calf serum. Cells were cultured
for 24 hours at 37°C in 5% CO2 and observed by inverted
phase-contrast microscopy. Cellular movements were
recorded by time-lapse cinemicrography. A technique for
fixing individual cells for electron microscopy was
developed. Cells from nineteen patients were studied; in
6/19, mobile lymphocytes attached to adherent
macrophages and peripolesis occurred, beginning between
four and eighteen hours from the start of culture. Patients
with inflammatory conditions such as sarcoidosis and
tuberculosis, with a high lymphocyte count in BAL fluid,
were most likely to show peripolesis. In no case was there
evidence of a cytotoxic effect mediated by peripolesing
cells. Transmission electron microscopy showed that
peripolesing cells were lymphocytes but not the large
granular type associated with cytotoxicity. Scanning
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electron microscopy confirmed that the non-motile cells
were alveolar macrophages.
Antitumour activity of pulmonary alveolar macrophages
(PAM) In patients with lung cancer
CF McDONALD, RC ATKINS Department of Nephrology,
Prince Henry's Hospital, and Department of Thoracic
Medicine, Repatriation General Hospital, Melbourne,
Victoria, Australia Macrophages are thought to play an
important immune effector cell role in antitumour host
defence. Despite several previous studies it is still not clear
whether PAM antitumour activity in lung cancer patients is
abnormal. Therefore this study examined PAM cytostasis
in a group of lung cancer patients and controls, and
determined whether the in vitro PAM response could be
enhanced by gamma interferon. Seven untreated lung
cancer patients and 15 control patients with non-malignant
respiratory disease underwent bronchoalveolar lavage
(BAL). Antitumour activity of PAMs was assessed by
tumour growth inhibition (cytostasis). Cytostatic activity
was estimated by inhibition of incorporation of tritiated
thymidine into the tumour target cell U937, as previously
described. (Andreesen et al, Cancer Res
1983;43:5931-5936). There was a significant difference in
baseline cytostatic activity between cancer (57.6 (SD
5.08%)) and control patients (86.3 (4.6%))(p<0.05). The
increase in cytostatic function obtained after stimulation
with 1250pg/ml gamma interferon was higher in the cancer
group (33.46 (12.8%) increase from baseline) than in
controls (7.68 (2.96%)) (p<0.01). Post-stimulation
cytostasis was not significantly different between the two
groups. These results indicate (a) that PAM baseline
cytostatic activity in cancer patients is lower than in
controls and (b) that gamma interferon can significantly
augment cytostatic function in cancer patients, to levels
comparable with those achievable in non-cancer patients. It
may be inferred from these results that PAMs from lung
cancer patients are not fully stimulated in vivo, and this
may provide an avenue for future therapeutic endeavours.
Do macrophage subsets determine the pathogenesis of
cryptogenic fibrosing alveolitis (CFA)?
BK NOBLE, RM DU BOIS, LW POULTER Departments of
Immunology and Thoracic Medicine, Royal Free Hospital
and School of Medicine, London Using a comprehensive
panel of monoclonal antibodies (McAbs) immunohistological
techniques have been employed to investigate the
distribution and phenotype of non-lymphoid mononuclear
cells in sections of lung tissue from 10 patients with CFA.
McAbs that in normal tissues identify antigens on
monocytes (UCHM1), macrophages (RFD7), dendritic cells
(RFDI) and epithelioid cells (RFD9) were used. It was
found that the macrophages packed into the air spaces were
all D9 + ,DI + and 50% were D7 +. The cells of the
interstitium were D9- ,DI + and 30% of these were D7 +.
Within follicular clusters of lymphocytes macrophage-like
cells were either Dl + or D7 +. Very few (<5%) of non-
lymphoid cells were UCHM1 +. These results suggest: 1)
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few monocytes are attracted into the inflammatory
reaction; 2) the macrophage-like cells in the air spaces
express a highly abnormal phenotype and 3) cells with the
phenotype of antigen-presenting cells are present within
lymphoid follicles. Subsequent double immunofluorescence
studies indicated that the D7 + but not the Dl + cells in the
interstitium contained fibronectin while the D9 + DI + cells
in the air spaces both contained and appeared to be
"secreting" fibronectin. These results raise the possibility
that macrophages may induce local T cell responses in CFA
as well as subsequent fibrosis.
Human T cell lines and clones specific for the house dust
mite Dermatophagoides farinae - a tool for research in
asthma and rhinitis
RE O'HEHIR, JR LAMB, AB KAY Cardiothoracic Institute,
Brompton Hospital, and MRC Tuberculosis Unit,
Hammersmith Hospital, London The precise role of cell-
mediated immunity in atopic allergy and extrinsic asthma
remains unclear. Since there are usually very small numbers
of circulating allergen-specific T cells, cloning techniques
have to be employed in order to obtain sufficient numbers
of homogeneous cells for detailed study. We have raised
human T cell lines from peripheral blood lymphocytes of
atopic individuals with perennial rhinitis or asthma using a
modification of a previously described method
(Lanzavecchia et al, Clin Exp Immunol 1983;52:21-28).
From these lines a panel of T cell clones (n = 40) has been
derived which are responsive to the house dust mite D
farinae, one of the commonest clinically relevant
aeroallargens in asthma. One such clone, DD1 1, has been
characterized in detail and found to be highly antigen-
specific. It is unreactive to D pteronyssinus and a panel of
other common aeroallergens. The response is MHC class II
restricted at the DR level and dependent on the presence of
antigen-presenting cells. Phenotypic analysis showed the
lines and clone DD 11 to be of T helper type. Such clones
might provide an in vitro system for further evaluation of
the role of the T lymphocyte in the pathogenesis of allergic
disease.
Injection of virus-specific cytotoxic T cells can enhance
disease in mice Infected with respiratory syncytial virus
PJM OPENSHAW, MJ CANNON, BA ASKONAS Immunology
Division, National Institute for Medical Research,
London The pathogenesis of bronchiolitis induced by
respiratory syncytial virus (RSV) is poorly understood.
Clincal studies have shown an association with strong cell
mediated immunity to RSV, but it has been shown that
passive transfer of RSV-specific cytotoxic T (Tc) memory
cells can clear virus from the lungs of persistently infected
immunodeficient mice. Similarly, mice given a lethal dose
of influenza A virus can recover if injected with cloned
influenza-specific Tc cells. Lines and clones of RSV-
specific Tc cells were derived from mice primed with RSV.
After intranasal challenge with live human RSV, normal
mice given these Tc cells intravenously became ill, and
some given-more than 106 cells died. Neither virus nor cells
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alone caused appreciable illness. At day five cells were
recovered by bronchoalveolar lavage as previously
described (Openshaw et al, Clinical Science 1987;72 (suppl
16):35). Mice infected with RSV showed increased
proportions of lymphocytes, whilst mice also given Tc cells
had increases in neutrophils and red cells in addition. Mice
given cells alone showed none of these effects. We conclude
that cloned Tc cells may cause haemorrhagic neutrophilic
pneumonitis in RSV infected mice.
A longitudinal study of non-specific bronchial
responsiveness in asthma
LK JOSEPHS, I GREGG, DJG BAIN, ST HOLGATE Medicine I and
Aldermoor Health Centre, University of Southampton,
Southampton While increased non-specific bronchial
responsiveness is of significance in the pathogenesis and
diagnosis of asthma, the contribution of this abnormality in
day-to-day asthma is not known. In this study we have
investigated the longitudinal relationship between bronchial
reactivity to methacholine (Yan et al, Thorax
1983;38:760-765), measured as that dose producing a 20%o
fall in FEV1 (PD20), and respiratory symptoms, changes in
PEFR, and treatment requirements in a group of 19
patients in whom the clinical diagnosis of asthma had been
established. Over a period of 12-18 months these patients
underwent 15-33 (mean 25) provocation tests at 2-3 week
intervals. No constant relationship could be discerned in the
group as a whole between PD20 and baseline airway calibre,
diurnal variation in PEFR or symptom score, over three
days surrounding each challenge test. However, in
individual subjects three patterns of response emerged: 1)
reactivity varying during the study period in parallel with
symptoms and changes in PEFR, 2) reactivity that varied
little despite obvious symptoms and falls in PEFR, 3)
changes in reactivity that were not necessarily accompanied
by parallel changes in symptoms and/or PEFR. In three
subjects the fall in FEV1 was frequently insufficient to
derive a PD20. We conclude that the relationship between
bronchial hyperresponsiveness and clinical episodes of
asthma is complex and that this functional airway
abnormality is only one component contributing to
symptomatic bronchoconstriction.
Volume history effects on bronchial hyper-responsivene,s
in smokers
J PERTUZ#, A WATSON, NB PRIDE Department of Medicine,
Royal Postgraduate Medical School, Hammersmith
Hospital, London Smokers with mild airflow obstruction
but without asthmatic features show bronchial hyper-
responsiveness (BHR), but some aspects of their BHR
differ from asthma. Thus, we studied volume history
effects and whether a plateau of partial
bronchoconstriction (bc) occurs, in 10 male smokers (age
60.8 (SD 5.2) years) with baseline FEV1 85.3 (17%o)
predicted. During histamine-induced bc we measured FEVy
and flow at 40% initial vital capacity (VC) during
maximum (Vm40) and partial (CP40) flow volume
manoeuvres. Baseline 4m4o/Vp4o ratios averaged 0.77
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(0.19); with bc, tp4p fell more than Vm4m and the
Vm40/Vp40 ratio rose to 2.08 (1.25) during max. bc. BHR
assessed by AVp4o (PC40Vp) was 3.02 mg/ml, while
PC4,0Vm was 3.7 mg/ml significantly different from PC20
FEVI, which was 5.22 mg/ml. VC assessed from max.
flow-volume curves (VCm) during baseline conditions was
3.47 (0.76)1 and VCp was 3.51 (0.67)1. With max. bc VCm
decreased to 2.48 (0.64) 1 whereas VCp decreased to 2.19
(0.45)1. Seven of the men inhaled further concentrations of
histamine after reaching a > 20% fall in FEVI; average
max. falls from baseline were 4407 (10%) for FEV1, 74%
(12%o) for Vm4m and 87% (12%) for Vp4o. Only one man
showed a plateau of FEV, and Vm4o dose-response curves
and none on the Vp4' response. In summary three features
characteristic of asthma - 1) low baseline 4m4o/`p4o ratio
in "spontaneous" airway narrowing, 2) increase in
Vm4m/Vp4p0 ratio with induced airway narrowing and
consequent greater sensitivity of PC40Vp > PC20FEVI, 3)
absence of limited bc as found in normal subjects - were
also found in smokers with BHR.
Correlation between the airway reactivity to ultrasonically
nebulised hypertonic saline, exercise and histamine in
asthmatic subjects
N BELCHER, TH LEE, TJH CLARK, PJ REES Department of
Respiratory Medicine, Guy's Hospital, London Ten
asthmatic subjects 6M, 4F mean age 21 years (range 16-25
years) undertook three different bronchial challenges. No
therapy was taken for 12 hours before studies. Challenges
were performed each day at the same time of day in random
order. Challenges were spaced over 2-4 weeks. Baseline
FEV1s differed by less than 10% in the study. FEVy was
taken as the best of two readings. On one day ultrasonically
nebulised hypertonic saline (3.6%7o) was inhaled in 10-15
litre aliquots with FEVI recorded 30 seconds later. The dose
required to produce a 20%o fall in FEV1 (PD20HS) varied
between nine and 75 litres (mean 31.6 1). Exercise challenges
consisted of eight minutes of exercise on a fixed cycle
ergometer at 60Gb of maximal predicted oxygen uptake.
FEV1 was recorded at the end of exercise and 60 minutes
thereafter. The mean maximum post exertional fall in FEV1
was 23.6% (range 6-54%). On a third day bronchial
reactivity to histamine was measured and expressed as the
PC20 FEV1 (PC20Hist) mean 1.89mg/ml (range 0.03-3.6
mg/ml). Correlations between pairs of challenges in
individuals were calculated using Spearman's rank
correlation test. Bronchial reactivity to HS correlated with
EX (r = 0.659, p<0.02), and also PC20Hist (r = .74,
p<0.02) but there was no correlation between PC20Hist
and EX (r=0.311, p<0.1).
Increases in airway histamine responsiveness precede
allergen-induced late asthmatic responses
CF CRADDOCK, SR DURHAM, WOCM COOKSON, MK
BENSON Osler Chest Unit, Churchill Hospital,
Oxford Seven atopic asthmatic subjects underwent
inhalation challenge with allergen (D pteronyssinus five
subjects, Timothy grass two subjects) and a separate
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control challenge with allergen diluent. The challenges were
given in random order with an interval of 14 days. Airway
histamine responsiveness (Cockcroft, Clin Allergy
1977;7:235-243) was measured pre-challenge and at 3
hours, 24 hours and 48 hours post-challenge. The mean
(SEM) maximal early (0-60 minute) and late (4-12 hour) %
falls in FEVY after allergen were 32.9 (3.0) and 24.9 (7.0)
respectively. The geometric mean changes in histamine
PC20 (expressed as the ratio pre-challenge: post-challenge
PC20w) after allergen were: 3 hours, 3.66 (when mean FEVY
was 987o the pre-challenge value); 24 hours, 3.66 (FEVI,
97%); 48 hours 2.33 (FEVI, 98%). These changes in
histamine PC20 were significant at all three time points
when compared with the corresponding values after diluent
(p<0.05), Wilcoxon paired test). When these changes in
histamine PC20 were compared with the maximal late %
falls in FEVI, the correlation coefficients (Spearman's
method) were: 3 hours, r=0.86 (p<0.05); 24 hours r=0.75
(p<0.1); 48 hours r= -0.07 (p<0.1). We conclude that
increases in airway histamine responsiveness precede the
late asthmatic response, occur independently of changes in
airway calibre and correlate with the magnitude of the late
response.
Histamine stimulation causes tachyphylaxis to both inhaled
histamine and acetylcholine In asthmatic subjects
PJ MANNING, PM O'BYRNE Department of Medicine,
McMaster University, Hamilton, Ontario,
Canada Tachyphylaxis occurs to inhaled histamine but
not acetylcholine in mild asthmatic subjects. Histamine
tachyphylaxis is therefore not a consequence of
bronchoconstriction alone. The purpose of this study was
to determine whether histamine causes tachyphylaxis to
subsequent acetylcholine inhalation. Eight mild asthmatic
subjects with previously demonstrated histamine
tachyphylaxis were studied on four separate days. On each
day two inhalation tests were done one hour apart as
described by Cockcroft et al (Clin Allergy 1977;7:235-43).
The response was expressed as the provocative
concentration of histamine causing a 20% fall in FEV1
(histamine PC20). The tests were as follows: Histamine and
histamine; histamine and acetylcholine; acetylcholine and
acetylcholine; acetylcholine and histamine. The mean
baseline FEV1 values were similar before each inhalation
test on each study day (p>0.25). Acetylcholine did not
cause tachyphylaxis to either acetylcholine or histamine.
However, tachyphylaxis occurred following histamine
inhalation tests to both histamine and acetylcholine in all
subjects. Thus, the mean PC20 histamine increased from
3.74 mg/ml (%SD 1.65) to 5.92 mg/ml (%SD 2.02)
(p<0.005) and the mean PC20 acetylcholine increased from
3.59 mg/ml (%SD 2.00) to 7.76 mg/ml (%SD 1.80)
(p<0.0005). This study confirms that tachyphylaxis occurs
following histamine but not acetylcholine inhalation and
that prior histamine inhalation reduces airway
responsiveness to acetylcholine.
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Effect of inhaled terbutaline on nocturnal change in
bronchial reactivity in asthma
AS VATHENEN, A KNOX, B HIGGINS, J BRITTON, A
TATTERSFIELD Respiratory Medicine Unit, City Hospital,
Nottingham To determine whether a rebound increase in
reactivity occurs overnight in asthmatic patients using
inhaled beta agonist therapy we have investigated the effect
of regular doses of inhaled terbutaline on bronchial
reactivity measured at intervals over 24 hours. Eight
subjects aged 18 to 45 with mild asthma were given placebo,
50 pg or 2000 ug terbutaline via a Nebuhaler at 10, 16 and
22 hours on separate non-consecutivie days in a
randomised, double blind design. Histamine PD20 FEV1
was measured at 09, 11, 15, 21 and 23 hours and overnight
at 03, 06 and 09 hours with additional FEV1 measurements
at 07 and 08 hours. Following placebo there was a circadian
change in mean FEV1 and in geometric mean histamine
PD20 FEVY with peak trough differences of 0.29 1 and 1.3
doubling doses (DD) of histamine respectively. The lowest
values of both measurements occurred at 23.00 hours. Both
doses of terbutaline increased mean FEVY (0.45 and 0.4 1
after the first dose of 500 jg and 2000 pg respectively,
p<0.001) which remained elevated relative to placebo
except at 0700 hours after the 500 pg doses when the FEVY
fell to the value seen after placebo. Histamine PD20 FEVY
was also increased after terbutaline (2.2 DD and 3.4 DD
one hour after the first 500 ug and 2000 pg dose, p<0.001)
and remained elevated relative to placebo throughout the 24
hours. Thus terbutaline caused no rebound increase in
reactivity at any time in these subjects with mild asthma.
Gas exchange during exercise in patients recovering from
acute asthma
GE PACKE, W FREEMAN, RM CAYTON Department of
Respiratory Physiology, East Birmingham Hospital,
Birmingham In patients recovering from acute severe
asthma, disturbance of lung function may persist despite
improvement in symptoms at rest (McFadden et al, N Engl
JMed 1973;288:221-5). Little is known about the effects of
exercise in such patients, particularly on gas exchange. We
studied 17 adults (seven male, 10 female; mean age 26 (SD
8) eight years) recently treated in hospital for acute asthma.
PEFR and arterial blood gas tensions (breathing air) were
measured on admission. Before discharge, when
asymptomatic at rest, patients performed five minutes
steady-state exercise on a bicycle ergometer (IOOW male,
75W female). Ventilation, oxygen uptake and carbon
dioxide output were measured before and during exercise.
Blood gas tensions were measured on arterialised ear-lobe
capillary blood taken at rest and during the last 15 seconds
of exercise.
Admission Rest Exercise
PEFR (% Pred.) 26.8 (5.7) 87.6 (21.0) -
PaO2(kPa) 8.64 (1.26) 13.19 (1.39) 13.93 (1.34)
A-aO2 (kPa) 5.98 (1.34) 1.71 (1.32) 1.67 (1.24)
Symptomatic improvement paralleled improvement in
PEFR, arterial oxygen tension (Pao2) and alveolar-arterial
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oxygen gradient (A-ao2). There was no significant change
in A-ao2 during exercise. Early resumption of moderate
exercise in young patients recently treated for acute asthma
is unlikely to have an adverse effect on gas exchange.
Reproducibility of walking tests in chronic obstructive
airways disease
AJ KNOX, JFJ MORRISON, MF MUERS Respiratory Medicine
Units, St James's and Killingbeck Hospitals,
Leeds Previous workers have suggested that the learning
effect in the performance of repeated walking tests is
confined to the first two walks, but none has evaluated it
fully. We studied 36 patients with chronic bronchitis and
airflow obstruction to examine the reproducibility of
walking tests, spirometry, and subjective scores when 12
five minute walking tests were performed either over three
consecutive days or four consecutive weeks. In 12 subjects
we randomised walks to fixed and random starting points
to assess the role played by visual clues. Distance walked
increased with walk number (p<0.001) and with day
(p<0.001); subjective breathlessness decreased with day
(p =0.012). Spirometric values did not change either with
day or with walk number. Randomising the starting point
did not affect distance walked. Five minute distance
correlated with all spirometric values but not subjective
scores. Whilst walks 1-3 showed the greatest increase in
walking distance, a further 12% increase occurred between
walks 3 and 12, learning effects continuing throughout the
first 10 walks. The corridor walking test is not as
reproducible as previously thought. It should not be used as
an indicator of an individual's response to therapy, e.g.
during steroid trials. In clinical studies a placebo group is
essential.
Upper airway obstruction due to goitre
MR MILLER, AC PINCOCK Department of Medicine,
University of Birmingham Upper airway obstruction
(UAO) due to goitre has previously been thought to be rare.
We have recorded flow volume loops (FVL) on 144 subjects
with goitre who complained of either breathlessness, a sense
of choking or neck discomfort. Presence of UAO was
determined by inspection of the FVL. UAO was diagnosed
in 44 subjects (31%) and 29 of these plus 14 without
evidence of UAO were retested after subtotal
thyroidectomy. The 14 without UAO showed no change in
FVL. Of the 29 with UAO, 23 showed improvement in FVL
and symptoms, two did not improve but still had marked
UAO and four were deemed false positives. This suggests
that FVL shape has 100% sensitivity, 86% specificity and
91% accuracy in diagnosing UAO. Of many indices tested
as predictors of UAO only Empey Index (EI = FEVI in ml
divided by PEF in 1/min) was helpful. An EI>8 had a 68%
sensitivity, 94-1o specificity and 79% accuracy in diagnosing
UAO. An EI>10 had only a 36% sensitivity. We conclude
that UAO due to goitre is more common than previously
believed and that a FVL should be recorded routinely on
patients with symptomatic goitre.
713
The effect of low dose nebulised morphine on exertional
dyspnoea in patients with chronic lung disease
IH YOUNG, E DAVISKAS Department of Thoracic Medicine,
Royal Prince Alfred Hospital, Sydney, N.S. W.,
Australia We have studied the effect of low dose (approx.
0.6 mg) nebulised morphine which could have a direct
action on lung afferents to relieve dyspnoea. Seventeen
adult patients with advanced chronic lung disease (FEV1
range 0.4-1.5 1) performed a one minute progressive
exercise test on an electrically braked cycle ergometer to
determine maximum work load (WMAX) and limiting
symptom. Eleven patients (nine with COPD, two with IPF)
were limited by dyspnoea and two hours later proceeded to
an endurance test at 80% WMAX. One hour later, they
inhaled SOLI (5 ml of either I mg morphine/ml (A) or
saline placebo (B)) for 12 minutes from a jet nebuliser
(Hudson) driven by 6 1/minute oxygen. An endurance test
was repeated 15 minutes later and the per cent change in
endurance time calculated. The above was repeated on a
separate day with SOL2. The allocation of A or B as SOLI
or SOL2 was double blind and in random order. All tests
were performed inhaling 10001o 02 from a demand valve.
n 80% WMAX NEB.MORPHINE %INCR.ENDUR. TIME
watts Total mg. Morph. Placebo
11 40.5 (23.4)' 1.7 (0.7)* 34.9 (10.5)** 0.8 (6.7)"*
*mean (SD) *mean (SEM)
The paired differences between endurance time responses to
morphine and placebo were all positive (34.10o (10.8%),
t= 3.15, p<0.02, paired t test). There was no correlation
between nebulised dose and endurance time response
(r = 0.32). Assuming 30% retention of the nebulised dose by
each patient, approx. 0.6 mg (mean) morphine improved
exercise tolerance. It is possible the small amount delivered
to the lungs (approx. 0.2 mg mean) acts directly on lung
afferents.
The use of negative pressure ventilation (NPV) to facilitate
weaning from intermittent positive pressure ventilation
(IPPV)
AK SIMONDS, EH SAWICKA, N CARROLL, MA
BRANTHWAITE Brompton Hospital, London Restoration
of spontaneous ventilation following IPPV may be difficult
in patients with chronic respiratory disease. We report the
use of NPV to wean 10 patients (5M, 5F; age 18-61 years)
with acute on chronic respiratory insufficiency in whom
conventional weaning methods had failed. Six were scoliotic
(mean VC 25% predicted) and four had chronic airflow
limitation two with emphysema, one with cystic fibrosis, one
with pulmonary sarcoid; mean FEVY 30% predicted). In
three IPPV had been required following thoracic surgery
(pleurectomy, pneumonectomy and drainage of bullae) and
the remainder were ventilated for acute respiratory failure,
in four associated with evidence of respiratory tract
infection. Mean duration of IPPV was 8.4 days. Subjects
were able to breathe spontaneously for 15 minutes, had
intact airway reflexes, stable cardiovascular system and
functioning gastrointestinal tract before extubation in the
iron lung. In seven patients NPV was then successfully
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withdrawn over one-two weeks. Two others were returned to
IPPV as copious sputum production made control of
ventilation impossible. One was later weaned using NPV.
One patient died of postoperative complications unrelated
to NPV. Using this technique, arterial blood gas tensions
can be controlled and respiratory muscles rested without the
disadvantages of endotracheal intubation. NPV should' be
considered before performing tracheostomy as this limits
formation of an adequate neck seal.
Direct measurement of pressure and gas concentrations
within emphysematous buliae
MDL MORGAN, J MORRIS, HR MATrHEWS East Birmingham
Hospital, Bordesley Green East, Birmingham
Emphysematous bullae are often described as structures
with poor ventilation containing gas under pressure which
compresses surrounding lung. Since direct evidence is
lacking, we have performed percutaneous puncture of
bullae in four patients immediately before thoracotomy.
Gas samples for analysis of PBO2 and PBCO2 were
withdrawn during spontaneous ventilation and at one
minute intervals during oxygen wash in. Simultaneous
arterial blood gas samples were taken. In three patients the
intrabulla pressure (Pbul) was recorded, combined in two
cases with oesophageal pressure (Poes) and later with
airway pressure (Paw) during IPPV. PBO2 (12.9 (SD 0.7)
kPa) was greater than Pao2 (8.4 (1.3) kPa). After four
minutes of oxygen wash in there was an increase in PBO2
(26.7 (11.5) kPa) but it was always overtaken by the rise in
Pao2 (39.2 (16.6) kPa). The inspiratory excursion in Pbul
was always negative (range -7 to -12 cm H20) and was
similar in degree and phase to Poes. During IPPV, Paw was
poorly transmitted to the bulla but did produce PEEP
within it. We conclude that during tidal breathing bullae
have patent airway communications but ventilate slowly.
The relationship between Pbul and Poes suggests that
compression is unlikely to be the cause of collapse of
peribullous lung and PEEP rather than peak Paw is the
major hazard during IPPV.
Carcinoma of the bronchus with microscopic resection line
involvement
DK KAPLAN, RI WHYTE, DAC SHARPE, RJ
DONNELLY Broadgreen Hospital, Regional Adult
Cardiothoracic Unit, Thomas Drive, Liverpool In a series
of 560 consecutive pulmonary resections for bronchial
carcinoma, unsuspected microscopic tumour was present at
the bronchial resection margin in 26 cases (4.5%).
Adjuvant chemotherapy or radiotherapy was given in two
cases. In follow-up ranging from one to 60 months (mean
16 months), 6207 of patients were alive and free of
recurrent disease. Twelve patients underwent periodic
surveillance bronchoscopy in an attempt to identify early
local recurrence. Ninety-two per cent of these patients were
alive and disease-free in follow-up from four to 49 months
(mean 18 months). No cases of local recurrence were
identified. It was concluded that microscopic residual
resection-line tumour does not preclude prolonged survival
and that no benefit from surveillance bronchoscopy could
be demonstrated in this small patient sample.
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Management of tracheal lesions
K MOGHISSI Humberside Cardiothoracic Surgical Centre,
Castle Hill Hospital, Cottingham, N. Humberside
Eighty-seven patients with tracheal lesions are reviewed.
These are divided into Group one (n = 32) non-neoplastic
and Group 2 (n = 55) neoplastic lesions. Twenty-six of
Group one patients had post-intubation tracheal stenosis,
of whom 23 had resection and reconstruction with one
hospital death (4.3170) and one late recurrence; 21 patients
are well after 5-16 years: three other patients with stenosis
were treated by endoscopic Nd YAG laser with complete
success. One patient with amyloid tumour was treated
successfully by endoscopic laser, two with tracheomalacia
were treated conservatively and two remaining patients with
traumatic rupture underwent operation; all are alive and
well. Group two patients are subdivided into 2a (n = 18)
primary tumours, 2b (n =5) bifurcation lesions and 2c
(n = 32) with secondary tracheal tumours: 47 of Group 2
patients had resection and reconstruction (21 with patch
graft of Marlex mesh + pericardium); five died (10.607)
and 10 (2107) survived more than five years. Six remaining
patients had laser therapy with or without radiotherapy.
We conclude: 1) The majority of tracheal lesions require
excision and reconstruction, some with a patch graft. 2)
Some lesions can be treated by laser and achieve a cure
(when benign) or a good palliation (when malignant).
Postpneumonectomy achalasia of the cardia - a new
entity?
K MOGHISSI, PB RAJESH Humberside Cardiothoracic
Surgical Centre, Castle Hill Hospital, Cottingham, N.
Humberside Primary idiopathic achalasia of the cardia
and its variants is well documented in the literature.
Secondary achalasia is, however, rare. Achalasia occurring
after major pulmonary surgery has not been reported. In
this paper we present four patients with achalasia of the
cardia after pneumonectomy. There were three male and
one female, age range 52-63 (mean 57.5) at the time of
operation. There were three right and one left
pneumonectomies and at the time of operation no
complaints or abnormalities referrable to the alimentary
tract were recorded. The time lapse between
pneumonectomy and the presenting symptoms were from 9
to 18 years (mean 14.25 years). In three patients the
diagnosis was made endoscopically and radiologically; in
one (living) patient the diagnosis was further confirmed by
manometric and isotope scan. We believe that interference
with the vagus nerves is the basis of the secondary
achalasia, after pneumonectomy. All patients in this series
were treated by repeated oesophagoscopy and dilatation.
Open lung biopsy in patients with Hodgkin's disease and
pulmonary infiltrates
JR CATTERALL, RE MCCABE, JS REMINGTON Division of
Infectious Diseases, Stanford University Medical Center,
California; Department of Respiratory Medicine,
Edinburgh We have reviewed the results of open lung
biopsy (OLB) in 41 patients with previously diagnosed
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Hodgkins's disease (HD: 17 with stage II; 10, stage III; and
14, stage IV) who were found to have pulmonary
opacification on chest radiography. Nineteen (46%o) of the
diagnoses from OLB were specific and 22 non-specific. The
most common specific diagnosis was Hodgkin's disease (12
patients), the others being P carinii pneumonia (3), solitary
fungal granulomas (2), cytomegalovirus pneumonia (1) and
adenocarcinoma (1). Specific diagnosis were made in 11
(69%) of the 16 patients with nodules or masses on chest
radiography but in only eight (32%) of the 25 patients with
non-nodular radiographic opacification. Eleven (58%) of
19 patients who were asymptomatic or had had symptoms
for > four weeks had specific diagnoses, compared to one
of six patients (17%) symptomatic for < one week.
Survival of hospitalisation correlated more with stage of
HD than with specific diagnosis. However, treatment was
changed on the basis of the OLB result in 18 (4407) of the
patients biopsied. Three of the patients with a non-
diagnostic OLB had progressive infiltrates which were
diagnosed as HD, either by necropsy or sputum cytology,
3-16 months later. Three patients had increased respiratory
failure after OLB but no complication could be attributed
unequivocally to the procedure. These results suggest that,
in HD, OLB can help in the management of pulmonary
radiographic opacities, especially if the radiographic
opacities are nodular and the patient's condition is
relatively stable.
Comparison of CT scanning, 57cobalt bleomycin scanning
and barium swallow in assessment of the mediastinum in
lung cancer
CG WATHEN, KM KERR, A MILLAR, AJA WIGHTMAN, JJK BEST, EW
CAMERON, NJ DOUGLAS City Hospital and Royal
Infirmary, Edinburgh Accurate non-invasive assessment
of mediastinal lymph node involvement in patients with
lung cancer would decrease the need for mediastinoscopy
and thoracotomy. Fast breath-hold CT scanning is thought
to be the most accurate method (Mintzer et al, Radiology
132:653-9) but others have proposed that 57cobalt-
bleomycin scanning is superior (Nieweg et al, Thorax
1983;38:16-21), although no direct comparison has been
done. In Edinburgh mediastinal nodes are traditionally
assessed by barium swallow, but no prospective evaluation
has been reported. Thirty-one patients with proved tumours
have entered a prospective study comparing barium
swallow, 57cobalt-bleomycin scanning and GEC 8800 CT
scan with enhancement prior to mediastinoscopy and/or
thoracotomy with lymph node exploration. Nine had
histologically positive mediastinal lymph nodes. The results
are:
Sensitivity Specificity Neg Prediction
CT 78% 58% 83%
57Co-bleo 33% 60' 68%
Ba Swallow 22% 67% 70%
Where neg prediction = true negative - total negative x 100
While CT scanning has the highest sensitivity, if non-
invasive assessment is used to select patients to proceed to
thoracotomy without mediastinoscopy, these preliminary
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results show that the negative predictive power of the
barium swallow is not significantly worse than that of the
more expensive alternatives. 57Cobalt-bleomycin scan
seems to have little role in mediastinal staging.
The nutritional status of patients undergoing surgery for
lung cancer
Y BASHIR, TR GRAHAM, A TORRANCE, P BUAMAH, GJ GIBSON, CJ
HILTON, GN MORRITT, PA CORRIS Departments of
Respiratory Medicine and Thoracic Surgery, Freeman
Hospital, Newcastle upon Tyne Both malnutrition and
inadequate perioperative nutritional support have been
shown to correlate with increased morbidity in patients
undergoing general surgery (Surg Clin N Am
1981;61:465-487). Since both malignant disease and chronic
airflow obstruction predispose to nutritional deficiency we
have assessed the nutritional state of 39 consecutive patients
with bronchial carcinoma prior to surgery. Eighteen
patients (4607) fell below the 25th percentile for body mass
index and for triceps/subscapular skinfold thickness,
indicating depleted energy reserves; in 23 patients (591o) the
creatinine-height index was below 80%o predicted,
indicating low static protein reserve. Although mean (SD)
albumin level for the group was 40.3 (0.57) g/l and only
three patients had subnormal levels, serum transferrin was
reduced with a mean (SD) value of 1.77 (0.1) g/l (Ref 2-3
g/l). Moreover sequential measurements of transferrin and
prealbumin (which is a circulating protein with a half life of
only 24 hours) at 48 hour intervals up to the sixth
postoperative day showed progressive depletion of both
proteins, suggesting that nutritional support following
surgery was inadequate over this period. In this series four
patients developed bronchopleural fistulae; all had
significant protein-energy depletion preoperatively and two
died. We conclude that protein-energy malnutrition
occurred commonly in this series of patients undergoing
surgery for lung cancer and that routine postoperative
feeding failed to prevent further depletion of circulating
proteins over the first week. Prospective studies are needed
to determine whether preoperative nutritional screening can
identify patients at risk of increased morbidity and
mortality following surgery for lung cancer.
A radiographic scoring system to assess diffuse pulmonary
shadowing in sarcoidosis
MF MUERS, WG MIDDLETON, GJ GIBSON for BTS Sarcoidosis
Subcommittee A method of radiographic assessment,
suitable for serial and between patient comparison of
subjects recruited for the BTS Sarcoidosis Study, has been
devised and evaluated. Radiographic assessments were
made of a) the predominant abnormality (reticulonodular,
micronodular, confluent or fibrotic), b) any subsidiary
abnormality and c) presence of hilar and mediastinal
lymphadenopathy. The extent and profusion of each type
of pulmonary abnormality was scored on a four point scale.
The method was tested on 169 entry radiographs by two
independent readers. Inter-observation variation was 7.6%7o
for predominant abnormality, 16.5%o for the presence of
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subsidiary abnormality and 15% for the presence of
adenopathy. In 422 comparisons of scores given for extent
and profusion a one point discrepancy occurred on 139
occasions (337o) and two point discrepancy occurred on
seven occasions (1.6%). Blind comparison of 55 patients in
whom the pulmonary abnormality had improved
spontaneously at six months and 58 patients with static or
worsening pulmonary shadows showed that the latter more
often had fibrotic shadowing at presentation (14 vs 2:
p =0.004), 'had a higher total score 10.6 (4.1) vs 8.6 (4.9):
p = 0.023) and were less likely to have adenopathy (30 vs 40:
p = 0.035).
Numbers and activity of cells obtained at bronchoalveolar
lavage (BAL) from sequential aspirates in sarcoidosis
CA KELLY, C WARD, G BIRD, DJ HENDRICK, EH
WALTERS Department of Medicine, Newcastle General
Hospital, Newcastle on Tyne There is increasing interest
in the involvement of a variety of cell types in the
pathogenesis of sarcoid. We studied cell numbers and
metabolic activity in the separate aspirates (Al, A2, A3) of
three sequential 60 ml aliquots of sterile buffered saline
introduced into a middle lobe segment in eight patients with
biopsy-proved sarcoid and in eight normnal controls.
Differential and totail cell counts were performed prior to
centrifugation. Cell pellets were resuspended in medium
199 at a concentration of 5 X 105 cells/ml. After 5% latex
stimulation, we measured chemiluminescence (CL) in each
of the suspensions using an 'LKB 1250 luminometer.
Luminol was used to enhance neutrophil (PMN) CL, and
lucigenin to enhance macrophage (AM) CL. There were
significantly more lymphocytes in patients with sarcoid in
all' three aspirates (p<0.01). There were *no other
significant differences in cell counts between controls and
sarcoid patients, although AM numbers rose (p<0.05) and
'PMN numbers fell (p<0.05) from Al to A2 in both groups.
Median (range) values for peak CL were;
Luminol CL/103PMN Al A2 A3
Controls (n = 8) 0.36 (0.1-0.9) 0.25 (0.1-0.7)' 0.29 (0.1-0.7)*
Sarcoid (n= 8) 0.42 (0.1-0.9) 0.64 (0.4-3.2)* 0.58 (0.1-2.4)*
Lucigenin CL/I106AM Al A2 A3
Controls (h=8) 8 (1-20) 7 (1-30)* 8 (1-30)*
Sarcoid (n=8) 14 (1-30) 22 (13-100)* 29 (4-70)*
Wilcoxon rank test ' p<0.05.
Luminometry provides evidence of an increase in both
PMN and AM activity in sarcoidosis which is most marked
and significant ohly in A2 and A3, while the increase in
lymphocyte numbers in sarcoid appears less specific.
* Autologous mixed lymphocyte reactions probe macrophage
function in sarcoidosis
M SPITERI, LW POULTER Departments of Thoracic Medicine
and Immunology, Royal Free Hospital and School of
Medicine, London Alveolar macrophages from healthy
subjects are poor stimulators of autologous mixed
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lymphocyte reactions (AMLR) (Lipscomb et al, J Immunoi
1986;136:497). As sarcoidosis is characterized by a
lymphocytosis seen in lavage and the activation of these
cells, the question arises as to whether changes in the
macrophage or lymphocyte populations present in this
disease state are responsible. It is also unknown whether
any aberrations in cell-interaction are restricted to the lung.
The studies reported here address these questions. BAL and
peripheral blood mononuclear cell (PBMC) suspensions
were obtained from five sarcoid patients and five healthy
volunteers. These two populations were cultured in AMLR
either separately or mixed together. In mixtures of BAL
and PBMCs, preincubation of one' population with
mitomycin C was used to create "one way" reactions. All
cultures were for four days followed by an 18 hour pulse
with tritiated thymidine. Results revealed that, as with
normal cells, BAL populations from sarcoid patients
exhibited reduced AMLR reactivity when compared with
PBMC cultures from the same individual. One-way
AMLRs with cross-over mixtures of PBMC and BAL from
the same patients showed that the ability of BAL non-
lymphoid cells to stimulate PB lymphocytes was also
impaired. This result, and a subsequent observation that
PBMC treated with mitomycin C are unable to stimulate
lavage lymphocytes, suggest that both lymphoid and non-
lymphoid cells in sarcoid BAL are compromised.
Expiratory lung crackles in patients with fibrosing alveolitis
MJ WALSHAW, M NISAR, MG PEARSON, PMA CALVERLEY, JE
EARIS Regional Thoracic Unit, Fazakerley Hospital,
Liverpool Late inspiratory crackles are a constant and
diagnostic feature of fibrosing alveolitis, but the prevalence
of expiratory crackles has not been described. To
investigate this, lung sounds were recorded in 13 patients
(mean age 67 years) with fibrosing alveolitis (10
cryptogenic, three autoimmune). All had restricted PFTs
(mean FVC 63%) and a low TLCO (mean 480/o) and none
produced sputum. Recordings were made at the right lung
base during tidal breathing with the patient seated, using a
high sensititivy crystal microphone. Airflow was measured
with a pneumotachograph. Signals were stored on a FM
tape recorder and reproduced on a chart recorder. All
patients had late inspiratory crackles in every breath.
Expiratory crackles occurred in 12 patients and 84%'took
place in the last two thirds of expiration. No patient had
more than five crackles in any on expiration and 70%
contained at least one crackle. Varying* the pattern of
respiration (deep breathing, breathing to'residual volume,
measurement after breath holding) did not alter the
prevalence or distribution of crackles. The proportion of
expirations containing crackles was inversely related to the
TLCO (p<0.05). Expiratory lung crackles are a common
physical sign in fibrosing alveolitis. They are easier to
measure than the more'numerous inspiratory crackles and
appear to be related to disease severity. Further work needs
to be done to assess their significance and aetiology.
Airflow obstruction in sarcoidosis: its development in
smoking and non-smoking populations
R COATES, E NEVILLE Department of Medicine, Saint
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Mary's Hospital, Portsmouth Serial respiratory function
tests were examined in smokers and non-smokers with
sarcoidosis to study the frequency and progression of
airflow obstruction in these populations. Restrictive defects
are well described in sarcoidosis, but airways obstruction is
increasingly recognised. Large airway obstruction
(bronchostenosis) does occur in sarcoidosis, but is
fortunately rare, and small airways function has also been
studied. However, no longitudinal study has been
performed. Thirty patients with histologically proved
sarcoidosis have been studied retrospectively over a period
between eight months and 21 years (median four years).
Chest radiographic abnormalities included eleven (37%)
stage I, three (10%) stage II and sixteen (53%) stage III. Of
14 smokers, nine (641o) had FEV/VC - 70% at the most
recent follow up, while five of 16 non-smokers (31%) had a
similar obstructive defect. At presentation, only seven had
FEVI/VC - 70%, and six were smokers. FEV1 and VC
both deteriorated in eight (60%) smokers and seven (44%)
non-smokers; FEV, alone fell in one smoker and two non-
smokers. One smoker and two non-smokers had asthma.
Steroid therapy was given to ten smokers and nine non-
smokers. We conclude that airflow obstruction is
significantly worse and more frequent in smokers
presenting with sarcoidosis (43%) than in non-smokers
(6%) and becomes more common during follow up (64io
and 31% respectively). However, one third of non-smoking
patients with sarcoidosis developed airways obstruction
during follow-up in this series.
Fine structural changes in idiopathic pulmonary
haemosiderosis
B CORRIN, A DEWAR, M JAGUSCH, MF TUNGAKAR, M TURNER-
WARWICK, JO WARNER, D EMPEY Cardiothoracic Institute,
Brompton and London Chest Hospitals, London Lung
biopsy specimens from four children and two adults with
idiopathic pulmonary haemosiderosis have been examined
by transmission electron microscopy. No qualitative
differences were identified between the children and the
adults but the changes were more severe in the children. In
each case the major damage involved the capillary
endothelium and its basement membrane. Capillary
endothelial swelling, luminal narrowing and platelet
aggregation were common. The capillary endothelial
basement membrane showed focal thickening, particularly
on the thick side of the air/blood barrier, but no electron
dense deposits were identified. Degenerative changes in the
alveolar epithelium were not so marked as those in the
capillary endothelium and the epithelial basement
membrane was normal except for haemosiderin deposition.
Haemosiderin was also noted on elastin and within intra-
alveolar macrophages. Other secondary changes included
mild interstitial oedema and fibrosis. These findings
indicate that the major site of damage is the alveolar
capillary but provide no evidence of the cause of the
disease.
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Epidermal growth factor ligand binding studies in lung
cancer and in normal lung
D VEALE, N KEER, GJ GIBSON, AL HARRIS Cancer Research
Unit, Royal Victoria Infirmary, Newcastle upon
Tyne Epidermal growth factor (EGFr) binds to a receptor
(EGFr) causing phosphorylation, which in some cell types
leads to cell proliferation. The number of EGF, on tumour
cells is related to the staging of squamous lung cancer
(Veale et al, BR J Cancer, in press). We have therefore
investigated the binding of radiolabelled EGF to its
receptor in membrane preparations of normal lung and
lung tumours. Membranes were prepared by differential
centrifugation and EGFr binding was assayed using
1251-labelled mouse EGF in the presence of increasing
concentrations of non-labelled EGF. Binding sites were
saturated at EGF concentration of 5nM; at that
concentration the number of binding sites was calculated
for 22 tumour membranes and five normal lung
membranes. There were significantly more binding sites
(Bma) on the tumours (range 29.9-3181 fmol/mg protein)
than on normal lung (16.25-71.8 fmol/mg
protein)(p<0.05, Wilcoxon rank sum test). Using
scatchard binding analysis on 19 of the tumours and the
five normal lung membranes we found evidence of high and
low affinity binding sites. BmaX for the high affinity sites on
tumours was significantly greater (52.6-5185 fmol/mg
protein) than for high affinity binding sites on normal
membranes (32.8-137.2 fmol/mg protein)(p<0.05). The
mean dissociation constants (Kd) of the high affinity sites
on tumours and normal membranes were 2.96 x 10-10 M
and 4.1 x 10-10 M respectively (NS). There were no
significant differences in the number of binding sites when
comparing histological types of tumours or stage by TNM
classification. We have therefore shown that lung tumours
express more EGF, than normal lung, which might provide
a targetting site for ligand bound cytotoxic drugs.
Ploidy: its significance in operable lung cancer
MH BINT, GA HAWSON, PG PARSONS, PV
ZIMMERMAN Department of Thoracic Medicine, The
Prince Charles Hospital, Brisbane, Queensland,
Australia The signficance of cellular DNA content
(ploidy) as a prognostic determinant in surgically treated
lung cancer was evaluated in 100 patients. Though ploidy of
lung cancer has previously been determined, its clinical
significance has not been established. Flow cytometric
analysis was performed on cells obtained from archival
paraffin embedded tumour blocks. Forty-five per cent of
tumours were aneuploid and 55% were diploid. Overall,
patients with aneuploid tumours had significantly shorter
survival (p<0.0005) than those with diploid tumours.
Patients with diploid tumours, without nodal involvement
at surgery (NO), were found to have particularly long
survival. Ninety-one per cent of these patients were alive at
three years compared with only 51% of patients with
aneuploid tumours and NO disease. This subset of patients
with such an excellent prognosis has not been previously
recognised. Univariate analysis showed ploidy was
unrelated to age, sex, type of operation, site of primary
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tumour, histological type or TNM stage. Cox multivariate
analysis demonstrated only nodal status and ploidy to be of
significance as prognostic indicators. Increasing nodal
status was related to shorter survival (p = 0.0001). Ploidy
was independent of the other variables and was the most
important (p<0.0005) prognostic determinant. Hence
ploidy should be taken into account in determining
management strategy, estimating prognosis, and stratifying
patient groups for clinical trials.
Surfactant-containing vesicles in rat lung tissue: a second
source of surfactant or vesicles of reuptake?
JHT POWER, TE NICHOLAS, HA BARR Department ofHuman
Physiology, School of Medicine, Flinders University,
Adelaide, Australia After isolating our normal lamellar
body fraction (lb) by isopycnic density gradient
ultracentrifugation, we diluted it to 0.25M sucrose and
centrifuged first at 8000g for 30 min, then at 80000g for 60
minutes. Electron microscopy revealed that the first pellet
(lbA) contained intact lb (diam:0.7-l.0jim), whereas the
second pellet was a mass of small vesicles (diam 0.4*m)
without lamellae. Both fractions had similar phospholipid
profiles. However, whereas IbA had a mean phospholipid:
protein ratio of 6.4 (SD 0.73, n = 12), IbB was 9.2 (SD 2.7,
n = 11). Likewise, the fractions differed in marker enzymes
with lbB having significantly greater amounts of the plasma
membrane marker 5'-nucleotidase, and lbA having a much
greater amount of the lysosomal marker
/
-glycerophosphatase. Following infusion of 3H-choline,
the specific activity-time curve of lbA was broader and
peaked earlier than that of IbB; there was no apparent
precursor-product relationship. Most interestingly, whereas
lbA contained a 15 kd protein, lbB contained a 35 kd
protein. When the rats swam for 30 minutes in
thermoneutral water, a stimulus known to release
surfactant, we obtained the following results:
IbA lbB lbA/lIbB ratio
control: 2.4 (0.37) (7) 2.2 (0.46) (7) 1.10 (0.11) (6)
30 min swim: 1.8 (0.37) (8)** 1.3 (0.43) (8)** 1.65 (0.42) (7)*
3hr post swim: 3.3 (0.52) (5) 2.3 (0.58) (5) 1.45 (0.36) (5)
*p<0.025 **p<0.01
Results are expressed as mean (SD) (pg DPPC/lOOg body
wt). Hence, although swimming releases both IbA and lbB,
IbA was depleted 29% while lbB was depleted 42%. The
pattern of recovery also differed. We conclude that there
are two distinct organelles containing surfactant in lung,
and these can be released differentially.
Pleural mesothelioma of epithelial type and pulmonary
adenocarcinoma: an ultrastructural and cytochemical
comparison
A DEWAR, M VALENTE, NP RING, B CORRIN Cardiothoracic
Institute, Brompton Hospital, London Twelve diffuse
pleural mesotheliomas of epithelial type have been
compared with 20 intrapulmonary adenocarcinomas. All
mesotheliomas were negative for epithelial mucin by
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diastase periodic acid Schiff stains and for
carcinoembryonic antigen by immunoperoxidase staining,
whereas 17/20 carcinomas stained for epithelial mucin and
15/20 for carcionembryonic antigen. Hyaluronidase
sensitive alcian blue positive material was present in 6/10
mesotheliomas and 0/20 carcinomas. Previously described
electron microscopic differences were validated, including
one which has so far received insufficient emphasis:
microvilli making direct contact through basement
membrane deficiencies with collagen fibres on the
abluminal side of tumour cells were identified in 10/12
mesotheliomas and in 0/20 carcinomas.
Significant intimal abnormalities in the muscular
pulmonary arteries of smokers
JM FERNIE, D LAMB Institute of Occupational Medicine and
University Medical School, Edinburgh Intimal changes in
muscular pulmonary arteries in man are a common and
variable features of ageing: pronounced intimal
abnormality is usually associated with specific disease
states. We have found substantial intimal changes,
unrelated to ageing, in resected lobes/lungs of 30 smokers
without significant respiratory disease (22 males, 8 females:
age range 46-74 years: FEV1% predicted range 47-119%).
The area of arterial intima was measured using a digitiser
and expressed as a proportion of the area enclosed by the
internal elastic lamina (IEL), correcting for constriction
(intima index). Arteries were subdivided into four size
groups (based on length IEL), and mean intima indices
calculated for each. For the smallest size group (.600um
length IEL) the mean intima index (II600) ranged from 0.09
to 0.34. Half the patients had values >0.20 - i.e. > 20%
lumen occulusion. Intimal abnormality was unrelated to the
presence of tumour or to macroscopic emphysema. 11600
values were significantly correlated with microscopic
emphysema (expressed as alveolar wall surface area per unit
lung volume), smoking (expressed as pack years) and
FEV1% predicted. The latter two factors were also
significantly associated with intimal abnormality in arteries
measuring 601-1200pm length IEL. Smoking and
respiratory function appeared to be the key factors in these
relationships.
Ultrastructure of the alveolar wall before and after
cardiopulmonary bypass
PS HASLETON, L MCWILLIAM, A WEBSTER, RAM
LAWSON Department of Pathology and Surgery,
Wythenshawe Hospital, Wythenshawe, Manchester Ten
patients with angina of effort but no evidence of congestive
cardiac failure had after informed consent pre and post
bypass lung biopsies. The prebypass biopsy specimens were
ultrastructurally normal. Post bypass a series of changes
were seen. The type I cells showed an increase in
micropinocytosis with the formation of numerous vesicles
in their cytoplasm. The luminal surfaces developed variable
numbers of surface, finger-like protrusions. There was an
increase in the mitochondria. In two caes there was focal
necrosis of type I cells, leaving a bare basement membrane.
 group.bmj.com on May 11, 2010 - Published by thorax.bmj.comDownloaded from 
Proceedings
These latter structures showed some oedema. The
endothelial cells showed focal electron lucency suggesting
early degenerative change.
A self management plan in the treatment of asthma
CRW BEASLEY, ST HOLGATE Medicine I, Southampton
General Hospital, Southampton In this open prospective
study we have investigated whether routine assessment of
peak expiratory flow rate (PEFR) in association with a self
management plan based on inhaled corticosteroid use is
effective in the management of asthma. Thirty-six
consecutive adult asthmatic patients attending an
outpatient chest clinic were studied. All patients were
treated with inhaled salbutamol and beclomethasone (B)
and the dose of B was adjusted to a maximum of 2 mg/day
in an attempt to achieve normal lung function. Patients
measured PEFR each morning. If PEFR dropped by
>30% from predicted normal values or previous baseline
(if greater than predicted), the dose of B was doubled until
PEFR returned to normal. If PEFR fell by> 50% in those
patients confident to self administer oral steroids,
prednisolone was started at 40 mg/day until PEFR returned
to normal, then 20 mg/day for the same number of days. In
all patients, if PEFR fell to 150-200 I/min, they contacted
emergency medical assistance. In the 30 patients who
completed the trial, comparison was made between the six
months prior to and the six months following intervention
with the self-management plan. There was a significant
improvement in predicted FEVy (76% (5%) vs 92% (4%),
p<0.00l), reduction in nights woken per two weeks (4.3
(1.0) vs 0.7 (0.5), p<0.001) and days lost from work per six
months (12.9 (3.1) vs 1.7 (1.0), p<0.01). We conclude that
routine measurement of PEFR in association with a self
management plan based on inhaled corticosteroid use is
effective in the management of adult asthma.
Survey of domiciliary nebuliser use on the Isle of Wight
D MURPHY, S HOLGATE St. Mary's Hospital, Newport, Isle
of Wight, and University of Southampton There is
considerable concern over the use and abuse of home
nebulisers for the bronchodilator treatment of airways
disease. In this study we report the evaluation of
domiciliary nebuliser use covering all ages in a well defined
population on the Isle of Wight. A questionnaire was
administered to 167 known users of nebulisers and all were
returned. The indication for nebuliser therapy was asthma
(137), bronchitis (32), and emphysema (30). Twenty-three
had never had a metered dose inhaler prescribed and, of the
others, 13 had never had instruction in its use. One hundred
and fifty-three had used the nebuliser within the previous
year and, of these, instruction was provided by
physiotherapist (87), general practitioner (30), nurse (19)
and hospital doctor (6). Nine received no advice. The drugs
used comprised mostly salbutamol (140) and sodium
cromoglycate (51). Twenty-six mixed medicines for use in
the nebuliser and 24 admitted to exceeding the
recommended dose. Side effects reported most frequently
were tremulousness (44), palpitation (32), throat
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discomfort (20). Twenty-three patients had a peak flow
meter available at home. With treatment failure 108 would
call a doctor or report to hospital, while 25 would persist
with nebuliser therapy. Thirty-two patients had no help at
home in the event of an emergency. While the
overwhelming opinion of these patients was that they
benefited greatly from nebuliser treatment at home, it is
clear that better monitoring of its need, efficacy and safety
is advisable.
The use of nebulised salbutamol by ambulance personnel
LS HILL Warwick Hospital, Warwick By June 1983 all 46
emergency ambulances of the Warwickshire Ambulance
Service were equipped with Inspiron nebulisers, driven by
oxygen at six litres per minute. The crews were trained to
recognise appropriate indications for the administration of
2.5 mg salbutamol nebules. The first one hundred usages
were evaluated by analysis of specially written crew reports,
a questionnaire completed during transfer and subsequent
hospital records. Ninety-four administrations were for
asthma. By arrival in hospital 87% were subjectively
improved, 12% unchanged. Only one patient deteriorated
(and was ventilated on arrival). Six per cent of
administrations were inappropriate (three myocardial
infarcations, three LVF). However in no case did the
admitting clinician consider that the patient had been
adversely affected. The ventilated patient would probably
not have survived the eighteen mile journey without
bronchodilator and oxygen. Salbutamol nebulised in
oxygen appears a simple, safe and effective therapy when
administered by trained ambulance personnel. It is
particularly appropriate for a service covering a wide rural
area with prolonged transfer times. An unexpected but not
unsurprising benefit was a considerable improvement in
morale and job satisfaction in the crews.
Video education for patients who use inhalers
EMT MULLOY, MK ALBAZZAZ, ARH WARLEY, JE
HARVEY Bristol Chest Clinic, Bristol The use of
pressurised aerosol inhalers is often limited by inadequate
patient technique. We therefore investigated whether the
viewing of an eight minute educational video improved
patients' inhaler technique and understanding of their
inhaler therapy. Two groups of patients taking regular
inhaled drugs were invited to participate; 64 were attending
the Bristol Chest Clinic, 69 were attending their general
practitioners. Forty-five chest clinic but only nine general
practice patients completed the study. All patients had
initial assessment of lung function, inhaler technique and
knowledge of their therapy. Half of them (Group A) then
saw the video, were re-assessed six weeks later and saw the
video a second time before a final assessment at 12-16
weeks. Group B had two baseline assessments six weeks
apart before being studied in the same manner as Group A.
Both groups of patients showed significant improvements
in inhaler technique and comprehension only after seeing
the video, with further improvement after a second
viewing. There were no significant changes in PEFR, even
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in those with bad initial technique. Recruitment and
compliance was poor in general practice patients. Regular
showing of educational videos may be a useful addition to a
chest clinic.
Hospital asthma management: a comparison between
general medical units with and without a respiratory input
CE BUCKNALL, C ROBERTSON, RD STEVENSON, F
MORAN Department of Respiratory Medicine, Royal
Infirmary, and Department of Mathematics, Strathclyde
University, Glasgow Full details including admitting ward
were available for 77% (150) of all asthma admissions in a
prospective audit of hospital asthma management. Cases
could be subdivided into 64 admitted to general wards with
a respiratory input (A) and 86 to similar wards without such
specialist interest (B). Cases in A and B were similar in
terms of age, previous severity of asthma, previous
treatment and initial pulse rate. Fewer cases in B were
treated with oral corticosteroids (A 83%, B 67%; p = 0.04),
had regular peak flow recordings made (A 73%, B 42%;
p<0.005) or review planned (A 92%, B 56%; p<0.005)
and fewer had their regular inhaled therapy increased after
discharge (A 55%, B 28%; p<0.005). These differences in
management were associated with more cases from B
reporting sleep disturbances (A 23%, B 41 %; p = 0.03),
morning chest tightness (A 37%, B 55%; p=0.03) or
wheeze on one flight of stairs (A 34%, B 58%; p<0.005) at
interview 13 days later. In addition 20% of cases first
admitted to B were readmitted within the year compared
with 2% for A. The better outcome in cases admitted to A
shows that the more intensive management practised in
these wards is worthwhile.
Difficulties in establishing a regional adult cystic fibrosis
unit
AK WEBB Monsall Hospital, Newton Heath,
Manchester In 1982 an Adult Cystic Fibrosis Unit was set
up at Monsall Hospital to receive adolescents from the two
main Manchester childrens' hospitals. By March 1987
approximately 100 CF patients had been referred to the
adult clinic from all over the North West. B.T.S
recommendations are that there should be a Regional CF
Unit. Such units require allocated beds, extra
physiotherapists, social workers and specified monies to
meet drug costs. Overall financing far exceeds a district
budget. Practical regional support is essential but not easily
given. The efforts to obtain regional support for an adult
CF clinic in the North West are described and may be of
assistance to other chest physicians.
Plasma levels of atrial natriuretic peptide in primary
pulmonary hypertension
A MORICE, J PEPKE-ZABA, L DAVIES, M BROWN, T
HIGENBOTTAM Clinical Pharmacology Unit,
Addenbrookes Hospital, and Respiratory Physiology
Laboratory, Papworth Hospital Atrial natriuretic peptide
(ANP) is released into the circulation in response to atrial
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distension, and plasma levels are elevated in pathological
states such as congestive cardiac failure where right atrial
pressure is known to be elevated. We have investigated by
selective plasma sampling ANP levels in patients with
primary pulmonary hypertension (PPH) both at rest and
during infusion of prostacycline (PGI). Eight patients (age
32-59 years) with PPH were studied during right heart
catheterisation. Right atrial (RA), pulmonary artery (PA),
and mean systemic artery pressures (MAP) were recorded
using a Swan-Ganz catheter and a Roshe pressure monitor.
Plasma ANP was estimated by radioimmunoassay after
preliminary acetonitrile extraction. Pulmonary artery
pressures were elevated in all patients. Mean (SD) PA
pressure was 74.3 (12.7) mm Hg. In contrast MAP was 69.6
(7.5) and RA 8.6 (5) mm Hg and pressures were not
significantly altered by PGI infusion (200-600 ng/min): PA
74.2 (15.5), MAP 76.8 (14), and RA 8.1 (5.9). Plasma ANP
(NR during rest < 10 pmol/l) was elevated in all but one
subject: RA 36.9 (21.9), PA 48 (34.7), and systemic artery
36.9 (21.6) pmol/l. Plasma ANP was not significantly
changed by PGI infusion. Because RA pressure is not
significantly raised in these subjects the cause of their
elevated plasma ANP is obscure and it is probable that
mechanisms other than right atrial distension are
responsible for the increased plasma levels of ANP seen in
PPH.
Users, use and usefulness of ventilation-perfusion lung
scans In the management of suspected pulmonary embolism
CR SWINBURN, CB CLAYTON Departments of Medicine and
Medical Physics, Royal Victoria Infirmary, Newcastle upon
Tyne Between 150 and 250 ventilation-perfusion (4/Q)
isotope lung scans are performed annually at this hospital.
To establish the source of requests for these scans, the
accuracy of clinical estimates of the likelihood of
pulmonary embolism (PE) and the impact of the scan
results on management, a questionnaire was prospectively
completed by the requesting doctor to accompany all
requests for in-patient /4i scanning over a six month
period. Sixty scans were requested, 49 by physicians and 11
by surgeons. Clinically, PE was thought to be unlikely in 25
and probable in 35 patients. Overall, 44 scans were reported
as negative (strongly in 26) and 16 as positive (strongly in
11). The scan result supported the clinical impression of
unlikely PE in 23/25 (92%), but in only 14/35 patients(401o) felt on clinical grounds to probably have PE was the
scan concordant (p<0.01). Surgeons were significantly
better (p<0.05) in their clinical assessment than physicians,
but junior and senior doctors did not differ. Anticoagulants
were started in nine and stopped in eight patients because of
the scan result. No patient proceeded to angiography. In
conclusion, a "near categorical" report was given in 37
patients (62%). Anticoagulation was altered in the light of
the report in 17 patients (28%). The results also indicate
that clinically (as judged by the scan results) we appear able
to confidently predict when PE is unlikely but that we may
be inaccurate when we feel PE is clinically probable.
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Abnormalities of pulmonary function in primary
pulmonary hypertension (PPH) and chronic
thromboembolic pulmonary hypertension (TEPH)
J SCOTr, C COUTTS, J WALLWORK, T HIGENBOTTAM Papworth
Hospital, Cambridge The diagnosis of pulmonary
hypertension is often delayed; breathlessness, a common
initial symptom, is commonly attributed to other causes.
Pulmonary function tests (PFTs) including gas transfer for
carbon monoxide (TLCO) can be normal (CM Burke et al,
Thorax 1987;42:131-135). We have questioned these data,
suspecting that patients with advanced disease may be
mistaken as having a restrictive ventilatory defect on
function testing. Twenty-nine patients are reported, all with
clear radiographs; 11 had pulmonary angiographic or
histological evidence of thromboembolic disease and 18 had
normal V/Q lung scintigraphy. All patients had mean
pulmonary artery pressures above 40 mm Hg.
Mean % predicted FEVI VC TLC TLCO
(SD)
TEPH (n= 11) 86.3 (23.4) 86.1 (20.3) 86.9 (18.4) 62.3 (11.4)
PPH (n= 18) 84.5 (18.8) 89.3 (19.6) 99.4 (12.7) 64.7 (18.0)
There was a general reduction of dynamic lung volumes
FEVI, VC and also TLC; for the latter 50% TEPH and
26% PPH were lower than 1 SD of mean predicted. The
TLCO was markedly reduced: 100% TEPH and 84% PPH
lower than 1 SD below this mean predicted. Caution must
be observed when interpreting PFTs in breathless patients
showing reduction in lung volumes and TLCO.
CT determined main PA diameter does not predict PA
pressure in pulmonary hypertension
NR MOORE, JP SCOTT, CDR FLOWER, TW
HIGENBOTTAM Departments ofRadiology and Respiratory
Physiology, Addenbrooke's and Papworth Hospitals,
Cambridge Computed tomography (CT) measurement of
main pulmonary artery (PA) diameter has been proposed as
a method of assessing PA pressure. We have compared
these measurements in two groups of patients with
pulmonary arterial hypertension. Ten patients (3 male, 7
female; mean age 37.6 years) had pulmonary vascular
disease comprising seven with primary pulmonary
hypertension (PPH) and three with thromboemboli and
five had chronic obstructive airways disease (COAD). The
mean PA pressure of the PPH group (69 mm Hg, SD = 9)
was significantly greater than the COAD group (35 mm Hg,
SD = 9): p<0.001. The CT PA diameters were corrected for
body surface area (BSA). There was no difference in the PA
diameters (PPH = 36 mm, SD = 6; COAD = 33 mm,
SD = 5). Non-parametric analysis showed no correlation
between mean PA pressure and PA diameter and no
correlation between age and PA diameter for either group.
Patients with PVD showed a weak positive correlation
between PA diameter and pulmonary vascular resistance
(PVR), and a weak negative correlation with cardiac output
(CO). There were no correlations in COAD. No
relationship was observed between total lung capacity and
PA diameter.
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Altered lung vascular permeability during the early stages
of intermittent haemodialysis
D BELL, M JACKSON, AM MILLAR, JJ NICOLL, R WINNEY, AL
MUIR Departments of Medicine and Medical Physics,
Royal Infirmary, Edinburgh Hypoxia during
haemodialysis is associated with complement activation and
pulmonary neutrophil margination (N Engl Med,
1977;769-774). Although hypoxia is partly due to
hypoventilation (J Appl Physiol, 1981;259-264), this does
not explain the varying hypoxaemia produced by differing
dialyser membranes. We used a dual isotope method (J Clin
Invest, 1980;869-877) to measure pulmonary vascular
permeability in eight patients (age 17-61 years) on chronic
haemodialysis. Indium (1l3mln) transferrin was the protein
marker. The blood pool marker was technetium (99%Tc) red
blood cells. Transient leucopenia developed in all patients.
The mean WBC pre-dialysis was 6.49 (SD 2.67) x 109/1; it
fell maximally 15 minutes after commencing haemodialysis,
(1.28 (0.51)x 109/l, p<0.001) and recovered within 90
minutes. Po2 fell significantly from pre-dialysis (12.83
(1.72) kPa) compared with the maximal fall during dialysis
(10.56 (1.39) kPa, p<0.001), which always occurred during
the leucopenic phase. During this period, indices of lung
permeability and ratio of In/Tc lung increased significantly
in all patients (1.13 ± 1.27) compared with pre-dialysis
(0.06 ± 1.81, p<0.05), as did lung/heart ratio (1.64 x 10- 3
+ 2.3) compared with pre-dialysis values (-1.41 (3.39),
p<0.05), although lung/heart ratio increased in only four
patients. These results suggest increased lung permeability
during the leucopenic phase of haemodialysis and may
further explain the development of hypoxaemia.
Effect of inhaled leukotriene C4 on cardiopulmonary
haemodynamics in man
MK ALBAZZAZ, S SHAKIR, JM REID, HJ DARGIE, KR
PATEL Departments of Respiratory Medicine and
Cardiology, Western Infirmary, Glasgow In animals
leukotriene C4 (LTC4) causes increase in the mean
pulmonary artery (PAP) and pulmonary capillary wedge
(PCWP) pressure with decrease in cardiac output (Qp) and
oxygen tension (Pao2) (Ahmed et al, Am Rev Respir Dis
1985;131:554-558). In asthmatic patients LTC4 inhalation
causes significant arterial oxygen desaturation before
bronchoconstrictor response is observed (Albazzaz and
Patel, JAllergy Clin Immunol 1987;79:140). In the present
study we have measured the changes in cardiopulmonary
haemodynamics and arterial blood gases after LTC4
inhalation in seven patients undergoing right heart cardiac
catheterisation. After baseline measurements, each patient
inhaled 10g of LTC4 and measurements were repeated at
5, 10 and 15 minutes. The mean Qp fell by 15% (SEM 3.9
p<0.05) Pao2 decreased from 12.7 (1.1) to 8.0 (1.1) kPa
(p<0.01) and the mean D(A-a)02 gradient increased from
2.3 (0.8) to 7.1 (0.6) kPa (p<0.01). The changes in mean
PAP, PCWP and heart rate were not significant. In two
patients given 20jg of LTC4 the PAP and PCWP increased
by 18% and 58% respectively from the baseline. The results
suggest that inhaled LTC4 has a negative inotropic effect
and causes significant hypoxaemia. The impaired gas
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exchange may result from LTC4's effect on pulmonary
vasculature and/or increase in peripheral airflow
obstruction.
Long term lung function changes in patients with
obstructive sleep apnoea during treatment with nasal
continuous positive airway pressure
IH YOUNG, M MIHALYKA, L COSTAS, CE
SULLIVAN Department of Thoracic Medicine, Royal
Prince Alfred Hospital, Sydney, N.S. W., Australia Nasal
continuous positive airway pressure (CPAP) has been
successfully used to reverse obstructive sleep apnoea (OSA)
for the last six years. The long term changes in lung
function in a group of 29 treated patients with OSA who
presented for routine testing from January to June 1986
were followed. Total lung capacity (TLC), functional
residual capacity (FRC), and residual volume (RV) were
measured by closed circuit helium dilution while vital
capacity (VC), inspiratory capacity (IC), and FEV1 were
measured by spirometry and all expressed in litres (BTPS).
Single breath transfer factor for carbon monoxide (TLCO,
ml/min/mmHg/l) was also measured. Baseline values were
recorded before the start of CPAP and a linear regression
model fitted to the per cent change from baseline of each of
the tests with respect to time (range four months to five
years).
LUNG FUNCTION RA TE OF CHANGE p VALUE FOR SLOPE
% Baseline/Year (SEM) (Rate of Change)
TLC -3.68 (1.4) <0.001
FRC -6.25 (2.3) < 0.005
RV -6.02 (2.4) <0.01
There were no significant changes in VC, IC, FEVI, or
TLCO. The significant falls in TLC, FRC, and RV were
more apparent after one year of treatment and those
patients who were initially hyperinflated tended to show
greater proportional falls in FRC and RV. These results are
consistent with changes in respiratory muscle tone rather
than any changes in lung compliance or alveolar capillary
membrane function.
Criteria for diagnosing abnormal breathing during sleep
GA GOULD, KF WHYTE, MAA AIRLIE, GB RHIND, JR CATTERALL,
CM SHAPIRO, NJ DOUGLAS Rayne Laboratory, Department
of Respiratory Medicine, City Hospital, Edinburgh The
sleep apnoea syndrome is usually diagnosed by the number
of apnoeas/hours of sleep, without reference to the
patient's symptoms, frequency of hypopnoeas,
desaturations or arousals. To try to improve on this
definition we initially performed sleep studies on 30 normal
subjects (21-68 years); all had < 13 apnoeas/hours of sleep,
< 14 apnoeas + hypopnoeas (a + h)/hour of sleep with<
2 4% desaturations/hours and < 10 arousals/hour of
sleep. We have evaluated the sleep results from 50
consecutive patients (18-70 years, 45 M) found to have
abnormal breathing during sleep and referred because of
suspicion of the sleep apnoea syndrome. All had at least
two of the following clinical features: loud snoring (42),
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excessive daytime somnolence (45), disturbed sleep (13),
morning headache or secondary polycythaemia and ankle
swelling for which no other cause is known. Thirty of the 50
patients had > 10 apnoeas/hour of sleep; the remaining 20
were clinically indistinguishable and had numerous
hypopnoeas, such that all 50 had > 14 a + h/hour of sleep
(range 16-170, mean 63, SD 34 a + h/hour). Forty-six of the
50 had more than five 4% desaturations/hour of sleep, the
four others having 0-5 desaturations/hour, mild but
significant symptoms and 18-50 a+h with 13-33
arousals/hour of sleep. The results indicate that the
occurrence of more than 15 apnoeas + hypopnoeas/hour
of sleep is the best definition of symptomatic abnormal
breathing during sleep currently available, but that
oximeter screening alone will miss a few patients with
relatively mild symptoms and slightly abnormal breathing.
Eye movement density during rapid eye movement sleep
does not alter ventilation in man
GA GOULD, M GUGGER, J MOLLOY, CM SHAPIRO, NJ
DOUGLAS Rayne Laboratory, Department of Respiratory
Medicine, City Hospital, Edinburgh The most severe
nocturnal hypoxia occurs during rapid eye movement
(REM) sleep in both the sleep apnoea/hypopnoea
syndrome and chronic bronchitis and emphysema. REM
sleep is a heterogenous state, which has been divided into
phasic REM with frequent eye movements (EMs) and tonic
REM with few EMs. There is some evidence in animals
(Sullivan, JAppl Physiol 1979;47:1304-10) and preliminary
evidence in man (Millman, Am Rev Respir Dis
1986;133:308) that ventilation and ventilatory responses
may be decreased during phasic REM and that the most
severe hypoxia during sleep in bronchitics occurs during
phasic REM (George, Am Rev Respir Dis 1985;131:302).
We have thus examined the relationship between the
number of EMs/20 second epoch in REM sleep with
simultaneous breathing pattern recorded using a face mask
(with CO2 leak detector) and a dead space of 60 ml,
connected to a Fleisch No. 3 pneumotachograph. Six male
normal subjects were studied and a mean of 119 (SD 66)
breaths during REM sleep analysed in each subject. In no
subject was there a significant correlation between EM
density and either minute ventilation or tidal volume. The
mean levels of ventilation during epochs with no EMs (6.49
(SD 0.52) 1/min) was not significantly different from that
during epochs with maximal EM density (6.64 (1.22)
1/min). Furthermore, the variability of breathing pattern
did not alter with EM density. These results suggest that the
heterogeneity of breathing pattern during REM does not
relate to eye movement density in man, contrary to
preliminary results in which ventilation was measured by
surface techniques.
Ventilation and occlusion pressure responses to added
resistance during sleep
M GUGGER, GA GOULD, J MOLLOY, CM SHAPIRO, NJ
DOUGLAS Rayne Laboratory, Department of Respiratory
Medicine, City Hospital, Edinburgh The ventilatory
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response to added resistance during sleep is important as
airflow resistance increases during sleep not only in normal
subjects but also in patients with the sleep hypopnoea
syndrome and in patients with nocturnal asthma. Iber et al
(J Appl Physiol 1982;52:607-14) suggested that the
ventilatory and occlusion pressure responses to increased
resistance were impaired during non-REM sleep, but they
studied only five breaths in five subjects. We thus measured
the occlusion pressure (P0.1) and ventilatory responses to
inspiratory resistive loading (4-10 cm H2O/l/s) during
wakefulness (W) and non-REM and REM sleep in seven
normal subjects using a face mask system with a CO2 leak
detector. Both ventilation and P0.1 were measured each
breath, using a computer driven occlusion system with
rapid off phase. The occlusion pressure increased following
the addition of both seven and 10 cm H20/l/s resistances
during both W (control 0.71 (SE 0.10), 7 cm H2O/l/s,
resistance 0.85 (0.10) cm H2O; p<0.05) and during non-
REM sleep (0.71 (0.12), 0.91 (0.14) cm H2O; p<0.05). In
the five subjects with REM studies, the same trend was
shown but was not significant (0.73 (0.20), 0.87 (0.18) cm
H20). In each sleep stage the addition of four and seven cm
H2O/l/s did not alter ventilation but in non-REM sleep the
10 cm H2O/l/s resistance decreased (p<0.05) ventilation
(6.33 (0.33), 5.94 (0.46) I/min). We conclude that contrary
to earlier reports non-REM sleep does not alter the
occlusion pressure response to added resistance but that
ventilation is decreased by high resistive loads during sleep.
Domiciliary positive pressure ventilation, using a nasal
mask, for nocturnal hypoventilation
N CARROLL, MA BRANTHWAITE Brompton Hospital,
London Nocturnal hypoventilation, associated with
respiratory or cardiorespiratory failure, was treated with
overnight positive pressure ventilation using a nasal mask.
Nine patients (6 male, 3 female), aged 41 to 67, were
studied. Seven patients had restrictive chest wall disease
with a mean FVC of 27.6% predicted. Two had severe
chronic airflow obstruction with a mean FEVY of 25.8%
predicted. The hypoventilation and consequent respiratory
failure had been uncontrolled by protriptyline and/or
negative pressure ventilation. A Lifecare PLV 100
ventilator was used overnight for between three and 12
months. Air was delivered through a tightly fitting nasal
mask, and ventilation triggered by the patient's own
inspiratory effort. Tidal volume, frequency and inspiratory
flow rate were determined by overnight monitoring. Six
patients were studied overnight. The mean O70 of total sleep
time spent with an oxygen saturation of . 80% fell from
45% to 3%. Diurnal arterial blood gas tensions also
improved. The mean Pao2 increased from 6.87 kPa (range
5.39 - 9.64) to 8.78 kPa (range 7.55 - 10.14; p =0.05). The
mean Paco2 fell from 8.2 kPa (range 6.72 - 9.84) to 6.77
kPa (range 5.44 - 7.36; p = 0.05).
First night effect in middle aged patients
MB ALLEN, K PROWSE Department of Respiratory
Physiology, City General Hospital, Stoke on Trent The
First Night Effect (FNE), which describes changes in sleep
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architecture which improve on subsequent nights when an
individual sleeps in a different environment, is recognised
by all. Studies to define the features of FNE used paid,
young adults who were monitored by electroencephalogram
(EEG) only (HW Agnew, Psychophysiology 1966;2:263-6).
The effect of age on sleep stage is well reported but
information on the FNE in middle aged and elderly patients
undergoing assessment of airflow, ventilation, oxygen
saturation and sleep is lacking. In an attempt to define the
features of the FNE we have studied six patients, mean age
of 57.6 years (range 51-69), on consecutive nights. All
patients were in good health, none took hypnotics and only
one reported problems with sleep (insomnia). Airflow,
abdomen and chest movements, ECG, oxygen saturation,
EEG (four channels), EOG and EMG were recorded by
standard, non-invasive methods. Sleep was scored in 20
second epochs and staged according to standard criteria by
one observer (MBA). There were significant (p<0.05)
increases in the time to onset of light and rapid eye
movement (REM) sleep, increased time awake and reduced
REM sleep and sleep efficiency (time asleep/time in bed) on
the first night. REM sleep is the period when ventilation is
less stable and arterial desaturation tends to occur. If REM
time is short or the sleep efficiency is poor the severity of
respiratory problems may be underestimated.
LY171883 as an oral leukotriene D4 antagonist in non-
asthmatic subjects
GD PHILLIPS, P RAFFERTY, ST HOLGATE Medicine I,
Southampton General Hospital, Southampton Leukotriene
D4 (LTD4) has been suggested as a pro-inflammatory
mediator in the pathogenesis of asthma. We have
investigated the inhibitory activity of the oral LTD4
antagonist LY 171883 (1 -(2-hydroxy-3-propyl)
-4-(4-(1H-tetrazol-5-yl)butoxy)phenyl)ethanone) on LTD4-
induced bronchoconstriction in non-asthmatic subjects, in
a double blind, placebo controlled, randomised, cross over
study. Twelve subjects, mean age 26.3 (SD 1.7) years,
participated. On four separate days, baseline measurements
of FEVY and maximum flow at 30% of vital capacity above
residual volume (4max30) were performed, following which
subjects ingested either 50 or 200 or 400 mg of LY171883,
and then undertook a dose-response study with inhaled
LTD4. Measurements of FEV1 and Ymax30 were made at
intervals for eight minutes after inhalation of each
concentration of LTD4, and increasing concentrations
administered until FEV1 had fallen by > 20%, or the
maximum concentration of LTD4 (1000 pmol/l) had been
given. Cumulative dose-response curves were constructed
on a logarithmic scale, and the provocation dose of LTD4
producing a 12% fall in FEV1 (PD12 FEV1) and a 30% fall
in Vmax30 (PD30 4max30), determined by linear
interpolation. LY171883 caused a dose-related shift to the
right of the LTD4 dose response curve in 10 of the 12
subjects, ranging from 0.7-16.2 fold with a mean of 4.6
(1.3) for PD12 FEV1, and 0.4-20.7 fold with a mean of 6.3
(1.8) for PD30 Ymax30, after the 400 mg dose. No
significant side effects were reported. We conclude that
LY171883 is an LTD4 antagonist in normal man.
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Effect of single and multiple dose therapy with azelastine
on leukotriene C4 (LTC4) and histamine (H) induced
bronchoconstriction in patients with asthma
MK ALBAZZAZ, KR PATEL Department of Respiratory
Medicine, Western Infirmary, Glasgow Azelastine (AZ) is
a new oral agent with antiallergic and anti-histamine
properties. In guinea pigs it antagonises the effect of LTC
and H. It also modifies allergen induced
bronchoconstriction in asthmatic patients (Ollier et al, J
Allergy Clin Immunol 1986;78:358-64). We have examined
the effect of AZ after a single dose (8.8 mg) and 14 days of
continuous treatment (8.8 mg BID) on LTC4 and H induced
bronchoconstriction in a placebo controlled double blind
cross over study in 10 patients with asthma. LTC4 and H
were inhaled in doubling concentrations from a dosimeter.
The results were expresed as cumulative dose (PD20)
producing 20% fall in FEVY (SEM). The mean
pretreatment baseline FEV1 was comparable on placebo
and AZ. A single dose of AZ produced significant
bronchodilatation with a mean increase in FEV1 of 10.3%
(0.67, p<0.05). The geometric mean PD20 - LTC4 (nmol)
was 0.60 and 0.59 after single dose and fortnight treatment
with placebo respectively compared to 0.65 and 0.75 after
single and fortnight treatment with AZ(NS). In contrast the
geometric mean PD20 - H(umol) was 0.51 and 0.54 after
single and fortnight treatment with placebo respectively
compared with 22.85 (p<0.001) and 15.18 (p<0.001) after
AZ. These results suggest that AZ is a potent HI antagonist
but has no effect on LTC4 induced bronchoconstriction.
Furthermore, prolonged LTC4 induced
bronchoconstriction and prolonged H, receptor blockade
in the airways does not modify leukotriene responsiveness
in asthmatic patients, suggesting an independent action of
H and LTC4 on the bronchial smooth muscle.
Ketotifen inhibits the cutaneous responses but not the
bronchoconstriction and bronchial hyperresponsiveness
induced by PAF in man
KF CHUNG, M MCCUSKER, P MINETTE, PJ BARNES Department
of Clinical Pharmacology, Cardiothoracic Institute,
Brompton Hospital, London Ketotifen, an oral
antiallergic and antihistaminic drug, is prescribed for the
prophlaxis of asthma but there are few data as to its effect
on the hyperresponsiveness of asthma. Platelet activating
factor (PAF), a potent mediator of inflammation, causes a
sustained increase in airway responsiveness to methacholine
in man. We have studied the effect of ketotifen on PAF
responses in the airways and skin in a double blind,
randomised crossover study in six normal subjects.
Ketotifen (three doses of 2 mg taken over a 24 hour period
prior to PAF) did not alter PAF-induced
bronchoconstriction, nor did it prevent the accompanying
flushing and coughing. The transient neutropenia (74.5%
(SD 4.8%) fall; p<0.001) and rebound neutrophilia (104
(55%) rise) induced by PAF were not affected by ketotifen.
Airway responsiveness to methacholine increased with
PC40, decreasing from 69.2 mg/ml (GSEM 2.69) to 23.3
mg/ml on day three (p<0.001); this was not inhibited by
ketotifen (PC40 on day three = 21.5 mg/ml (2.14)).
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However, ketotifen reduced the flare areas from 8.1 (3.6)
cm2 (mean (SEM)) to 1.1 (0.3) (p<0.05) and the wheal
volumes from 0.68 (0.10) cm3 to 0.45 (0.08) cm3 (p = 0.02)
induced by 200 ng PAF. There was also significant
inhibition of the cutaneous flare (p<0.002) and wheal
(p<0.01) responses to 1 M*g histamine. We conclude that the
bronchoconstriction and bronchial hyperresponsiveness
induced by PAF are not inhibited by ketotifen; in contrast
to the effects of PAf in the skin, these are not mediated by
histamine.
Inhibition of PAF-acether induced neutrophil and
eosinophil chemotaxis by the gingkolide-derived PAF
antagonist (BN 52021)
K KURIHARA, AJ WARDLAW, R MOQBEL, AB KAY Department
of Allergy and Clinical Immunology, Cardiothoracic
Institute, Brompton Hospital, London PAF-acether has
been shown to be a very effective chemotactic agent for
human granulocytes and may be partially responsible for
the inflammation associated with asthma and other lung
diseases. We have attempted to inhibit PAF-acether
induced in vitro chemotaxis of human eosinophils and
neutrophils by BN 52021, a specific PAF-acether receptor
binding antagonist derived from the Chinese tree Gingko
biloba. Chemotaxis was assayed using a 64 well
microchamber (Boyden technique). Normal density human
eosinophils were obtained by metrizamide separation of
leucocytes from eosinophilic subjects (7-32%). Drug was
added either to the lower compartment or both
compartments of the chemotaxis chamber and PAF-acether
(10-6 ML - 1) to the lower compartment. Mean chemotaxis
counts (10 hpf) in the absence of drug were 686 (SD 108)
eosinophils, 1534 (118) neutrophils, < 18 (5) background.
BN 52021 resulted in significant dose dependent inhibition
of eosinophil and neutrophil chemotaxis to PAF-acether
(eosinophils 10-4 M -10-7 M IC50 5xlO-6 M, n=9,
neutrophils l0-4M -10-5 M IC50 5xlO-5M, n=13).
Specificity of BN 52021 was demonstrated by its inability to
inhibit LTB4 (10-7 M) induced neutrophil chemotaxis.
Sodium cromoglycate and nedocromil sodium, two drugs
which inhibit granulocyte activation, were unable to inhibit
PAF-acether induced eosinophil or neutrophil chemotaxis.
This study demonstrates that BN 52021 might be effective
in vivo at inhibiting PAF-acether induced inflammatory
responses.
Eosinophils and eosinophil-derived proteins in allergic
asthma
SR DURHAM, S DUNNETTE, D LOEGERING, GJ GLEICH, AB
KAY Cardiothoracic Institute, Brompton Hospital,
London, and Mayo Clinic, Rochester, U.S.A. Blood
eosinophils (Eos) and peripheral concentrations of the
eosinophil-derived proteins, major basic protein (MBP),
eosinophil-derived neurotoxin (EDN), eosinophil
peroxidase (EPO) and eosinophil cationic protein (ECP)
were measured in 12 atopic asthmatics and 23 normal
controls. The same measurements were performed in six
asthmatics with previously documented dual (early + late)
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asthmatic responses after inhalation challenges with
methacholine and allergen. Eos (p<0.001), MBP
(p<0.01), EDN (p<0.01) and ECP (p<0.03) were elevated
in the asthmatics compared with the controls, whereas EPO
(p<0.01) concentrations were reduced (unpaired t test).
There were no significant differences between baseline
measurements of FEVy, Eos, MBP, EDN, EPO or ECP on
the methacholine and allergen challenge days. When the
changes in these variables after allergen were compared
with the corresponding changes after methacholine, there
were no significant differences at 0-60 minutes or at three
hours, whereas EDN (p<0.025), EPO (p<0.05) and ECP
(p<0.025) were relatively increased at 6-12 hours and
accompanied the late falls in FEVy (p<0.001) (paired t
test). Eos (p<0.025) were elevated at 24 hours, when there
was a small relative increase in MBP (p<0.05). Eosinophils
appear to be "acivated" in allergic asthmatics and further
activation may occur during late asthmatic responses.
The effects of dietary supplementation with fish oil on
neutrophil biochemistry and function, and the natural
history of bronchial asthma
JP ARM, CE HORTON, NM EISER, TJH CLARK, B SPUR, TH
LEE Department of Medicine, Guy's Hospital,
London The effects of dietary supplementation with fish
oil on neutrophil biochemistry and function and the natural
history of bronchial asthma have been studied. Twenty
subjects with mild asthma were studied. Twelve subjects
received 3.2 g of eicosapentaenoic acid (EPA) and 2.2 g of
docosahexaenoic acid (DCHA) daily, and eight subjects
received olive oil for ten weeks in a double blind fashion.
Bronchial response to histamine and exercise, diurnal peak
flow readings, symptom scores, bronchodilator usage,
neutrophil fatty acid composition, neutrophil leukotriene
(LT) B4 and B5 generation and neutrophil chemotactic
responses to f-met-leu-phe and LTB4 were assessed.
Following dietary supplementation with fish-oil, EPA
increased from being undectable to comprising 2.5%
(0.73%) (mean (SEM)) of total neutrophil fatty acids.
There was a 50% inhibition of total LTB (LTB4 + LTB5)
generation by ionophore stimulated neutrophils (p<0.01)
and neutrophil chemotaxis was markedly depressed.
Neutrophil function remained unchanged in the placebo
group. No significant changes in the clinical indices of
severity of asthma were found in either group of subjects.
Airways histamine reactivity and morning and evening
peak-flow readings were 0.32 umol (geo.mean), 485 (25) 1
min- 1, and 490 ± 27 1 min- I respectively before and 0.37
,umol, 490 (27) 1 min-1, 490 (27) 1 minm- after fish oil. In
subjects with mild asthma, a fish-oil enriched diet
attenuates neutrophil function without changing the
severity of asthma.
Heart-lung transplantation in patients with end-stage lung
disease
ARL PENKETH, J WALLWORK, TW HIGENBOTTAM
Departments of Respiratory Physiology and Surgery,
Papworth Hospital, Cambridge Combined heart and lung
transplantation was initially used to treat patients with
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primary pulmonary hypertension or pulmonary
hypertension secondary to cardiac disease. We have treated
seven patients with "end-stage" primary lung diseases. All
were severely disabled and their disease had a poor
prognosis. The underlying conditions were cystic fibrosis,
bronchiectasis, sarcoidosis, cryptogenic fibrosing alveolitis,
histiocytosis X and emphysema (2). Six patients are well, six
months to three years after transplantation. One patient
died after 44 days from a primary cytomegalovirus
infection transmitted from the donor. Lung function of the
six survivors improved progressively over four to six
months to reach near normal predicted volumes for the
recipient. All survivors have a normal exercise tolerance
and have either returned to work or are fit to do so. The
major complications have been opportunistic infections,
cytomegalovirus (3) and tuberculosis (1). One patient has
had a rejection episode, which responded to treatment.
Heart and lung transplantation offers a treatment for
suitably selected patients with "end-stage" chronic lung
disease.
Diagnosis of rejection after unilateral lung transplantation
JR PEPPER, JA READER, GJ PARFETr, JA KIRBY Department of
Immunology, St. George's Hospital Medical School,
London A series of left unilateral lung allografts were
performed between inbred PVG (RTlC donor and Lewis
(RTI1) recipient rats; the ischaemic time ranged between 32
and 50 minutes with 70% of the recipients surviving
surgery. On the basis of examination at post mortem and in
situ chest radiograph, the lungs appeared to consolidate
between four and five days after transplantation. This
rejection was more rapid than that observed for heterotopic
cardiac allografts performed using the same rat strain
combination; such grafts lost function a mean 5.9 days
after transplantation. Bronchoalveolar lavage of the lung
allografts on day four gave a yield of 7.3 (4.8) x 106 (mean
(SD); n = 9) leucocytes, of which a mean 43% were
lymphocytes. These cells were found to proliferate rapidly
in response to brief culture with recombinant IL-2,
suggesting in vivo activation, and to lyse 51Cr-loaded donor
cells without the need for in vitro pre-activation, suggesting
the presence of specific cytotoxic cells within the
bronchoalveolar space. Limiting dilution analysis of the
frequency of donor reactive cytotoxic lymphocytes has
shown a similar frequency (1/781 - 1/1283) of such cells
within both the bronchoalveolar population and that
released from the parenchyma of the lung. This suggests
that immunological analysis of the leucocytes derived by
lavage of lung allografts can provide an accurate measure
of the parenchymal events underlying acute rejection.
Comparison of techniques for lung preservation prior to
transplantation in dogs - use of bronchoalveolar lavage
(BAL)
TJ LOCKE, G JACKSON, RT PEASTON, P. MCARDLE, CGA
MCGREGOR, PA CORRIS Department of Respiratory
Medicine and University Department of Surgery, Freeman
Hospital, Newcastle upon Tyne The early function of a
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transplanted lung is critically dependent upon satisfactory
preservation during the ischaemic period. We have
compared two current methods of lung preservation in a
dog model. Seven beagle dogs underwent unilateral left
lung transplantation following six hours ischaemia. In four
the donor lung was preserved by topical cooling (TC) and
stored at 4°C. In three it was preserved by flush perfusion
using modified Euro-Collins solution and prostacyclin (EC)
and stored at 4°C. All donor animals received methyl
prednisolone 250 mg iv 15 minutes prior to excision of the
lungs. Thirty minutes following transplantation, the
contralateral right main bronchus and pulmonary artery
were ligated and animals maintained on positive pressure
ventilation at fixed settings until death or sacrifice at 24
hours. FIO2 was maintained at 407o and arterial blood gases
regularly sampled. Immediately following death, the
transplanted lung was lavaged with 60 ml saline and
samples taken for cell count, cell differential and albumin
levels. Control lavage specimens were taken immediately
following resection of the recipients left lung prior to
transplantation and all results expressed per unit volume of
lung fluid using serum and lavage urea concentrations and a
simple dilution equation. The results (meas (SD)) were:
Neutrophils Albumin A-aDo2 at I h Post Survival
(x 1091 - 1) (g l- 1) Transplant (kPa) (h)
Control n =7 0.11 (0.09) 1.5 (0.9)
EC n=3 0.26 (0.23) 6.4 (1.9) 5.7 (3.7) All sacrificed at 24 h
TC n=4 0.65 (0.30) 10.5 (2.4) 22.2 (5.8) 3.2 (1.9)
Lung vascular injury following transplantation was
characterised at BAL by neutrophil sequestration and high
lung fluid albumin concentrations. Although the numbers
are small, injury was much less in the group where lungs
were preserved by EC and these animals showed improved
early function and survival.
Transbronchial lung biopsy is effective in the diagnosis of
rejection and opportunistic infection in heart-lung
transplantation
ARL PENKETH, S STEWART, T HIGENBOTTAM, J
WALLWORK Papworth Hospital, Cambridge Most of the
long term complications of heart-lung transplantation
appear to be pulmonary. It was initially incorrectly believed
that by combining heart with lung transplantation,
rejection would be monitored by endomyocardial biopsy.
We have used transbronchial lung biopsy with fibreoptic
bronchoscopy to provide a repeatable method of obtaining
material for the histological diagnosis of opportunistic
infection and rejection of the lung. Transbronchial biopsies
were performed on 40 occasions in 18 patients. All but six
routine biopsies were performed because of respiratory
symptoms and reduced lung function. Histological criteria
for rejection were perivascular infiltrates and mucosal
inflammation (Youseman et al, Hum Pathol
1985;16:911-923). Cytomegalovirus pneumonia and
Pneumocystis carinii pneumonia were diagnosed by their
typical histological appearance. From 18 episodes of
rejection, confirmed by a symptomatic and physiological
response to augmented immunosuppression, 16 positive
sets of biopsy specimens were obtained. Two biopsies were
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falsely positive and two falsely negative. Overall sensitivity
was 88% and specificity 71%7. For opportunistic infection
sensitivity of the biopsy was 61% and specificity 100%
from a total of eight episodes of infection and 15 sets of
biopsies.
Immunomodulation by colophony, an agent causing
occupational asthma
RT CULLEN, P JOHNSON, G BROWN, CA SOUTAR Institute of
Occupational Medicine, Edinburgh Published clinical
studies have so far failed to find evidence of specific
immune responses to this agent. However, we have found
that injection of saline suspensions of Portuguese
colophony can modulate leucocyte function in C57 BL/6
mice. The in vitro production of hydrogen peroxide by
peritoneal macrophages seven days after an intraperitoneal
injection of colophony was significantly greater (p<0.02)
increased (2.35 (SD 0.31) nmol/106 cells/hour) than that of
control macrophages (1.21 (0.37) nmol). The ability of
colophony-induced macrophages to spread on glass was
also significantly (p<0.001) enhanced: saline 13.41 (7.20)
um, colophony 18.98 (8.03) pm. In further experiments we
found that intraperitoneal injection of 2 mg colophony,
two days before a subcutaneous injection of Keyhole limpet
haemocyanin in Freund's complete adjuvant, affected the
ability of draining lymph node cells to proliferate in vitro in
response to this antigen seven days later. Some variation in
this result may be related to the colophony preparation, and
is being studied further. The mechanism of this
immunomodulation is not known but may be related to the
observed activation of macrophages by colophony.
Occupational asthma: the effect on health
DC WEIR, AS ROBERTSON, S JONES, PS BURGE Department of
Occupational Lung Disease, East Birmingham Hospital,
Birmingham We have followed up 45 patients (34 male,
11 female) with occupational asthma from a variety of
causes for one to five years after presentation. Patients
were identified from positive bronchial provocation tests
and work related peak flow records held in the unit.
Symptoms were assessed by a modified MRC questionnaire
and spirometry performed. The age at follow-up ranged
from 21 to 72 (mean 48.5) years; 35 patients were taking
regular prophylactic treatment at follow-up and eight
patients were still exposed to the causative agent. The FEVy
of the group had improved significantly from (as %
predicted (SD)) 72 (24) at presentation to 77 (22) at follow
up (p<0.02) and the FVC from 85 (21) to 94 (18)(p<0.01).
However 41 % of patients complained of frequent
wheezing, and 61 /o of significant breathlessness. Fifty-nine
per cent of patients fulfilled MRC criteria for chronic
bronchitis. Patients unemployed as a result of developing
occupational asthma had significantly lower spirometry at
presentation and follow-up and were significantly more
breathless than those still employed. Complaints of
wheezing, cough and sputum were similar between
employed and unemployed groups at follow-up. The
patients with continued exposure had similar lung function
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and symptoms to the non-exposed group. Initial lung
function was higher in the non-exposed group, but did not
show the significant improvement at follow-up.
Estimated prevalence and relative risks of respiratory and
allergic symptoms in wool textile workers
RG LOVE, TA SMITH, CA SOUTAR Institute of Occupational
Medicine, Edinburgh A recent report (Thorax
1987;42:208) has demonstrated a clear relationship between
respiratory symptoms and current exposure to inspirable
wool mill dust in 2151 wool textile workers. We now
present the estimated prevalences and relative risks of
persistent cough and phlegm (chronic bronchitis), rhinitis
and conjunctivitis and grade three breathlessness in this
population in relation to dust concentration for men and
women of European and Asian origin, smokers and non-
smokers. Estimated prevalences have been calculated from
logistic regression models, which included terms on age,
sex, ethnic group, language used at interview, smoking
habits and dust concentration. A rapid rise in prevalence is
predicted over the dust concentration range from 0-5
mg/m3 and a slower increase at higher concentrations up to
20 mg/m3 and above. The highest relative risks in non-
smokers were in European women and were, in relation to
non-dust exposed, non-smoking women aged 40, 2.47 for
rhinitis, 2.77 for chronic bronchitis, 3.56 for conjunctivitis
and 6.20 for breathlessness at concentrations of 10 mg/m3,
the current nuisance dust limit. Other groups of workers
have lower relative risks than these. These data can be
helpful in decisions on an airborne dust standard for the
wool textile industry.
Course and determinants of diffuse pleural thickening after
crocidolite asbestos exposure
WOCM COOKSON, NH DE KLERK, AW MUSK, JJ GLANCY Osler
Chest Unit, Churchill Hospital, Oxford, and the
Department of Respiratory Medicine, Sir Charles Gairdner
Hospital, Nedlands, Western Australia The serial plain
chest radiographs of 280 claimants for compensation for
asbestosis among former crocidolite miners and millers at
Wittenoom Gorge, Western Australia, were examined side
by side by two independent observers for evidence of
pleural disease using the 1980 ILO criteria for classification
of radiographs for pneumoconiosis. Each subject had an
average of 10 radiographs extending over a median period
of 14 years. Observer one found that 163 patients (580o)
and observer two found that 135 subjects (480/o) showed
evidence of pleural disease at some time. The median time
to onset of diffuse pleural thickening was 23 years from
first exposure to asbestos. The latent period to the onset
and the risk of contracting diffuse pleural thickening was
unrelated to total cumulative exposure to asbestos (fibres
cc-1 year), site of work at Wittenoom (i.e. mining or
milling of asbestos), or age at first exposure. Once
established, pleural thickening progressed more rapidly in
millers than in miners but there was no effect of estimated
total cumulative exposure to asbestos on the rate of
progression. No regression of pleural thickening was
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observed in any subject. Diffuse pleural thickening was
observed rather than localized pleural plaques: in most
cases the thickening was initially less than 5 mm in thickness
but extended for more than 50% of the length of the lateral
chest wall.
Respiratory changes in laryngeal dimension in patients with
chronic airflow limitation (CAL)
W KELLY, A TULLY, A BRANCATISANO, LA ENGEL Thoracic
Medicine Unit, Westmead Hospital, Sydney,
Australia To study the respiratory function of the larynx
in patients with CAL, we measured the glottic and
supraglottic lateral diameters (Dg and Dsg) at mid-tidal
inspiration (i) and expiration (e) in 13 patients with an FEVY
of 3607 (4%) predicted. Real dimensions were obtained
from fluoroscopic images recorded on videotape with the
use of known skin markers. Synchronous recordings of
flow and volume were derived from a pneumotachograph.
Five to six breaths were analysed during quiet breathing
(QB) on application of 10 cm H20 continuous positive
airway pressure (CPAP) and during hyperoxic hypercapnia
(RB) after ventilation (4E) and expired Co2 concentration
(Feco2) had increased.
Mean RE FeCO2 Dgi Dge Dsgi Dsge
(SEM): (l/min) (%) (mm) (mm) (mm) (mm)
QB 12.3 4.8 7.7 4.2* 12.2 8.5S
n=13 (1.3) (0.3) (0.4) (0.5) (1.0) (1.0)
CPAP 15.4 4.8 8.7 5.6* 14.6 11.2*
n=8 (1.5) (0.3) (0.5) (0.6) (1.3) (1.2)
RB 20.7 7.8 8.5 3.00 12.7*" 8.6
n=8 (1.5) (0.1) (0.9) (0.5) (1.0) (1.1)
'p<0.02 (relative to Di); **p<0.02 (relative to QB). Mean ± SE.
Thus, unlike in normal subjects (England et al, J Appl
Physiol 1982), in CAL the expiratory glottic narrowing is
not reduced during hyperpnoea. Similarly, unlike in acute
asthma (Collett et al, Am Rev RespirDis 1986), CPAP does
not widen glottic diameter in patients with CAL. Our
results are consistent with a persistent and stable pattern of
laryngeal braking of expiratory flow in CAL.
Valve closure in the Nebuhaler in patients with low
expiratory rates of flow
WOCM COOKSON, RM HIGGINS Osler Chest Unit, Churchill
Hospital, Oxford We have previously shown poor
bronchodilator response in patients with severe COAD
using the Nebuhaler tube spacer device. The function of the
valve in the mouthpiece and inspiratory and expiratory
flows through the Nebuhaler were measured in 12 patients
(mean age 67.2 (SEM 2.6), mean FEVY 0.76 (SEM 0.09)
litres, mean peak expiratory flow (PEF) 106.8 (SEM 10.7)
litres/min. Using a compressed air source, the valve in a
Nebuhaler mouthpiece was found to close when flow past it
reached 42.6 (SEM 4.6) litres/min (mean of 10
measurements). Whilst breathing according to the
manufacturer's instructions (deeply and slowly) through a
Nebuhaler, seven of the 12 subjects (mean PEF 87.0 (SEM
17.8) litres/min) were unable to close the mouthpiece valve.
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The mean volume exhaled through the spacer chamber in
the subjects who did not close the valve was 0.21 (SEM
0.08) litres, with a range up to 0.59 litres. This air exhaled
through the spacer chamber may allow any aerosol
suspended in the chamber to be lost. The full 0.75 litres
volume of the Nebuhaler was not inhaled by 10 of the
subjects (overall mean volume inhaled 0.47 (SEM 0.07)
litres) whilst using the Nebuhaler, so they would not be
expected to receive all the aerosol suspended throughout the
spacer chamber. In its present form, the Nebuhaler may not
be suitable for some patients with severe COAD.
A comparison of high dose inhaled with oral corticosteroids
In corticosteroid trials in chronic airflow obstruction
(CAO)
RI GOVE, AS ROBERTSON, PS BURGE Department of
Respiratory Diseases, East Birmingham Hospital,
Birmingham One hundred and twenty-one patients with
adult onset CAO completed a double blind randomised
crossover trial of inhaled and oral corticosteroids. Three
two week phases of treatment with a two week washout
period consisted of 1) prednisolone 40 mg/day and a
placebo inhaler, 2) beclomethasone dipropionate (BDP)
500 ug inhaled tds and placebo, 3) both preparations as
placebo. A response was a change a 201o in FEVI, FVC or
mean PEFR during the second week of treatment as
compared with baseline. A change :a 15% in any one
measurement or a 10% in any two measurments was
labelled an equivocal response. Patients with clinical
asthma were excluded. There was a significant effect of
order on the response to placebo, but not on the other two
treatments (log liklihood ratio test; x2= 20.4, 2p<0.001).
Because of this responses were compared with baseline
values, or placebo only if the placebo period came first.
Forty-eight patients (40%) had a full response, and 10
patients (8%) an equivocal response. Nineteen of the
responders responded to both active treatments, 23 patients
responded only to prednisolone and six only to BDP.
Significantly more patients responded to prednisolone
(McNemar's test; 2p<0.025). Of the 23 prednisolone
responders nine had an equivocal response to BDP; of the
six BDP responders one had an equivocal prednisolone
response. The mean percentage change from baseline in the
responders' FEV, and FVC were similar after prednisolone
and BDP, but the changes in mean PEFR were greater
following prednisolone (2p<0.001). The BDP only
responders had significantly greater cigarette consumption
and reversibility in response to ipratropium bromide than
the other responders. Prednisolone is more effective than
BDP in inducing a corticosteroid response in CAO,
although some patients with a different pattern of airflow
obstruction may respond better to the inhaled drug.
Mood, attitudes to health and respiratory impairment in
redundant shipyard workers
B KING, JE coTEs Respiration and Exercise Laboratory,
Department of Occupational Health, Medical School,
Newcastle upon Tyne In patients with disabling bronchitis
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Morgan and colleagues (BMJ 1983;286:171-3) found that
attitudes and beliefs tontributed more to the description of
the 12 minute walking distance than mood and ventilatory
capacity. We have examined the relationships of these
factors to lung function and performance on a cycle
ergometer, the latter expressed as maximal 02 % of
reference value. The 161 shipyard workers had a mean age
of 56 years (range 27-71 years) and forced expiratory
volume (FEVI) of 2.69 1 (range 0.34.8 1). The scores for
anxiety, depression and attitudes to health were highly
inter-correlated. After allowing for age, stature and
smoking history, scores for anxiety or depression
contributed significantly to the descriptions of FEVI,
forced vital capacity, peak expiratory flow and transfer
factor. Dichotomous scores explained rather more of the
variance than continuous scores and anxiety more than
depression. Lung function was also related to attitudes to
health but not to breathlessness. Both mood and attitudes
contributed to grade of breathlessness; FEV1 and wheeze
also contributed, obesity and smoking did not. Exercise
capacity was significantly correlated with attitudes to
breathlessness and general health, and also with anxiety but
not depression. Anxiety was associated with shallower
breathing during exercise. These results confirm the
association between mood, attitudes to health, respiratory
impairment and disability. They suggest that anxiety and
depression result from negative attitudes to health, which in
turn are probably aggravated by respiratory impairment
and disability.
Intermittent humidification influences occurrence of
humidifier fever
K ANDERSON, AD WATT, D SINCLAIR, G BOYD Department of
Respiratory Medicine, Royal Infirmary, Glasgow, and
Employment Medical Advisory Service,
Glasgow Humidifier fever has been described as an illness
of clearly defined periodicity (Finnegan and Pickering, Clin
Allergy 1986;16:389). Recognition of this pattern probably
relies on continuous use of contaminated humidifiers
maintaining airborne antigen at a high level. Two factories
are described where the humidifiers (cold water spray and
ceiling mounted spinning disc) were used on an intermittent
basis and only when relative humidity was less than 45%.
This would occur commonly in winter, when air intake
required warming and humidification more continuously
than in the other seasons, when the external air temperature
was above 10°C. Symptoms occurred irregularly in 40 out
of 250 workers in one factory and 17 out of 50 in the other
until two more classical episodes of humidifier fever
occurred during summer periods when humidification of
air intake was necessary. Symptoms were particularly
common in night shift workers who had changed from day
shift, suggesting altered exposure to antigen from
humidifiers operating more often at night in response to
cooler nocturnal air intake. We conclude that the nature
and form of humidifier fever is altered by intermittent use
of humidifiers.
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Serology of farmer's lung, following a dry and a wet
summer in south-west Ireland
CP BREDIN, D KERINS, BV FOLEY Departments ofRespiratory
Medicine and Microbiology, Regional Hospital, Wilton,
Cork, Ireland In a retrospective study, the positive
serology rate and other characteristics of farmer's lung
antibodies were compared over two years, from October 1
1984 to September 30 1985 following a low rainfall
summer, compared with the same period one year later
following a high rainfall summer. Serology was considered
positive if antibodies were detected by either counter-
immunoelectrophoresis (C.I.E.P.) or enzyme linked
immunosorbent assay (E.L.I.S.A.). Four out of 20 sera
were positive in the first year (1984-85); 23 out of 61 were
positive in the second year (1985-86)- an expected increase
after the wet summer. There were positive antibodies to
Micropolyspora faeni in 26 patients, and to
Thermoactinomycetes vulgaris in 11 patients. All positive
sera were detected by E.L.I.S.A. and only one by C.I.E.P..
The peak period of positive sera occurred in June of each
year. This is a later peak than in Finland and Britain, and
may be due to variation in local farming methods.
Pulmonary eosinophilia with and without
bronchopulmonary aspergillosis
S CAPEWELL, BJ CHAPMAN, F ALEXANDER, R GIBSON, AP
GREENING, GK CROMPTON Respjratory Unit, Northern
General Hospital, Edinburgh Sixty-five patients with
pulmonary eosinophilia (PEo) presenting to one respiratory
unit have been reviewed. All had fleeting chest radiographic
abnormalities and a peripheral blood eosinophilia >
500x 106/1. Eighteen had one episode and 47 patients had
recurrent episodes of PEo during a mean follow-up period
of 13.8 years. Thirty-three/65 (51%) patients were
considered to have PEo associated with bronchopulmonary
aspergillosis (BPA) on the basis of skin tests, serum
precipitins and sputum culture of A fumigatus (at least 2/3
tests positive). BPA patients differed from non-BPA
patients. BPA patients were more frequently male (58% vs
28%; p<0.01), had a higher incidence of asthma (97% vs
81%, p<0.05) with an earlier age of onset (15.6 vs 26.0
years; p<0.01) and more commonly had radiographic
evidence of bronchiectasis/fibrosis (54% vs 12%,
p<0.001). During episodes of PEo non-BPA patients had a
greater incidence of associated systemic features (fever,
night sweats, weight loss, arthralgia, rash, anaemia,
cardiovascular involvement)(44% vs 9%; p<0.005) and a
higher mean (SEM) eosinophil count (2858 (516) vs 1406
(224) x 106/1; p<0.01). Pulmonary eosinophilia associated
with BPA appears a distinct clinical syndrome which results
in greater permanent radiological abnormality but which is
associated with fewer systemic symptoms and lower
peripheral blood eosinophilia.
Aspergillus fumigatus counts in the beds of asthmatics with
and without bronchopulmonary aspergillosis
IJ GORDON, CC EVANS Regional Adult Cardiothoracic Unit,
Broadgreen Hospital, Liverpool Bronchopulmonary
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aspergillosis (B.P.A.) affects 1% of asthmatics and the role
of environmental factors or host susceptibility is unknown.
Patients spend up to one third of their lives in bed and the
mattress contains stuffing rich in fungi and bacteria. Ten
patients with B.P.A., six asthmatics with aspergillus
positive skin prick tests but no other criteria for B.P.A. and
nine asthmatics with negative skin prick tests to aspergillus
were studied. Each was visited at home every three months
for one year and bed dust was collected using a portable
vacuum cleaner and filter. The dust was filtered, weighed
and spread onto Sabourauds medium in equal aliquots. The
number of aspergillus colonies were counted after 48 hours'
incubation and the number of colonies per square metre of
bed was calculated. No seasonal rhythm in aspergillus
counts was detected, nor was there any significant
difference in counts between any of the groups, although
very high counts were occasionally recorded.
Smoking cessation in patients with smoking-related diseases
IA CAMPBELL FOR BTS RESEARCH COMMITTEE Sully Hospital
Cardiff From October 1984 to June 1986 sixty-seven
physicians entered 1415 new out-patients into the Second
B.T.S. Smoking Withdrawal Study. Patients were
randomised to physician's advice alone (Group I) or to
physician's advice reinforced by a signed agreement, two
visits by a health visitor and repeated postal encouragement
(Group III). Clinic follow-up was at six months, when non-
smoking claims were validated by COHb and thiocyanate
measurements. Of 710 Group I patients 105 denied smoking
and blood was taken from 94, among whom 70 claims were
supported. In Group II the corresponding figures were 705
entered, 164 claimed non-smoking status, 147 blood tests
performed and 95 claims supported. Thus 13.5% of Group
II and 9.9% of Group I were not smoking at six months,
X2 4.1, p=0.04. Males did better than females, 14.8%
compared to 7.0%. Follow-up continues to 12 months: if
the difference is maintained physicians will have, for the
first time, a means of increasing cessation above the rate
achieved by advice alone.
BCG SYMPOSIUM PAPER
Protective effect of BCG vaccination in newborn Asians: a
case-control study
GE PACKE, JA INNES Birmingham Chest Clinic,
Birmingham BCG vaccination has been routinely offered
to newborn Asian children in Birmingham since 1965. We
conducted a case-control study to assess the protective
effect of this scheme. One hundred and eight Asian children
aged under 13 years and born since 1965 were included in
the analysis; they were notified as suffering from
tuberculosis on objective evidence other than a positive
tuberculin test. Asian children notified with tuberculosis
only on the evidence of a positive tuberculin test were not
included, nor were those given BCG as contacts or at any
time other than the newborn period. For each case, four
controls were selected from vaccination records, matched
to the case by month and year of birth, sex, and ethnic
origin. Cases and controls were all born in Birmingham. Of
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the cases, 57q7o (62/108) had received BCG, and of the
controls, 7807 (336/432) had received BCG. The estimated
protective efficacy of vaccination was 64%7o (95
confidence limits, 43% and 77%o), indicating useful
protection against the development of tuberculosis in
childhood.
Contribution of histamine to benzalkonium chloride-
induced bronchoconstriction in asth-ma
K MISZKIEL, R BEASLEY, P RAFFERTY, ST HOLGATE Medicine
I, Southampton General Hospital, Southampton We have
presiously shown that benzalkonium chloride (BAC), a
preservative present in some nebuliser solutions, is a
bronchoconstrictor agonist. The ability of BAC to cause
histamine release from rodent mast cells in vitro suggests
that its adverse airways effect may be secondary to
histamine release. To investigate this possibility 12 atopic
asthmatic subjects underwent inhalation challenge with
BAC or histamine (H) three hours after treatment with
terfenadine 180 mg or placebo. On four occasions
concentration-response studies were undertaken to
determine the concentration of each agonist required to
cause a 20% fall in FEV1 (PC20 FEVI). On four further
occasions, FEV, was measured for 45 minutes after
inhalation of the PC20 FEV1 agonist concentration.
Terfenadine caused significant displacement to the right of
the H and BAC concentration-response curves. The
geometric mean PC20 FEV, concentrations (mg/ml) for H
and BAC were 0.61 and 3.98 after placebo, and 39.3
(p<0.001) and 10.28 (p<0.01) after terfenadine
respectively. Compared with H the bronchoconstriction
provoked by BAC was slower in onset and more sustained.
Terfenadine inhibited the first 15 minutes of
bronchoconstrictor response due to H by 92.2%o (17.0o)
(p<0.001) and that due to BAC by 22.7% (16.07o)
(p<0.05). Almost identical results were obtained with the
chemically unrelated HI-antagonist astemizole. We
conclude that, although part of the bronchoconstriction
induced by BAC is mediated through the release of
histamine within the airways, it represents a small
component of the overall response.
The optimum aerosol size and dose of salbutamol in the
treatment of asthma
MA JOHNSON, R BLOOM, S NEWMAN, SW CLARKE Department
of Thoracic Medicine, Royal Free Hospital, London It
has been suggested that adrenergic receptors predominate
in the small airways and that /2 agonists should therefore
be targeted to the small airways to ensure high
concentrations at their site of action. This study examines
the effect of aerosol size on bronchodilation with nebulised
salbutamol using much smaller doses than conventionally
used (to avoid saturation of the adrenoreceptors) and
administered in a dose response fashion. Eight patients with
moderate asthma were studied on two occasions in a
randomised single blind crossover study. On each visit they
each received 250, 250, 500 and 1000 pg of salbutamol,
nebulised to dryness, at 35 minute intervals delivered via
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two different types of nebuliser with different compressed
gas flow rates to generate an aerosol size of 3 pm (MMD)
and an aerosol size of 7 pm (MMD). The bronchodilator
response was assessed by change in FEV1, FEV, PEFR,
Vmax25, ('maxs0. There was significantly greater increase in
all measurements following 3 pm aerosols. The increase in
FEVY following 1,000 yg was 52.9%7 for the 3 pm aerosol
and 39.9% for the 7pum aerosol (p<0.02). In addition there
was no significant further bronchodilation following 1000
pug of salbutamol delivered via either aerosol. These results
suggest that aerosol size is important when administering
2agonists and that the optimum dose of salbutamol may
be much smaller than that presently used.
Theophylline increases salbutamol induced hypokalaemia
and tachycardia
KF WHYTE, C REID, R WHITESMITH, GJ ADDIS, JL
REID Department of Materia Medica, University of
Glasgow, Stobhill General Hospital, Glasgow Salbutamol
and adrenaline cause hypokalaemia by stimulating a
membrane bound Na + /K + ATPase linked to a
/32-adrenoreceptor (Whyte et al, Brit J Clin Pharmacol
1987;23:65-71). Theophylline enhances adrenaline induced
hypokalaemia (Whyte et al, Eur J Respir Dis 1987; in
press). In a single blind placebo controlled study in 14
normal subjects we have examined the effects of
therapeutic theophylline levels on the haemodynamic
changes and hypokalaemia following salbutamol infusion
(4 pg kg - ' over five minutes and then 8 pug kg -' h - I for 55
minutes). Potassium levels fell during the salbutamol
infusion on both study days but this fall was significantly
greater on the theophylline limb (mean (SD) 3.9 (0.3) to 2.6
(0.3) mmol 1'- compared with the placebo limb (4.0 (0.3) to
3.0 (0.3) mmol 1- 1, p<0.05; repeated measures analysis of
variance (ANOVA)). Baseline heart rate was higher on
theophylline than placebo (78 (12) and 72 (7) beats min- I
respectively) and the rise in heart rate during the salbutamol
infusion was greater on theophylline (p<0.05, ANOVA).
Salbutamol infusion resulted in similar changes in diastolic
and systolic blood pressure on both treatments. We
conclude that theophylline significantly increases
salbutamol induced hypokalaemia and tachycardia.
Intensive bronchodilator therapy with salbutamol and
theophylline in acutely ill, hypoxic asthmatics may increase
the risk of cardiac dysrhythmias.
Can pursed-lip breathing prevent hyperventilation-induced
asthma?
JM WARDLAW, RJ FERGUSSON, PM TWEEDDALE, GJR
MCHARDY Respiratory Unit, Northern General Hospital,
and Pulmonary Function Laboratory and Department of
Medicine, Western General Hospital, Edinburgh As a
result of a personal observation by one of the authors that
breathing through pursed lips (PLB) could prevent the
development of exercise-induced asthma (EIA) a study was
performed to investigate the value of this manoeuvre in
blocking bronchoconstriction induced by isocapnic
hyperventilation (IH). Ten subjects (five male) with a
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history of EIA underwent three separate IH tests breathing
cold, dry air at a "target" minute volume (MV) for six
minutes (Tweeddale et al, Thorax 1981;36:598-9). FEV1
and FVC were measured before and at 1, 5, 10 and 15
minutes after each test. On the first visit (test one) a
standard mouthpiece and noseclips were used. On the two
subsequent visits, the subjects used a large, air-tight face
mask breathing either through a wide open mouth (OM) or
with pursed lips. The order of these two tests was
randomised. Pre-test FEVY and FVC and MV did not differ
significantly between visits. The mean maximum fall in
FEVY from pre-test values after test one and OM breathing
was virtually identical (1.37 1 (0.52) and 1.35 1 (0.54)
respectively). Bronchoconstriction was significantly
reduced by PLB when compared with test one and OM
(mean fall in FEVY, 0.68 (0.65) 1, p<0.01 using both
parametric and non parametric tests). PLB is a simple
manoeuvre which may be of practical benefit to some
patients with EIA, but the mechanism of the effect requires
further investigation.
A comparison of intravenous with nebulised salbutamol in
the treatment of acute severe asthma
B CHEONG, S REYNOLDS, KG RAJAN, MJ WARD Department of
Thoracic Medicine, Llandough Hospital, Nr.
Penarth Previous studies have claimed IV and nebulised
bronchodilator to produce similar bronchodilatation. This
study was designed to have adequate power to detect a true
15% difference in PFR response. Seventy-one patients with
acute severe asthma were admitted to hospital in whom the
PFR remained below 50% predicted 30 minutes after 5 mg
nebulised salbutamol were randomised to receive either
further nebulised or IV salbutamol. In the nebulised group
(n = 34) 5 mg was repeated to a total dose of 15 mg in two
hours. In the IV group (n = 37) 12.5 pg/minute was given
for four hours. No other bronchodilator was given. The
PFR and pulse rate were monitored for four hours. Both
groups were well matched for age, sex and severity of
attack. The admission mean PFR in the NEB and IV groups
was 111 and 91 1/min. The % increase in PFR was greater
in the IV group reaching statistical significance three hours
after admission (IV = 20.7% vs NEB = 12%, p<0.025, and
IV=25.5% vs 14.3%, p<0.01, after four hours).
Tachycardia was more prominent in the IV group,
becoming significant at 1.5 hours. An intravenous /3
agonist may be useful in severe asthma.
Bronchodilator efficacy of nebulised salbutamol and
ipratropium sequentially and in combination in acute
asthma
QA SUMMERS, RA TARALA Respiratory Medicine Unit,
Royal Perth Hospital, Perth, Western A ustralia,
Australia It has been suggested that nebulised
antimuscarinic bronchodilators, alone or in combination
with adrenoceptor agonists, may be useful in the treatment
of acute asthma. We have undertaken a double blind,
randomised trial of nebulised ipratropium and salbutamol
in acute asthma. We studied 64 patients with acute asthma.
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Each received two nebulised preparations, at time 0, and at
60 minutes, containing salbutamol 5mg (S) and ipratropium
0.5mg (I): Group (A) - S followed by I; (B) I followed by
S; or (C) S combined with I, followed at one hour by
normal saline. Peak flow (PEFR) was measured before the
first treatment (at time 0), then at 15 and 60 minutes after
nebulisation was completed; and at the same intervals after
the second treatment (75 and 120 minutes). There was a
significant rise in PEFR after each treatment- in Group A
(n = 23) between AO and Al5, A60 and A75, and A75 and
A120 (p<0.001 for each value); in group B (n = 18) between
groups BO and B1S, and B60 and B75 (p<0.005); in group
C (n=23) p<0.001 between CO and C15, and p<0.005
between C60 and C75. There was no evidence of an order
effect, in that the improvement after each agent was
similar, irrespective of whether the drug was given first or
second. The effect of I after S did not differ from the effect
of placebo given after S/I combined. The combination of
S/I was not superior to S alone at one hour. These results
do not suggest a substantial therapeutic effect from the
routine use of ipratropium added to salbutamol, either
sequentially or in combination, in the immediate treatment
of acute asthma.
The effect of house dust mite (HDM) avoidance measures
on adult atopic asthma
AJ DORWARD, MJ COLLOFF, NS MACKAY, NC
THOMSON Department of Respiratory Medicine, Western
Infirmary, Glasgow, and Department of Zoology,
University of Glasgow Twenty-one adult asthmatics,
skin-test positive to D pteronyssinus, were randomised to a
control group or to a group which performed HDM
avoidance measures including initial application of liquid
nitrogen to mattresses and bedroom carpets to kill the
HDM population. Histamine airway responsiveness was
measured by PC20 FEVI, symptom scores, peak flow rates
(PFR) and HDM numbers were measured during the two
week pre-trial and eight week trial periods. Nine patients in
each group completed the study. There was a significant
reduction in live mites in the avoidance group by the end of
the study but not in the control group. The avoidance group
showed a significant improvement in symptom scores,
number of hours wheezing and PFR. These changes were
not found in the control group. The PC20 FEVY increased
significantly in the avoidance group at eight weeks while
there was no change in the control group. Four out of the
nine avoidance group patients had a greater than four times
increase in PC20 FEVI. These results demonstrate that
HDM avoidance when combined with an initial kill of the
mites by liquid nitrogen diminishes airway responsiveness
over an eight week period in adult asthmatics with HDM
allergy.
Intermittent positive pressure hypoventilation and
inotropic support in severe acute asthma
SG BREAR, JD EDWARDS Wythenshawe Hospital,
Manchester and University Hospital of South Manchester,
Manchester As a last resort treatment of acute severe
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asthma, intermittent positive pressure ventilation is
lifesaving in the majority of patients. However, the
mortality remains high (in most units of the order of 30%)
and complications secondary to the high inflation pressures
and internal positive end-expiratory pressures generated are
frequent. During 10 episodes in eight patients requiring
intermittent positive pressure ventilation we have compared
the clinical and haemodynamic responses of patients during
initial "conventional" intermittent positive pressure
ventilation and subsequent intermittent positive pressure
hypoventilation with inotropic support (IPPH/IS). One
patient died of adult respiratory distress syndrome
secondary to gastric aspiration. All other patients survived
with no episodes of pneumothorax, mediastinal or surgical
emphysema. The mean peak inspiratory pressures fell from
96.4 in the intermittent positive pressure ventilation group
to 57.6 in the IPPH/IS group. The mean cardiac index rose
from 2.0 in the intermittent positive pressure ventilation
group to 4.6 in the IPPH/IS group, the overall effect being
to markedly improve tissue oxygen delivery.
Comparison of the efficacy of preservative-free
ipratropium bromide and Atrovent ipratropium bromide
nebuliser solution in asthmatic subjects
P RAFFERTY, R BEASLEY, ST HOLGATE Southampton General
Hospital, Southampton Isotonic Atrovent nebuliser
solution has been reported to produce paradoxical
bronchoconstriction in asthmatic subjects and we have
recently demonstrated that this is due to the preservatives
benzalkonium chloride and EDTA present in the solution
(Beasley et al, Br Med J 1987, in press). In this double blind
study we have compared the airway response to inhalation
of Atrovent nebuliser solution with that to preservative-free
ipratropium bromide (PFIB). Thirty asthmatic subjects
(21M, 9F, mean (SEM) age 55 (3) years, mean (SEM) FEVY
59% (5%) predicted) inhaled 2 ml of Atrovent nebuliser
solution or PFIB and airway calibre measured as FEVY
before and for 45 minutes after inhalation. Atrovent
provoked a fall in FEVY of 20% in five (17%) subjects
whereas this did not occur following PFIB. Inhalation of
PFIB resulted in greater bronchodilation than following
Atrovent with mean (SEM) increases in FEVY of 29.2%
(3.6%) and 18.5/o (2.8%) respectively (p<0.001). We
conclude that PFIB is safer and n¶ore effective as a
bronchodilator in asthma than the currently available
Atrovent solution.
Effects of salbutamol and ipratropium bromide on
intraocular pressure in chronic bronchitis with glaucoma
L KALRA, H KAZMI, MF BONE Department of Medicine,
Russells Hall Hospital, Dudley A controlled double blind
crossover study of ocular complications associated with
nebulised ipratropium bromide and salbutamol therapy for
respiratory distress was undertaken in 46 chronic
bronchitics (14 open angle glaucoma, 12 narrow angle
glaucoma, 20 controls). There was no significant rise in
intraocular pressure or change in anterior chamber angle in
patients with open angle glaucoma, narrow angle
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glaucoma, or controls following treatment with either drug.
However, when the two drugs were used in combination,
intraocular pressure rose by a mean of 5.8 (SD 0.3) (range
4-7) mm Hg at 90 minutes in patients with narrow angle
glaucoma but not in patients with open angle glaucoma or
controls (p<0.05). Transient angle closure was seen in five
of these patients. Intraocular pressures did not rise when
swimming goggles were used to protect the eyes or when
antiglaucoma treatment was continued. Nebulised
bronchodilator therapy is safe in non-glaucomatous
patients and those with open angle glaucoma. Ocular
complications can follow combined ipratropium bromide
and salbutamol nebulisation in patients with narrow angle
glaucoma but can be prevented by using the drugs
separately, protecting the eyes, and ensuring continued
antiglaucoma measures.
Warm-up exercise inhibits exercise induced asthma (EIA)
DB REIFF, N CHOUDRY, HA JONES, PW IND, NB
PRIDE Department of Medicine, Royal Postgraduate
Medical School, Hammersmith Hospital, Du Cane Road,
London Although refractoriness in EIA is well recognised
there has been little work on the effect of different exercise
regimes. Seven mild asthmatics (five male), aged 16-32
years, with a history of EIA were excercised on two study
days, in random order, within five days. On one day
standard treadmill exercise (EXI), six km/hour at 15%
gradient for six minutes, was performed and repeated after
45 minutes (EX2). Heart rate (HR) was continuously
monitored and minute ventilation (V) was measured. On
another day, the same exercise test (EX3) was repeated 21
minutes after a 30 minute "warm-up" run of six km/hour
at 3% slope. There was no significant difference between
baseline mean FEV1 on the two study days (80 (SEM 8) and
79 (7)% pred). These subjects were refractory with a mean
maximum fall in FEVI of 1.521 (46% baseline) after EXI
and 0.56 1 (19%) on EX2 and also felt less wheezy.
Environmental conditions, HR and V did not differ
significantly during EXI, EX2, EX3. After warm-up most
subjects developed slight bronchoconstriction with recovery
to FEV1 >85% baseline prior to EX3. During EX3 they
were refractory (mean maximum fall in FEV1 of 0.63 1,
21% baseline) with less wheeze on visual analogue score.
Thus refractoriness was equivalent to that induced by EX1
though work output (4o2) on warm-up was 3-4 fold
greater. Preliminary warm-up exercise can induce
refractoriness without itself producing marked E.I.A. This
has implications for asthmatics participating in sport and
also for understanding the mechanisms of E.I.A.
Serum neutrophil chemotatic activity (NCA), plasma
histamine and catecholamines in asthma induced by
hypertonic saline (HS) and exercise (EX)
N BELCHER, R MURDOCH, N DALTON, PJ REES, TJH CLARK, TH
LEE Departments of Medicine and Respiratory Medicine,
Guy's Hospital, London In nine subjects with exercise
induced asthma NCA and plasma histamine concentrations
have been measured following asthma induced by EX and
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HS on two separate occasions. In each subject HS and EX
produced a similar fall in FEVI. Venous plasma histamine
and catecholamines were measured by radioenzymatic
assays and NCA was assayed by a microchemotactic
method on 0.25, 0.5, 1.0 and 5.0% serum dilutions. At
optimal serum concentrations for analysis there were
significant time dependent increases in NCA at five and 15
minutes following both EX (mean (SD) % 183 (61), 246
(825), p<0.05, n=9) and HS (206 (103), 137 62, p =0.02,
n = 9). NCA released after EX and HS had a molecular
weight of approx. 700 kd. There was a significant increase
in plasma histamine from a baseline of 4.7 (1.2) to 9.1 (3)
nmol/l (p<0.05, n = 9) at 15 minutes following EX but not
following HS. There was a 110% (25070) (p = 0.02) and 3%
(1 0) (NS) increase in basophil counts after EX and HS
respectively. There was no significant rise in plasma
adrenaline following EX or HS (n = 7); there was a rise in
noradrenaline following EX from a baseline of 1.8 (0.29) to
3.15 (0.53) and 2.1 (0.33) nmol/l (p=0.02, p=<0.05,
n =7) at five and 15 minutes respectively but this was not
seen following HS.
Nocturnal asthma: role of snoring and obstructive sleep
apnoea (OSA)
CS CHAN, AJ WOOLCOCK, CE SULLIVAN Department of
Medicine, University of Sydney, N.S. W., Australia Many
mechanisms have been proposed for nocturnal asthma
attacks. We report the effect of nocturnal nasal continuous
positive airway pressure (nCPAP) on six patients (M:F 5:1)
who have a combination of persistent nocturnal asthma
attacks and recurrent upper airway obstruction (UAO).
These patients had common symptoms of heavy snoring,
nocturnal choking, excessive daytime sleepiness and
frequent sleep arousals. All night sleep studies confirmed
mild OSA in five patients and partial UAO in one patient.
All snored heavily. Peak Expiratory flow rates (PEF) were
recorded in three intervals of two weeks before, during, and
after cessation of nocturnal nCPAP therapy. The morning
and evening prebronchodilator PEF (mean (SEM) of 14
days), expressed as a percentage of the predicted PEF, is as
shown in the table. During the period of nCPAP therapy no
patient had symptoms of nocturnal asthma, snoring, or
nocturnal choking. These results suggest that recurrent
UAO and snoring are important triggering mechanisms of
nocturnal asthma attacks. Treatment of patients with
dominant nocturnal asthma attacks and recurrent UAO
with nCPAP may improve not only the symptoms of OSA
but also the severity of the asthma.
733
Is cosinor analysis an appropriate model for diurnal
variation in asthma?
CK CONNOLLY Friarage Hospital, Northallerton, North
Yorkshire Diurnal variation in asthma is frequently called
morning "dipping", which implies deviation from a
maximum. Characteristic patterns may be described
qualitatively (CK Connolly, Brit J Dis Chest 1979;73:357),
supported by simple calculation. Cosinor analysis is more
sophisticated, potentially able to avoid observer bias and
detect rhythms in "noisy" data. It requires a computer and
assumes oscillation about a mean, rather than a fall from a
baseline. Four hundred and seventy-six subjects with
airway obstruction (376 asthmatics) recorded their peak
flow rate four hourly during the day. Pattern analysis with
simple calculation and cosinor analysis were compared.
Consistent variation was demonstrated in 332 subjects by
pattern and in 253 subjects by cosinor analysis (p<0.01
approximating to 95%o confidence limits of acrophase +
three hours). Only 18 of these did not show a characteristic
pattern, and 95%o of subjects within each pattern group
showed an acrophase within ± three hours of the median,
corresponding to lowest PEFR at 0520 for morning dippers
and 0245 hours for double dippers. Calculated mean was
highly correlated with cosinor mesor (r=0.999), as was
cosinor amplitude with simply calculated "amplitude"
(r = 0.935) and morning dip (r = 0.86). Pattern with simple
calculation is a closer model of dipping than cosinor
analysis and, as the latter gives no more information, the
computer should be abandoned in favour of the eye,
pending the discovery of a more appropriate sophisticated
mathematical model.
Acute asthma in the Grampian Region, 1976-85: hospital
admissions and GP survey
PP SUTTON, ER ALEXANDER, G RUSSELL, JG DOUGLAS, JAR
FRIEND, JS LEGGE, SJ WATT Departments of Respiratory
Medicine, Community Medicine and Paediatrics, Aberdeen
Royal Infirmary, Foresterhill, Aberdeen Hospital
admissions from acute asthma (ICD code 493) were
examined for the Aberdeen hospitals serving the Grampian
Region (1984 population 497272) during 1976 to 1985.
There was a 105%o increase in total admissions during this
period and the mean stay fell from 9.4 to 6.1 days. The
increase was prominent in the young: 0-14 302%o, 15-44
48%o, over 45 years 100o. These changes persisted following
corrections for population changes and comprised both
new and return patients. It is unlikely that altered
prevalence or diagnostic accuracy could explain these recent
changes and therefore a postal survey of all general
practitioners in this region was conducted to study attitudes
towards assessment, treatment and supervision of acute
asthma. Two hundred and eighteen detailed replies were
received from 293 questionnaires (74%7o). Ninety-eight per
cent used peak flow meters during asthma supervision but
only 450o thought them useful in acute domiciliary
episodes. Eighty-five per cent used nebulised
bronchodilators in treating acute severe asthma with
steroids (57-79%7o) and aminophylline (527o)- although in
Am p Pm p
Control 40 (6) < 0.02 49 (7) < 0.02
nCPAP 52 (8) <0.02 60 (9) <0.05
Control 44 (6) 55 (9)
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57% of adults and 6407 of children the steroid regimen was
suboptimal. There was strong support for self-medication
(87%), self-referral (7507.) and shared-care schemes.
Questions on preventive treatment indicated considerable
scope for further prophylaxis in both adults and children.
Asthma mortality and drug therapy in Northern Ireland
SC WRIGHT, AE EVANS, D SINNAMON, J MACMAHON Chest
Unit, Belfast City Hospital; Department of Medicine,
Coleraine Hospital; Department of Community Medicine,
Queen's University, Belfast We have investigated asthma
deaths in Northern Ireland during 1981-84. The following
death certificates issued in Northern Ireland during this
period were extracted. 1) Asthma listed as the main cause of
death. 2) Asthma listed as the supplementary diagnosis. 3)
Airflow obstruction suggested by the listed diagnosis (age
> 55 excluded). Further information was obtained from
questionnires to each general practitioner, interviews with a
close relative or associate of the deceased, hospital charts,
and necropsy reports. Two chest physicians then decided
which of the 382 deaths were due to asthma. Although the
death certification of asthma was not accurate, the total
number of deaths confirmed by the panel differed little
from the total registered in each year. The registeed yearly
totals are therefore useful in the assessment of trends in
asthma mortality. Since 1960, two "peaks" were identified
- from 1964 to 1969 and from 1979 to 1985. During the
period 1977-1985, prescriptions for simple /3 agonist
inhalers rose from 77000 to 234000. Theophyllines rose
from 33000 to 135000. Steroid inhalers increased from
15000 to 46000. Prescriptions for nebulised /3 agonists rose
from one in 1980 to 7200 in 1985. Of the patients
investigated 82.507. were on inhaled /3 agonists, 33.70o were
on oral /3 agonists, 60.40o were on theophyllines, 13.60o
were on ipratropium, 30.20o were on inhaled
corticosteroids and 35.307 were on oral corticosteroids.
Only 5.907 were on nebulised /3 agonists. The use of
nebulised /3 agonists does not appear to have been a major
factor in overall asthma mortality.
Asthma mortality in the Republic of Ireland 1970-1984 and
analysis of hospital deaths in a single year
P MANNING, E MURPHY, L CLANCY, B CALLAGHAN Peamount
Hospital, Newcastle, Co. Dublin Mortality from asthma
since the 1960s epidemic has remained static in the Republic
of Ireland over the period 1970-1984. We reviewed asthma
mortality in Ireland and obtained copies of all death
certificates with asthma recorded as the cause of death for
1981. In 28 of these patients the primary cause of death
recorded on the death certificate was not asthma. Eighty
per cent of the remaining 104 deaths were in-patients over
50 years of age. Fifty-four patients died in status
asthmaticus/acute asthma (28 in hospital; 26 at home).
Patients who died at home from acute asthma were younger
than those dying in hospital, 26 patients had asthma for
over five years, 20 patients had three or less acute
exacerbations in the last year. Six patients had no previous
hospitalisation. Twenty patients had exacerbations of
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symptoms for less than one week ( < 24 hours in nine
cases). Death occurred within 72 hours of admission in 19
cases. We found that the nine patients dying within 24
hours of admission had little or no steroid therapy. Twelve
patients were given supplemental oxygen. Four patients
were given sedation shortly before death. In only four cases
were objective assessments of bronchial obstruction
recorded on admission or subsequently. Twenty-three
patients had chest radiographs. We found no single reason
to account for the majority of asthma hospital deaths. Most
patients were elderly and infection was a contributing
factor.
FEV1, age and smoking in working men aged 18-64
NM FARRER, KM VENABLES Department of Occupational
Medicine, Brompton Hospital, London Working
populations may include young adults. Some published
regression models which account for the increase and
plateau of FEV1 with age are complex. A cross-sectional
survey of industrial workers measured FEVY (Vitalograph).
Four hundred and sixty-seven technically satisfactory traces
from white males were analysed. Mean age was 41 years
(range 18-64). Fourteen per cent were under 27, at which
age FEVY appeared maximal. Loge(age) was included and
height (m) was squared (Cole J R Statist Soc A
1975;138:297-337). Residual standard deviation (RSD) of
the regression was 0.538 1. Smoking is often a confounding
variable. Pack-years (PY) of smoking and PY.year since
stopped smoking (up to a maximum of five years) (PY.Ex)
were additional significant predictors of FEVY (RSD 0.522).
The final equation was: (0.680.loge (age) - 0.029.age)
height2 - 0.010.PY + 0.002(PY.Ex). In separate
regressions for non-, ex- and current smokers (n = 125, 138,
204), FEVY difference with age was -32, -39 and -48
ml/year estimated at mean age and height. It was not a
stepwise regression, so did not explore all possible forms
and interactions, but showed (1) a simple curvilinear term
allows one equation for the whole working age range; (2)
smoking terms in the regression do not wholly explain the
greater age-related FEVY difference in smokers, who may
require separate analysis (Oldham Thorax, 1987;42:161-4).
Asthma and chronic bronchitis: mortality and hospital
discharge patterns in the West Midlands
G BENFIELD, DE STABLEFORTH Department of Respiratory
Medicine, East Birmingham Hospital,
Birmingham Deaths from asthma in England and Wales
now exceed 2000 per annum, with a continuing rise in older
age groups. This may not be a true reflection of the asthma
death problem because of the diagnostic confusion
presented by chronic bronchitis and emphysema (CB/E). In
the West Midlands the overall asthma mortality rate (MR)
increased from 1.7 to 3.3 per 105 population between 1974
and 1984, mainly attributable to a steep rise in the 65 + age
group. However, in the most diagnostically accurate 15-44
age group there was no increase in mortality, whereas
asthma hospital discharges for the group increased from
35.2 to 67.4 per 105, with deaths per thousand discharges
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decreasing from 6.9 to 2.7. Over the period the CB/E
mortality rate has fallen from 50 to 30 per 105,
predominantly because of to a change in the 65+ age
group, and the discharge rate has decreased from 42 to 26
per 105 over the same period. In the diagnostically less
accurate 45-64 and 65 + age groups asthma discharge rates
have increased in a diametrically opposite fashion to that of
CB/E. Asthma mortality in the 15-44 group has not
increased in the West Midlands despite markedly increased
admissions, which possibly reflect altered admission
criteria. The contrasting patterns of asthma and CB/E
mortality and hospital discharges rates suggest possible
changes in diagnostic attitudes, particularly in older
patients, which may significantly influence our view of
trends in deaths from asthma.
Dominant inheritance of atopic trait
WOCM COOKSON, JM HOPKIN Osler Chest Unit, Churchill
Hospital, Oxford Twenty sets of parents of a random
sample of atopic asthmatics aged< 25 were compared with
14 sets of parents of controls. Ninety-five per cent of
asthmatics had at least one atopic parent. The proportions
of atopic and non-atopic parents in marriages were as
follows:
Atopic: Both One Neither
Parents of Asthmatics 8(40%) 11(55%) 1(5%)
Parents of Controls 1(7%) 7(50%) 6(43%)
The proportions expected from a randomly distributed trait
with a prevalence of 3307 are not different from the
findings in controls (X2=0.18), but are significantly
different from parents of asthmatics (X2= 10.08,
p<0.005), indicating a major genetic component to atopy.
Three extended families (140 subjects) were studied,
showing a simple vertical transmission of the trait through
affected individuals from one generation to the next, so
that, of 29 matings producing atopic children, only on three
occasions did neither parent fulfil the criteria for atopy. In
the largest family (110 individuals), 55% of children were
atopic if one parent was affected, and 83% were atopic if
both parents were affected. The results suggest an
autosomal dominant inheritance of a single gene locus
predisposing to atopy, the fundamental cause of which may
be investigated by molecular genetic linkage analysis.
Measurement of peak expiratory flow rate variability in a
community population
BG HIGGINS, T JONES, S CHINN, JR BRITTON, PJ BURNEY, AE
TATTERSFIELD Respiratory Medicine Unit, City Hospital,
Nottingham and Department of Community Medicine, St.
Thomas' Hospital, London Serial peak expiratory flow
(PEF) measurement is widely used in the diagnosis of
asthma and may offer a means of estimating asthma
prevalence in epidemiological surveys. However, there is no
adequate description of the range of PEF variability in a
random population, and it is not clear which index best
expresses this variability. We have analysed PEF recordings
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made two hourly over seven days in 121 subjects selected at
random from a large general practice register, and in 221
subjects selected because of wheeze in the last year. PEF
variability was expressed for each subject as absolute
amplitude (highest - lowest reading each day); amplitude
%7o mean; amplitude %o mean for a fitted cosinor curve; and
morning dip. In the random sample, PEF variability
followed a skewed distribution for all these indices, the 90th
centiles being 70 litres/minute, 19%o, 13%o and 34
litres/minute respectively. The proportion of subjects with
wheeze lying beyond the 90th centile was similar for each
index, varying from 25%o to 34%o. Amplitude 0o mean and
cosinor amplitude %o mean had the highest intra-class and
correlation coefficients in the random sample, and appear
to be the most informative indices of PEF variability
between subjects.
Inpatient care of respiratory patients in one region
MJB FAREBROTHER Medway Hospital, Gillingham For
the fifteen districts of South East Thames Region the HAA
data base was used to examine admissions with respiratory
diseases (by ICD code) under thoracic physicians and under
all physicians and geriatricians during 1985. For all
physicians and geriatricians 15.80lo (range for districts
13.3-18.9%o) of all admissions were for respiratory diseases
with admission rates of 4.7 (range 3.2-6.4) per 1000 acute
catchment population. Twelve per cent (range 1-24%o) of all
admissions, but 23% (range 7-42%o) of respiratory
admissions, were under thoracic physicians; but 59%o of
asthma, 5207o of lung cancer and 34%o of respiratory
tuberculosis patients were not admitted under thoracic
physicians. Thirty per cent (range 15-80%o) of admissions
under thoracic physicians were for respiratory disease,
highest where there were physicians wholly in thoracic
medicine, but in some districts no higher than for all
physicians. Therefore in all districts only a minority of
patients with respiratory disease are admitted under
thoracic physicians, and in some districts there is little
specialisation of physicians with an interest in thoracic
medicine for in-patient work.
Attendance of asthmatic children at accident and emergency
departments
S O'HALLORAN, DP HEAF Royal Liverpool Children 's
Hospital, Alder Hey, Liverpool Hospital admissions for
childhood asthma have increased markedly in recent years,
despite advances in treatment. In 1986, 820 children made
1389 visits to the AED at RLCH Alder Hey for acute
asthma. To investigate reasons for repeated attendance,
those who came twice or more in 12 months were assessed
by questionnaire and, in those > five years, interval lung
function tests (LFTs), and compared with a control group
of OPD asthmatics who had not needed emergency
treatment for at least 12 months. LFTs showed lower mean
FEV, (79%7o vs 840o, p<0.05), Vmax75-25% VC (48%o vs
5907o, p<0.01), Vmax25% VC (56%o vs 701o, p<0.05) and
FEVI/FVC7o (75%7o vs 79%7o, p<0.005) in AED children.
Mean change in PEFR was greater on exercise (39%o vs
3307o, p<0.05) and bronchodilator (31 O7* vs 26%, p<0.02)
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and the lability index was higher (47Gb vs 38Gb, p<0.02) in
the AED group. Usual attacks were of equal severity, but
AED children had worse "worst ever" attacks (34% blue vs
14% OPD, p<0.05). There were no differences in
treatment; 97% AED, 99%0 OPD had a bronchodilator at
home; 73% AED, 68% OPD took prophylaxis and 11%
AED and 12% OPD had a home nebuliser. Parental
knowledge was similar. Seventy-three per cent of AED and
71% of OPD parents thought asthma could be fatal, but
71% ofAED vs 56% OPD had feared their own child might
die (p<0.05), and would seek medical help sooner
(p<0.005). Repeated attendance for asthma is related to
greater severity of disease and parental concern, but not to
differences in treatment, ignorance or social disadvantage.
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respiratory diseases showed a significant correlation with
hospital deaths and discharges by place of residence
(r = 0.69, p<0.02). Mortality rates were generally higher in
districts with a higher ratio of population per chest
physician. Mortality rates were also higher in districts
where hospital deaths and discharges per chest physician
were higher (r=0.72, p<0.05, one district with no chest
physician excluded). Districts where respiratory diseases, as
measured by mortality and hospital deaths and discharges,
are more prevalent, generally have fewer chest physicians
per 1000 population. These findings suggest a need for an
increase in consultant thoracic staffing in certain districts.
Mortality rates and Hospital Activity Analyses gave a
similar picture in terms of distribution of respiratory
diseases and relevant staffing structures within Wales.
Is asthma becoming more severe?
H REA, M SEARS, E MITCHELL, J GARRETT, J MULDER, R
ANDERSON Department of Respiratory Medicine, Green
Lane Hospital, Auckland, New Zealand In 12 of 15
countries studied, asthma mortality (5-34 years) was higher
in 1982-84 than in 1979-81. Hospital admissions for asthma
are rising and in Auckland Accident and Emergency
Department (A and E) use for asthma has doubled in the
last decade. These trends may indicate increase in
prevalence, severity, or changes in management, e.g. a shift
from community to hospital care. If increased hospital use
is due to the latter, those reaching hospital now should have
less severe disease on arrival. In Auckland with both
paediatric admissions and in the A and E department, pulse
and respiratory rate are recorded by a nurse as the patient
arrives and before any treatment is given. Records have
been reviewed. The mean pulse in 182 patients arriving at
the A and E department in a 2 month period in 1986 was
114 and the mean respiratory rate 28.7. Corresponding
figures for 1979 were 108 (p=0.076) and 33 (p=0.051).
Asthma admissions in 5-14 year olds tripled between 1977
and 1981. Mean pulse (p) and respiratory rates (rr) for all
European children admitted were: 1970 - n = 73, p = 122,
rr =35; 1978-n = 119, p = 123, rr = 36; 1985-n = 135,
p = 125, rr = 35. Since severity on presentation to hospital is
unchanged and since the pattern of change with time is so
similar in the admissions, A and E department use, and
mortality for all races, we believe that our data point to a
real increase in the number of severe asthma attacks.
Presumably a ubiquitous factor has increased severity.
Mortality rates and hospital activity analyses as
performance indicators for a regional thoracic service
PDO DAVIES Llandough Hospital, Penarth, South
Glamorgan Mortality rates and hospital discharges and
deaths by district health authorities are published annually
in the Monitors of the Office of Population Censuses and
Surveys. Data from these publications for Wales for the
years 1981 to 1984 have been extracted to provide a measure
of extent or respiratory diseases. Comparisons have been
made with thoracic consultant staffing in each district to
determine how staffing might be made more efficient. For
the nine health districts of Wales, mortality rates for
Interaction between phenytoin and antituberculous drugs
D O'REILLY, GS BASRAN, B HOURIHAN, JT MACFARLANE
Department of Thoracic Medicine, City Hospital,
Nottingham In epileptics the interactions between
phenytoin and anti-TB drugs are confusing: isoniazid
causes potentially fatal phenytoin toxicity in slow
acetylators whilst rifampicin increases phenytoin clearances
in both slow and fast acetylators. We present the clinical
and biochemical data from two cases to remind clinicians of
this complex problem and recommend a practical scheme of
management to avoid these interactions. The first case was
an epileptic stabilised on 300 mg of phenytoin daily who
developed progressive drowsiness during the first week of
triple therapy with isoniazid, rifampicin and ethambutol.
He had a toxic phenytoin level (table) and slowly recovered
on withdrawal of this drug. He was subsequently stabilised
on only 200 mg of phenytoin daily. On the basis of this
experience, when a second stable epileptic was started on
triple chemotherapy his dose of phenytoin was intentionally
reduced from 300 mg to 200 mg daily. However, three days
later he developed seizures and his blood phenytoin levels
were low. He required a final dose of 400 mg of phenytoin
daily to control his fits and on this dose the blood level was
in the therapeutic range. Determination of the acetylator
status in each case helped to explain the contrasting
pictures.
Phenytoin dose Phenytoin level Acetylator Phenytoin dose
(initial; mg/d) mg/l status (final; mg/d)
Case 1 300 46.1 Slow 200
Case 2 300 8.0 Fast 400
Case one was a slow acetylator (hence isoniazid-induced
phenytoin accumulation occurred) whilst case two was a
fast acetylator (presumably rifampicin induced phenytoin
clearance predominated). To avoid these serious
complications in epileptics stabilised on phenytoin the
acetylator status should be determined before starting
isoniazid.
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Reduced paediatric notifications for tuberculosis: the effect
of the introduction of chemoprophylaxis in a high incidence
district
LP ORMEROD The Chest Clinic, Royal Infirmary,
Blackburn In the Blackburn Health District in 1978-81,
children accounted for 136/642 (21.247o) of all notified
cases of tuberculosis. Following the introduction in
November 1981 of prophylactic chemotherapy, paediatric
tuberculosis has fallen significantly. Isoniazid (10 mg/kg)
and rifampicin (10 mg/kg) were given for a duration of nine
months from 1981-83, and for six months from 1984
onwards, to children with Grade three or four positive
tuberculin tests seen as new immigrants, contacts, or from
school screening. Paediatric cases fell to 55/418 (13.15%)
of total cases notified in 1982-86, a fall which is highly
significant (X2 11.04, p<0.001). This effect is due to
reduced notifications in the Indian Subcontinent (ISC)
ethnic group (X2 10.41, p<0.001), who made up 80.2!o of
the children given chemoprophylaxis. The notifications in
the white ethnic group were not affected by the
introduction of chemoprophylaxis (X2 0.59). Few side
effects have occurred, and only two of the 339 children
given chemoprophylaxis later developed clinical
tuberculosis (0.6%). Prophylactic chemotherapy is shown
to play an important part in the management of paediatric
tuberculosis in a high incidence district. The combination
of rifampicin and isoniazid may allow chemoprophylaxis to
be given for less than six months.
Changes In tuberculosis notification rates in the white
ethnic group in England and Wales between 1953 and 1983
VH SPRINGETT, AJ NUNN, I SUTHERLAND, JH
DARBYSHIRE MRC Cardiothoracic Epidemiology Group,
Brompton Hospital, London Since the early 1960s
notification rates for tuberculosis in England and Wales for
the whole population have been influenced by high rates in
some immigrant groups. Using data by ethnic group from
the MRC surveys in 1983 and 1978/79 and by country of
birth from the BTS survey in 1971, information on the rates
in the white population have been calculated and compared
with published rates for the total population for 1953, when
only a very small proportion of the population was born
abroad. Between 1953 and 1983 the notification rate for the
white ethnic group fell from 122.2 to 11.3 per 100 000 for
the males, a mean annual rate of decline of 7.7%, the
corresponding rates for the females being 90.1 and 5.8, an
annual decline of 8.8%. In both sexes the most rapid
decline occurred in young adults (age 15-24 years),
becoming less with increasing age. Between 1978/79 and
1983 the annual rate of decline was 6.9% for males and
7.3% for females, less than the decline over the whole
period 1953-1983, but greater than that for the period 1971
to 1978/79 (5.1% for both sexes). A more rapid fall in
notifiction rates in young adults than in the older age
groups has led to a different pattern of annual notification
rates by age. Thus in 1953 the highest rates occurred in
young adults in both sexes. In contrast, in 1983 the highest
notification rates were in the oldest age groups. There is no
evidence of any cohort showing an increase in notification
rate with increase of age.
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Is the hyperventilation syndrome simply a manifestation of
occult bronchiectasis?
LS HILL, Z THOMPSON, WJ ADAMS Warwick Hospital, Lakin
Road, Warwick Fifteen patients with classical
hyperventilation syndrome were studied prospectively (8M;
7F; ages 17-72, mean age 44). All were non-smokers and
non-atopic and had normal full physical examination, plain
chest radiography, blood count, biochemistry screen,
thyroid function, FEVI, FVC, carbon monoxide transfer,
total lung capacity, and Kco. There was no evidence of
asthma on peak flow charts or reversibility studies. The
mean resting minute volume from a sixty second tidal trace
(wet spirometer) was 14.5 1/minute (range 10.2-18.6
1/minute). Voluntary hyperpnoea reproduced symptoms
within twenty five seconds, gave respiratory alkalosis on
blood gas analysis, and provoked paradoxical dyspnoea
rather than apnoea. All breathed irregularly from the upper
chest and did not produce sputum. At bronchography all
had bronchiectasis, bilaterally in twelve and in the lingula
and left lower lobe in three. Four had involvement of four
or more lobes. Although conventional clinical examination
failed to detect the pathology, palmar palpation (akin to
cardiac thrill detection) was positive in all cases.
Conclusions: 1) Hyperventilation may be a manifestation
of occult bronchiectasis. 2) Should palmar palpation be
adopted as part of the routine examination of the chest as it
was the only method of clinical detection of pathology?
How should lung disease be assessed in cystic fibrosis (CF)?
DP HEAF, PR STUTCHFIELD, H DAVIES, DJ MATTHEW, J
STROOBANT Royal Liverpool Children's Hospital, Alder
Hey, and Hospital for Sick Children, London Lung
disease is the predominant factor responsible for prognosis
in cystic fibrosis. A trend towards regional CF clinics and
shared care increases the need for objective assessment of
lung disease to compare patients and monitor treatment.
Methods of assessing lung disease were compared in 21 CF
patients (age 6-15 years) during a clinical trial (Group A)
and 24 CF patients (age 5-19 years) during routine clinic
assessment (Group B). Lung disease was assessed using
Chrispin Norman X-ray score, V/Q lung scans, PEFR,
FVC, FEVI/FVC ratio, Vmax25., RV/TLC*, weight/age,
height* age and weight/height (*Group A only). In Group
A there was a highly significant correlation between X-ray
score, V/Q scan and lung function indices but a poor
correlation between these and measurements of weight and
height. X-ray and V/Q scan correlated best with FVC
(r= -0.84, p<0.00001; r=0.82 p<0.0001) and FEVy
(r= -0.84, p<0.00001; r=0.79 p<0.0001). In Group B
there was less significant correlation between radiograph
and lung function measurements (FVC r = -0.49, p<0.02;
FEVy r= -0.63, p<0.001). Group A had repeat four-
monthly assessments over 18 months. No significant
correlations were found between four-monthly changes in
X-ray score, V/Q scan, lung function and weight, but there
was a significant correlation between 18 month change in
X-ray score and FVC (r = 0.53, p<0.05), and 4/0 scan and
FEVy (r=0.78, p<0.01). X-ray score and simple
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spirometry but not weight and height can be used to assess
severity of lung diseases in CF patients over five, but may
not predict acute changes.
Knowledge of their disease in adults with cystic fibrosis in
the Trent region
JC TYRRELL, EJ HILLER, DJ SHALE Departments of
Paediatrics and Respiratory Medicine, City Hospital,
Nottingham In 1986, 102 adults with cystic fibrosis (CF),
median age 19 years (range 16-44), were identified in the
Trent Region. Of these 86 were interviewed (JT), using a
standard questionnaire, about their knowledge and
attitudes towards CF. Only 7/86 did not know why they
had CF, whilst 43 understood the genetics and were able to
quote the correct recurrence risk of their parents having
another affected child. In answer to the question "What is
cystic fibrosis?" only 19 knew CF could affect more than
"the lungs and digestive system". While 74 knew why they
took pancreatic supplements only 46 knew why vitamin
supplements were necessary. Within this group 42 (21 male,
21 female) were unaware that males are likely to be
infertile, including eight men over the age of 20. The effect
CF might have on a woman's reproductive ability was
unknown to 57/86. Only 11 regarded themselves as too sick
to work, with 63 either still in full time education or
employment. As more patients survive into adult life in
reasonable health it is important that they are given
accurate facts about their condition. This study of adult CF
patients has demonstrated relatively good knowledge of the
basic disease, but a serious deficit regarding fertility in both
sexes.
Measurement of nasal potential difference
EWFW ALTON, JO WARNER, DM GEDDES Brompton Hospital,
London We have previously reported measurements of
nasal potential differences (PD) amongst patients with
cystic fibrosis (CF) in comparison to normal or "diseased"
controls (Thorax 1985;40:704). The former group show
markedly more negative PD than either of the latter, raising
the possibility of its use in the diagnosis of CF. We have
further modified the technique allowing for easy and rapid
measurements in children as well as adults, and greatly
increased our experience in terms of patient numbers and
diseases. PD was measured along the floor of the nasal
cavity using a fine rubber catheter containing electrolyte
cream, into which was placed a silver/silver chloride
electrode connected to a high impedance voltmeter.
Voltages were recorded with reference to a surface electrode
placed on the forearm, following abrasion of the epidermal
surface with a hand-held skin burr (patent pending for
above technique). One hundred and twenty-two normal or
"diseased" controls with mean age 34 years (range 3-73)
showed a mean PD of -19 mv (-2 to -30 mv) in
comparison to 54 patients with CF of mean age 17 years
(2-37) and PD - 46 mv (- 33 to - 77mv). Of the above, 29
CF children aged 2-16 showed a mean PD of -47 mv and
eight asthmatic children aged 2-16 a mean of - 21 mV. We
conclude that with the above improvements this technique
Proceedings
is now easily applicable to children as well as adults. The
investigation retains the discrimination previously reported
following a total of 176 subjects tested, and may have a
place alongside established techniques in the routine testing
of CF.
The radiographic features of pneumonia in the community
MA WOODHEAD, JT MACFARLANE, JS MCCRACKEN, DH
ROSE Departments of Thoracic Medicine and Radiology,
City Hospital and Department of General Practice,
University of Nottingham From 1 October 1984, for one
year, 236 adults with pneumonia (defined as a lower
respiratory tract infection associated with new focal signs
on chest examination) presenting to 29 general practitioners
were studied in detail. An acute chest radiograph was
performed in all but two cases (96% within seven days of
initial consultation). Ninety-two per cent were performed in
the hospital radiology department and 8% by domiciliary
visit. Fresh radiographic shadowing (FRS) was present in 93
(39%). Only two without FRS developed such changes on
later radiographs. Of those with FRS the right lung (59%)
was affected more often than the left (41 1), with one lobe
affected in 81%, two lobes in 17% and three in 2%. FRS
was usually patchy (62%). Extension of FRS occurred in
only eight (9%o) and radiographic complications were
uncommon, with pleural effusion in six collapse in six and
cavitation in one. A number of clinical and laboratory
features were significantly associated with FRS, but only
leucocytosis, neutrophilia, lymphopenia and a CRP level>
100 mg/l remained after stepwise discriminant analysis.
Radiographic clearing was slow with 66% still showing
changes at two and 32% at six weeks. FRS in patients with
pneumonia in the community is seldom extensive and
usually uncomplicated, but slow to clear.
Antibody response to Bordetella pertussis antigens
PC SEDDON, P NOVOTNY, CA HART, CS SMITH Departments of
Child Health and Microbiology, Royal Liverpool
Children's Hospital, Alder Hey, and Wellcome Biotech
Laboratories, Kent We have conducted a prospective
survey of 46 consecutive cases of pertussis-like illness in
children admitted to the Royal Liverpool Children's
Hospital, Alder Hey. Routine clinical and laboratory data
were collected. In addition acute (within two weeks of onset
of coughing) and convalescent (after two weeks of illness)
sera and salivary samples were collected. Using an enzyme
linked immunoassay (ELISA) we have measured antibody
levels (IgM, IgG, IgA) to four Bordetella pertussis antigens
(LPF - lymphocytosis promoting factor; LPS -
lipopolysaccharide; 69 kilodalton protein; and FHA -
filamentous haemagglutinin). Ten patients had pertussis
confirmed by culture. Of these, six had both acute and
convalescent sera taken: all showed rising IgG antibody
titre, and four showed acute IgM antibody, to one or more
antigens. Seven culture positive cases had saliva collected:
four showed IgA antibody to one or more antigens.
Twenty-nine patients had pertussis diagnosed clinically. All
13 where acute and convalescent sera were available showed
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rising IgG antibody titre to one or more antigen. Ten of 21
saliva samples showed IgA antibody to one or more
antigens. It appears that the measurement of salivary IgA
antibody to Bordetella pertussis antigens may prove a
useful tool for studying the sero-epidemiology of pertussis.
Are enteric-coated microspheres of pancreatin more effective
than non-enteric-coated pancreatin with cimetidine in cystic
fibrosis?
RJ STEAD, I SKYPALA, ME HODSON Brompton Hospital,
Fulham Road, London Inactivation of pancreatin by low
pH contributes greately to persistent malabsorption in
cystic fibrosis (CF). Enteric-coating reduces inactivation,
enteric-coated microspheres of pancreatin (ECMP) being
more effective than standard enteric-coated pancreatin.
Alternatively intraluminal pH may be increased by H2
receptor blockade. In an open, randomised cross-over
study, ECMP (Creon) were compared with non enteric-
coated pancreatin (NECP, Pancrex V capsules) combined
with cimetidine (400 mg taken 40 minutes before the three
main meals), over two consecutive 28 day periods. Fourteen
adults with CF were studied. Lipase intake equalled their
previous needs and remained constant throughout. Patients
compared diary cards daily, and 72 hour faecal collections
at the end of each period. One patient withdrew owing to
inability to stabilse her dose of ECMP. Comparing ECMP
with NECP/cimetidine, bowel actions were less frequent on
ECMP (1.7 vs 2.4/day; p<0.001) and stool character was
improved (p<0.001). Mean daily faecal weight on ECMP
(319g) tended to be less than on the combination (451g;
p = 0.06) as did daily faecal fat excretion (20g vs 28g; NS),
whereas percentage fat absorption (8207. vs 7207; p = 0.06)
tended to be greater. Mean body weight increased 0.3 kg on
ECMP and fell 0.1 kg on the combination (NS). The data
indicate that ECMP are at least as effective as the
combination of NECP and cimetidine in CF and are
probably more effective. They are certainly more
convenient.
Multiresistant Pseudomonas aeruginosa in patients with
cystic fibrosis
CD SHELDON, ME HODSON Department of Cystic Fibrosis,
Cardiothoracic Institute, Brompton Hospital,
London We have followed the clinical progress of 40
patients with cystic fibrosis (CF) whose sputum cultures on
one or more occassions grew Pseudomonas aeruginosa
resistant to ceftazidine, azlocillin, carbenicillin, ticarcillin
and piperacillin. Twenty-seven patients had sputum
cultures persistently growing a multiresistant P aeruginosa
over several months and 13 patients had positive sputum
cultures once only. At first isolation neither group showed
any statistically significant change in PEFR, FEVI, FVC or
body weight when compared with the mean out-patient
values over the previous 12 months. Cough, sputum volume
and general well-being showed no significant change in
either group when compared with the symptoms recorded
at the out-patient visit before first isolation of a
multiresistant organism. The group whose sputum cultures
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persistently grew a multiresistant P aeruginosa showed no
significant difference in the number of days spent as an in-
patient in the 12 months before or after infection. There
was no significant change in the mean out-patient values for
PEFR, FEVI, FVC or body weight during the period when
a multiresistant organism was isolated when compared with
the mean out-patient values over the previous 12 months. In
these patients with CF, isolated or persistent culture of P
aeruginosa resistant to /B lactam antibiotics was not
associated with clinical deterioration.
Pyocyanin from Pseudomonas aeruginosa stimulates
airway mucus secretion in vivo
M SOMERVILLE, P RICHARDSON, H TODD, R WILSON, G TAYLOR, P
COLE Host Defence Unit, Cardiothoracic Institute,
Brompton Hospital, London, Department ofPhysiology, St.
George's Hospital Medical School, London, Department of
Clinical Pharmacology, RPMS, Hammersmith Hospital,
London Pseudomonas aeruginosa may colonise the
respiratory tract of patients with cystic fibrosis or severe
bronchiectasis, in whom there is a marked increase in
mucus production. Wilson et al showed that P aeruginosa
phenazine pigments slowed ciliary beating in vitro (J Clin
Invest 1987;79:221) and also noted mucus secretion. We
have studied the effect of pyocyanin on mucus secretion in
the cat trachea in vivo, using 3H-glucose and 35S-sulphate
to label glycoproteins (Gallagher et al, Proc R Soc Lond B
1975;192:49-76). Pyocyanin stimulated the output of
radiolabelled glyco-proteins in a dose-dependent manner
between the concentrations of 15 and 150 pm. At 50 pm,
there was a 50% (SD 6.5 %) increase in 3H-labelled
glycoproteins (p<0.001 cf. control) and a 20.5%7. (9.8%o)
increase in 35S-labelled glyco-proteins (0.1>p>0.05). The
increases at 150pm were 348% (3207) (p<0.001) and 11907
(33.807.) (p<0.02) respectively. As concentrations of
pyocyanin similar to the above have been found in sputum
sols from the respiratory tract of patients with cystic
fibrosis (Wilson et al, J Clin Invest 1987;79:221), these
results suggest that pyocyanin may have a significant role in
stimulating mucus production in the respiratory tract of
patients colonised by P aeruginosa.
Assessment of the efficacy of intramuscular and
intravenous replacement therapy in patients with adult
onset hypogammaglobulinaemia
ND GARBETr, DC CURRIE, PJ COLE Host Defence Unit,
Department of Thoracic Medicine, Cardiothoracic
Institute, Brompton Hospital, London Patients with
hypogammaglobulinaemia suffer from chronic and/or
recurrent acute sinopulmonary infection. In order to reduce
the incidence and severity of these infections, patients are
given immunoglobulin (Ig) replacement therapy. Although
it is now generally believed that intravenous (IV)
replacement is superior to intramuscular (IM), there is no
proof of this. An important purpose of substitution therapy
is to enhance the opsonic activity of the patient's serum,
since opsonisation is necessary for efficient phagocytosis.
We have used an in vitro neutrophil chemiluminescence
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(CL) assay to follow the in vivo replacement of Ig via both
IV (Intraglobin-F, Biotest; 300mg/kg/4 weeks) and IM
(Lister, Elstree; 25mg/kg/week) routes in 10 patients. The
opsonic activity for Haemophilus influenzae (non-
capsulated) and Streptococcus pneumoniae of sera
obtained pre-treatment and after six months' regular
replacement was measured. Results were expressed % CL
of that obtained with control pooled serum. There was no
significant difference between IM(mean 42 (SEM 5); 66 (5))
and four-weekly IV(48 (7); 68 (7)) replacement. However,
in a subgroup of patients treated IV at three-weekly
intervals there was a significant improvement in
opsonisation of both organisms (p<0.01). This difference
was even more significant in sera collected one and two
weeks post-infusion. We conclude that IV infusions of
Intraglobin F produce significant in vivo opsonic activity,
the magnitude depending on the interval between infusions.
These results support the view that IV replacement is
superior to IM.
Culture of bronchopulmonary samples in the diagnosis of
legionella pneumonia
J DORCA, J BOADA, G RUFI, R VERDAGUER, F GUDIOL, F
MANRESA Hospital de Bellvitge. Universitat de Barcelona.
Spain Since July 1985 selective culture medium for
Legionella pneumophila (BCYE-alfa) has been available in
our hospital. During this time, L pneumophila pneumonia
has been diagnosed in 48 cases, either by culture, serology
or both. The purpose of this study was to analyse the
reliability of the culture of different respiratory samples in
the diagnosis of these patients. Among the 48 cases, 34 were
community acquired, and 14 nosocomial. In 19 cases the
patient was considered to be severely immunosuppressed.
The results obtained by the different techniques are shown:
SAMPLE COLLECTED IN POSITIVE IN
Sputum or tracheal aspirate culture 33/48 22(66.6%)
$Transthoracic needle aspiration culture 35/48 27(77.1%)
Bronchoscopic samples culture 13/48 8(61.5%)
*Pleural fluid culture 3/48 2(66.6%)
Serology 33/48 31(93.9%)
At least one sample was cultured in 45 cases, and L
pneumophila was isolated in 40 (88.8%). Lung aspirates
appeared to be the most reliable way to isolate L
pneumophila, but it is important to point out that a less
invasive approach (sputum or tracheal aspirate culture) was
successful in 66.6% of cases. A complete serology could
only be obtained in 33 of our 48 patients, and was positive
in 31 (93.9%). The culture of respiratory samples is a highly
reliable method, and should be the diagnostic procedure of
choice in high risk patients.
Amoxycillin and amoxycillin and probenecid treatment in
patients with bronchiectasis
MB ALLEN, R FITZPATRICK, A BARRAT, RB COLE City General
Hospital, Stoke on Trent High dose amoxycillin (3g bd) is
effective in the management of patients with daily purulent
sputum due to bronchiectasis, improving general well being
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and spirometry while reducing sputum elastase
concentrations. Long term treatment may prevent disease
progression but would be relatively expensive,
approximately £1540 per patient, per annum. Probenecid is
a cheap drug which blocks renal amoxycillin secretion and
produces a two-four fold increase in serum antibiotic
concentration (R Barbhaiya, Brit J Venereal Dis
1979;55:211-3). Probenecid used in conjunction with a
smaller dose of amoxycillin may produce the same
pharmacological and clinical benefit but reduce the cost to
£524 p.a. To determine the efficacy of such a regimen five
patients, mean age 51.3 years (range 40-74), with long
standing daily purulent sputum were studied. Each received
in a randomised double blind, cross over design, with a one
week washout period, either amoxycillin 3g bd (as capsules)
(Regimen A) or amoxycillin lg bd plus probenecid ig bd
(Regimen B). After one week's treatment they were assessed
clinically and blood was taken for amoxycillin bioassay.
Both regimens produced symptomatic benefit, with
reduction in volume and purulence of sputum, although
two patients felt nauseated when taking probenecid.
Pharmacokinetic profiles for each regimen, calculated from
the serum amoxycillin levels, were similar. Mean trough
A = 1.73 ug/ml, B = 2.72 pg/ml and mean half life A = 2.3
hours, B = 2.96 hours. Both regimens were effective
clinically and pharmacologically; thus the use of
probenecid allows a saving of £1000/patient p.a.
Chest wall mechanics and pattern of breathing during
exercise hyperpnoea during induced bronchoconstriction
W KELLY, D DODD, D COTTON, J WHEATLEY, LA
ENGEL Thoracic Medicine Unit, Westmead Hospital,
Sydney, Australia To determine the manner in which
patients with bronchial asthma meet the increased
ventilatory demands of exercise, we studied six asthmatics
immediately after exercise (Ex) at 50%7 of the predicted
maximal work rate on a bicycle ergometer, before and
during bronchoconstriction (BC) induced by aerosolised
histamine. Inspiratory muscle pressures (Pmus) were
measured by relating oesophageal pressure during 5-6
breaths to the chest wall relaxation curve. Maximal
inspiratory muscle pressures (Pmax) were measured at
different lung volumes. End-expiratory lung volume (FRC)
was inferred from inspiration to total lung capacity (TLC)
after each run.
FEVI PE VT FRC Pmus/ Ti/ 7I(%P) (i/min) (I) (% TLC) Pmax Ttot Pmus
Ex 81.0 29.8 2.01 53.0 0.12 0.460 0.05
(mean (SD)) (5.0) (2.7) (0.22) (2.9) (0.02) (0.01) (0.01)
ExBC 38.0 30.4 1.01 71.5 0.34 0.380 0.13
(mean (SD)) (2.0) (2.7) (0.16) (3.3) (0.05) (0.03) (0.02)
NS
p< 0.02.
On ExBC the ratio of inspiratory to total cycle duration
(Ti/Ttot) was lower and FRC increased by 5% TLC above
resting value. The pressure-time index (TTPmus = Pmus/
Pmax. Ti/Ttot) was substantially elevated during ExBC.
Our results indicate that in severe induced asthma increased
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ventilatory demands of exercise are met by hyperinflation
and relatively rapid, shallow breathing with reduction of
the duty cycle. Nevertheless, the high Pmus/Pmax and
TTPmus levels suggest that inspiratory muscles may be
exposed to fatiguing loads.
Prevention of abnormal pulmonary mechanics in the
postmortem guinea pig lung
AM REYNOLDS, RD MCEVOY Department of Thoracic
Medicine, Royal Adelaide Hospital, Adelaide, South
Australia, Australia A phenomenon of severe
postmortem bronchoconstriction has been shown
previously in guinea pig lungs and linked to pulmonary
blood loss during exsanguination (J Appi Physiol
1984;56:308-314). We have reexamined this phenomenon
by measuring postmortem airway function in 46
anaesthetized, open-chest guinea pigs following circulatory
arrest. In control (C) animals the lungs were immediately
removed and allowed to deflate and relaxation gas volume
(Vrx) determined. The remaining animals were ventilated
for 15 minutes postmortem with different gases: Group 1
(Grl) room air; Gr2 5%CO2 in air (dry, room temp); Gr4
5%7CO2 in air (heated and humidified). Airway pressure
was continuously monitored to calculate dynamic
compliance (Cdyn). After 15 minutes Vrx and wet to dry
weight ratios (W:D) were determined. The results (mean
(SEM)) were as follows:
Or n % a Cdyn (15 min.) Vrx/g dry lung W:D
C 6 - 2.42 (0.42) 5.09 (0.08)
1 10 -50 (5)* 4.07 (0.42)** 4.88 (0.10)
2 10 -45 (3)* 5.05 (0.39)** 5.07 (0.22)
3 10 -31 (3)* 2.51 (0.38)** 4.58 (0.11)
4 10 -8(2) 2.95 (0.20) 5.22 (0.11)
*p<0.0S cf Gr4; *p<0.05 cf C.
The addition of CO2 to the inspirate prevented gas trapping
and attenuated the fall in Cdyn. Lung cooling and
dehydration may also contribute to the fall in Cdyn seen in
Gr3. When the inspirate was conditioned (Gr4) the fall in
Cdyn was almost eliminated. We conclude that marked
abnormalities in airway function occur postmortem in air
ventilated lungs. These changes occur in the absence of
pulmonary blood loss and appear to be due mainly to
airway hypocarbia.
Flow limitation and mechanisms of hypennflation in
bronchial asthma
JR WHEATLEY, PD PARE, LA ENGEL Thoracic Medicine Unit,
Westmead Hospital, Sydney, Australia To study the
mechanism of hyperinflation in bronchial asthma we
induced bronchoconstriction in five asthmatics in remission
who inhaled methacholine aerosol until their FEVY reached
< 5007 of the control value. We measured inspiratory
pulmonary resistance (RL) during tidal breathing, followed
by a forced expiration from tidal end-inspiration to residual
volume and an inspiration to total lung capacity (TLC). We
compared the flow at mid-tidal volume during quiet
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breathing (VT) with the isovolumic maximal flow (Vmax),
and calculated the hyperinflation (AFRC) by reference to
TLC. From an assumed respiratory system compliance
(0.125 1/cm H20) and the RL we calculated the respiratory
time constant in each subject, predicted the time (Tp) for
passive expiration of the tidal volume, and compared it
with duration of expiration (TE). At a mean RL of 41 (SD
15) cm H20/l/s (at 0.5 l/s) and an FEV1 of 45% (11%)
predicted, A FRC was 1.1 (0.2) 1 but VT/Vmax was only
0.73 (0.10) and the TE/Tp ratio was 2.7 (0.6). The results
indicate that in severe induced asthma substantial
hyperinflation may be present without expiratory flow
limitation and with adequate time for passive lung
deflation. We conclude that other mechanisms, e.g.
persistent inspiratory muscle activity and/or expiratory
glottic braking, must determine the degree of
hyperinflation even in severe induced asthma.
The effect of indomethacin on the hyperinflation induced
by continuous positive airway pressure breathing (CPAP)
in man
CJ DUGGAN, R SIMMUL, N BEREND Department of Thoracic
Medicine, Royal North Shore Hospital, St. Leonards,
N.S. W., Australia We have previously shown in dogs that
the cyclooxygenase inhibitor Indomethacin (I) reduces the
hyperinflation produced by positive end expiratory pressure
breathing (PEEP) (Am Rev Respir Dis 1982;126:646). We
hypothesized that PEEP induced release of a prostaglandin
which dilated alveolar ducts. Administration of
cyclooxygenase inhibitors has recently been shown to be
beneficial in an animal model of ARDS (J Clin Invest
1983;72:63). However, since the improvement in
oxygenation following PEEP in patients with ARDS is
directly related to the increase in functional residual
capacity (FRC), administration of I may be
counterproductive. We therefore examined the effects of
CPAP and I on lung volume in man. Ten normal subjects
had FRC determined in a constant volume plethysmograph
by the Boyle's law method. CPAP at 5 and 10 cm H20 was
then applied via a bias flow system for five minutes each.
At the end of each five minute period, FRC was remeasured
without removing CPAP. After a further five minutes off
CPAP the measurements were repeated. The subjects then
took I 75 mg tds for three days after which the above
protocol was repeated. One week or more later the protocol
was repeated for a third time. The mean (SEM) FRCs (1) are
shown below.
Baseline 5cm CPAP 10cm CPAP Post CPAP
Day0 4.0+ 0.2 5.3 +0.2 5.8 + 0.4 3.9+0.2
Day 3 4.0 + 0.2 5.0 + 0.3 5.1 + 0.3' 3.9 + 0.3
Day 10+ 4.2 + 0.1 5.0 + 0.3 5.2 0.3* 3.8 + 0.1
'Significantly different from Day 0, p<0.01.
We conclude that I reduces the hyperinflation induced by
CPAP breathing in man and this needs to be considered
when such treatment is advocated for ARDS.
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The non-invasive assessment of the acute effects of oxygen
breathing In patients with hypoxaemic chronic obstructive
pulmonary disease (COPD)
JM HUNT, RJ PIERCE, CE BARTER, PD ROCHFORD Department
of Thoracic Medicine, Repatriation General Hospital,
Heidelberg West, Victoria, Australia In patients with
hypoxaemic COPD receiving long-term domiciliary
oxygen, those who demonstrate a brisk fall in pulmonary
artery pressure (PAP) in response to acute oxygen (02)
breathing have a distinct survival advantage over those who
do not. To be able to predict this survival advantage non-
invasively has important clinical implications. The effects
of a acute 02 breathing were assessed by both invasive and
non-invasive means in 17 patients with severe stable
hypoxaemic COPD with the following baseline
characteristics (mean (SD)): age 69 (6) years, FEVY 2607
(10%) predicted, Pao2 53 (4) mm Hg, PacO2 45 (9) mm Hg.
The non-invasive measurements (dead space/tidal volume
ratio (Vd/Vt), effective pulmonary capillary blood flow
estimated by re.breathing and single-breath soluble gas
uptake (QRB, QSB). left ventricular ejection fraction
(LVEF), and echocardiography) were comapred with right
heart catheter measurements of PAP, thermodilution
cardiac index (QTD) and pulmonary vascular resistance
(PVR). The group changes were as follows (mean (SD)):
AIR 100% 02 28% 02
for 20 min for 24 hours
PAP (mmHg) 28.8 (8.1) 24.1 (7.5)* 24.9 (7.6)*
PVR dyne/sec/cm5 415 (179) 389 (170)" 376 (184)(TD (I/M2) 2.78 (0.54) 2.43 (0.46)* 2.61 (0.68)ORB (I/m2) 1.74 (0.49) 1.43 (0.39)' 1.50 (0.36)*
(?SB (1/M2) 1.44 (0.39) 1.18 (0.60) 1.64 (0.70)Vd/Vt 0.58 (0.07) 0.62 (0.06)* 0.58 (0.05)
*Denotes significant change from baseline: (p <0.05; **0.1 > p>P0.05)
LVEF did not change significantly. Coefficients of
variability for QTD, QRB, QSB and Vd/VT were 4.8, 17.3,
31.0 and 3.0%0o respectively. Following 100%o 02 the fall in
PAP was significantly correlated with the fall in QRB but
not with the fall in QSB or the rise in Vd/VT. We have
determined that cardiopulmonary responses to acute 02
breathing can be measured non-invasively. The variability
of these tests in severe COPD may limit their ability to
predict long term survival in individual patients receiving
domiciliary 02 therapy.
Effect of gas compression artefact on forced expiratory
flows
RE HYATT, MJ KROWKA, PL ENRIGHT, JR RODARTE (SPONSORED
BY N PRIDE) Division of Thoracic Diseases, Mayo Clinic,
Rochester, MN, U.S.A. The American Thoracic Society
recommends that the largest one second forced expiratory
volume (FEVI) be reported from a set of forced expiratory
vital capacity manoeuvres. However, increased expiratory
effort can decrease the FEVY. Peak expiratory flow rate
(PEFR) was evaluated as an index of expiratory effort and
was positively correlated with effort estimated by an
oesophageal balloon. We then measured the difference
(dFEVI) between the largest FEVI, using ATS standards,
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and the FEVY from the manoeuvre with the highest PEFR
in 10 normal subjects and 10 patients with mild to moderate
airway obstruction. The mean dFEV1 was 110 ml in
normals and 200 ml in patients. We also reviewed 9471
spirometry sessions from outpatients and found dFEVY to
be greater than 50 ml in 26%o of this population and greater
than 151 ml in 71o. We conclude that FEVY is inversely
dependent on effort. Maximal effort decreases FEVY
because of the effect of thoracic gas compression on lung
volume. We recommend that values from manoeuvres with
submaximal effort (decreased PEFR) be discarded. The
flow-volume curve display of superimposed efforts
facilitates the recognition of submaximal efforts.
Gas exchange and oxygen cost of breathing in patients with
chronic airways obstruction
C LANIGAN, J PONTE, J MOXHAM Departments of Thoracic
Medicine and Anaesthesia, Kings College School of
Medicine and Dentistry, London The work of breathing
in patients with severe chronic airways obstruction (CAO)
is increased even at rest, and might translate into higher
resting total oxygen consumption values (to2). Few
published data exist on the magnitude of this increase in
Vo2. We measured resting Vo2, carbon dioxide production
(4co2) and respiratory quotient (RQ) over 10 minutes by an
open canopy system (Hughes et al, J Physiol
1985;371:233P) in 13 patients with CAO (mean FEVY 0.78
1, VC 2.1 1, 0o predicted values = 30.907 and 61.907) and
13 age, weight and height matched controls. Mean RQ
values were identical in the two groups; average Yo2 and
VCO2 were higher in patients, and statistically different
when corrected for body surface area (BSA) (see table). The
severity of airflow obstruction was poorly correlated with
gas exchange data. We conclude that the average increase
of 107 in Vo2/BSA in patients reflects the burden imposed
on their respiratory muscles and their increased oxygen cost
of breathing at rest.
V02 C'CO2 RQ V02/BSA *
Controls 205 (30.9) 169 (29.9) 0.82 (0.03) 119 (12.5)
Patients 223 (49.1) 184 (43.2) 0.82 (0.04) 132 (17.7)**
*Mean (SD) V02, v'CO2 ml min- I STPD; BSA m2. **p<0.05
Dose-dependent fall in trapped gas volume in
"irreversible" chronic obstructive airways disease treated
with oral theophylline
H CHRYSTYN, BA MULLEY, MD PEAKE Pontefract General
Infirmary and University ofBradford, W. Yorks We have
shown that in chronic obstructive airways disease (COAD)
trapped gas volume (VTFG, i.e. the difference between total
lung capacity measured by body plethysmography and
helium dilution) falls acutely after theophylline
administration (Chrystyn et al, Thorax 1986;41:722). In the
present study 33 patients (mean age 61.2 years) with COAD
and < 1507 improvement in forced expiratory volume in
one second (FEVI) after inhaled bronchodilators were
treated for four randomly ordered eight week periods with
placebo and three different individualised doses of oral
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theophylline, the highest giving a steady state serum
concentration of 18.3 (0.39) mg/l (mean (SEM)). FEVI,
forced and slow vital capacities (FVC, SVC), peak
expiratory flow rate (PEFR), VTrG and six-minute walking
distance (WD) were measured before and after each
treatment. There were significant (p<0.01) dose-dependent
improvements in all the variables. Comparison of values at
the end of the placebo period with those at the end of the
highest dosage period showed the changes to be as follows:-
FEVI + 0.131 (13 %), FVC + 0.33 1 (13.5%), SVC + 0.621
(24.5%), PEFR + 17.7 1/min (12.5%), VTrG -1.16 1
(63%) and WD + 57 m (20%). Thus large falls in the VTrG
and improvements in WD (and SVC) can occur in COAD
following chronic theophylline therapy despite minor
improvements in FEVY and PEFR.
Changes in regional lung ventilation may explain the
hypoxaemia of histamine induced bronchoconstriction
KF WHYTE, M IP, AL MUIR, DC FLENLEY Rayne Laboratory,
Department of Respiratory Medicine, University of
Edinburgh, City Hospital, Edinburgh In 10 chronic stable
asthmatics (9M, IF; 27-61 years, initial FEVY 54-97%
predicted) we measured FEVI, Sao2, tidal volume (Vt),
fpnctional residual capacity (FRC) and minute ventilation
(Ve) before and during bronchoconstriction induced by
inhaled histamine (Yan et al, Thorax 1983;38:760-765) so as
to reduce Sao2 by 4% or FEVY by 30%. We simultaneously
measured regional Vt and regional FRC in three zones
(upper, middle and lower) of each lung by a respiratory
gated 127Xe ventilation scan as changes in lung geometry
during tidal breathing were corrected by recording of 99mTc
counts from labelled MAA previously lodged in lung
capillaries (Muir et al, Nuc Med Com 1985;6:127-139)
whilst the subject breathed into a computer linked closed
circuit spirometer. Regional ventilation was measured over
six minutes before and immediately after histamine
challenge. FEVY fell 0.45-1.87 1 as Sao2 fell by 04/o, 4e
rose in seven subjects but fell in three, whereas FRC rose in
all with histamine. The variability in regional Vt/regional
FRC of the six zones within each subject was exaggerated in
every patient by the histamine challenge. The
bronchoconstriction induced by histamine inhalation in
chronic asthmatics is not uniform throughout the bronchial
tree, even within the same subject. This variable change in
regional ventilation in response to histamine will increase
4/Q variance and may cause hypoxaemia following
histamine, if this is not overcome by an increase in overall
alveolar ventilation.
Interactions between swallowing and respiration in normal
man
J MOORE-GILLON, P WILKINSON, V MOORE-GILLON, R
RUDD The London Chest Hospital, London;
*Professorial Unit, Royal National Throat, Nose and Ear
Hospital, London There is little information regarding
the relationships between swallowing and breathing in
normal adults. We investigated eight healthy subjects (four
male, four female), all unaware of the purpose of the study.
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Respiration was monitored by repiratory impedance
plethysmography and swallows by bursts of activity
recorded by electromyographic electrodes placed
submentally. Subjects were seated reading, in a quiet room.
After a 10 minute run-in period swallowing and respiration
were recorded for 20 minutes. One hundred and twenty-
three spontaneous swallows were recorded. Only 10 (8%)
occurred during inspiration; after swallowing these breaths
were terminated and followed by expiration rather than
resumption of inspiration. Forty-seven swallows (38%)
occurred during expiration and were followed by
completion of expiration. Sixty-six swallows (54%)
occurred at end expiration, and were followed by a pause at
FRC before the next inspiration was initiated. Spontaneous
swallowing occurs predominantly during expiration or at
end expiration; whatever the phase of the respiratory cycle,
swallowing appears never to be followed immediately by an
inspiratory effort. We suggest this may help protect the
tracheobronchial tree against aspiration of residual matter
in the hypopharynx.
How often does response to salbutamol go unobserved in
chronic airflow limitation?
D ROGERS, MDL MORGAN East Birmingham
Hospital Although the value of the knowledge of the
bronchodilator response in chronic airflow limitation
(CAL) may be questioned, it is often sought by repeating
the FEVY FVC or PEFR after a few minutes. To understand
how often a significant response may go unobserved by this
practice we have examined the incidence and distribution of
bronchodilator response in 132 patients with CAL on eight
measurements derived from the flow volume loop, 15
minutes after 5 mg of nebulised salbutamol. These
measurements were FEVY FVC, PEFR, V50, V75, MMEFR
(maximum mean expiratory flow rate derived from area
under expiratory F/V curve by FVC), PIFR, MMIFR
(area under inspiratory curve IVC). In addition three
flow/volume loops from 10 subjects without CAL were
examined for reproducibility and to set a level for
significance. The coefficient of variation in the non-CAL
subjects ranged from 1.2% ± 0.9 (FEV1) to 10.0% ± 5.3
(MMIFR). One hundred and thirteen (86%) patients with
CAL had an improvement of > 20% in one or more
measurements after salbutamol, including 11 patients who
only had an inspiratory response. We conclude that a
response to salbutamol can be demonstrated by
flow/volume loop in most patients with CAL. However,
only 29 (25.7%) of these would be identified if the FEVY
and FVC were used and only 29 (25.7%) if the PEFR were
used alone.
Gas transfer in diabetes mellitus
DC WEIR, PE JENNINGS, MS HENDY, AH BARNETT, P SHERWOOD
BURGE Department of Thoracic Medicine and Academic
Department of Diabetes, East Birmingham Hospital,
Birmingham There is conflicting evidence about the effect
of diabetes mellitus (DM) on lung function. Recent
evidence suggests that gas transfer is reduced in insulin
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dependant diabetes (Sandler Metal Am Rev Respir Dis
1987;135:223-229). The reduction was not correlated with
the presence of complications of diabetes elsewhere. We
have examined this by comparing lung function in a group
of uncomplicated diabetics with a matched group of
complicated diabetics. Complications were defined as
proliferative retinopathy, or maculopathy, or proteinuria
or background retinopathy plus an increased urinary
albumin excretion rate. Nine pairs (six male, three female)
matched for age and sex were assessed. All were current
non-smokers and had no unrelated cardiorespiratory
disease. Spirometry and single breath carbon monoxide gas
transfer were measured on all subjects. Helium dilution
lung volume estimations were performed on 16 subjects.
(Two complicated subjects refused). The transfer factor
was corrected for haemoglobin concentration. There was
no significant difference in FEVI, FVC, total lung capacity,
residual volume or functional residual capacity between
pairs. The TLCO, however, showed significantly lower levels
in complicated subjects (as /o predicted mean (SD):
uncomplicated 111.7 (10.2); complicated 103.9 (15.5)
(p<0.05). The absolute value of TLCO/VA (Kco) showed a
similar reduction: uncomplicated 1.75 (0.21); complicated
1.55 (0.18) mmol minm- kPa-1.1- (p<0.02). The results
suggest that lower measures of gas transfer in diabetics are
associated with complications elsewhere.
Diaphragm weakness in Charcot Marie Tooth disease
CM LAROCHE, J MOXHAM, NN STANLEY, RJ COURTENAY-EVANS,
M GREEN Lister Hospital, Stevenage, Herts, Mayday
Hospital, Croydon, Surrey, and Brompton Hospital,
London Charcot Marie Tooth disease refers to a group of
inherited neuropathies, usually associated with a normal
life span. Respiratory muscle weakness has not been
described. We report two men with this disease who
developed severe diaphragm weakness. Both had a severe
generalised, mainly motor, neuropathy affecting all four
limbs, with some loss of touch and vibration sense in the
legs. They had become moderately breathless on exertion,
associated with paradoxical abdominal motion and
discomfort lying flat. Chest radiograph showed progressive
elevation of both hemidiaphragms. Lung function tests
showed a restrictive defect with a reduced total lung
capacity, normal residual volume, reduced TLCO but
normal Kco. Resting blood gases were normal. Inspiratory
mouth pressures were very low (24% and 34% predicted),
whereas expiratory mouth pressures were only moderately
reduced. Transdiaphragmatic pressure (Pdi) was very low
during a maximal inspiration against a closed airway (22.5
and 15 cm H20, normal >44), and during a maximal sniff
without a noseclip (17.5 and 23.5 cm H20, normal >100).
We conclude that diaphragm weakness can occur in
Charcot Marie Tooth disease but, because of the motor
disability, dyspnoea is only apparent when the patient is
lying supine or when diaphragm weakness is particularly
severe. Clincally unsuspected diaphragm weakness in these
patients may predispose them to respiratory complications.
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Respiratory pressure partitioning during quiet inspiration
in unilateral and bilateral diaphragmatic weakness
DR HILLMAN, KE FINUCANE Department of Pulmonary
Physiology, Sir Charles Gairdner Hospital, Nedlands,
Western Australia To compensate for diaphragm (D)
weakness, intercostal/accessory (I/A) muscles (mm) may
be recruited in inspiration and/or abdominal mm in
expiration with relaxation during subsequent inspiration.
These changes should increase the ratio of abdominal to
pleural pressure change during quiet inspiration
(APab/A Ppl (qi)), which is normally < - 1. To examine
the relationship between degree of D weakness and
APab/APpl(qi), we measured (erect) Ppl, Pab and
transdiaphragmatic pressure (Pdi) (balloons) during quiet
inspiration (qi), maximum inspiration (mi) and maximum
inspiratory effort at FRC in 10 subjects with bilateral and
eight with unilateral D weakness. A Pdi during mi
(APdi(max)mi) was low in all subjects (12.4 (10.2) cm H20
(mean (SD)), normal >25), as was A Pdi during maximum
inspiratory effort at FRC (APdi(max)FRC) (27.4 (19.3) cm
H20, normal >60). A Pab/A Ppl was increased in all
subjects (0.28 (0.7), normal <- 1) and was closely
correlated with both A Pdi(max)mi (r = -0.89, p<0.001)
and A Pdi(max) FRC (r = -0.76, p<0.001). There was
extensive overlap in the data between unilateral and
bilateral D weakness. The ratio of A Pdi during quiet
inspiration to A Pdi(max)FRC was 0.16 (0.11) and no
subject exceeded 0.31. The results suggest that
APab/APpl is a useful index of the degree of D weakness
and that unilateral weakness has functional implications for
quiet inspiration not rigidly separable from bilateral
weakness. That the ratio of A Pdi during quiet inspiration
to A Pdi (max)FRC was always less than the threshold for
fatigue (0.4) suggests that recruitment of I/A and
abdominal muscles allows ventilation to be maintained
without development of diaphragm fatigue.
Effect of lung inflation on airway function after induced
bronchoconstriction In normal and asthmatic subjects
JR WHEATLEY, PD PARE, LA ENGEL Thoracic Medicine Unit,
Westmead Hospital, Sydney, Australia To study the
bronchodilating influence of a deep inspiration (DI) on
airway function, we induced bronchoconstriction with
doubling doses of methacholine in five normal subjects and
five asthmatics in remission. At each dose pulmonary
resistance (RL) was measured during tidal breathing
followed by a partial (p) forced expiration from end-
inspiratory volume to residual volume (RV1), inspiration to
total lung capacity and complete (c) forced expiration to
RV (RV2). Isovolumic maximal expiratory flow (Vmax)
was measured at each dose during the partial (Vmaxp) and
complete (Vmaxc) expirations. Both groups of subjects
reached an RL of 6-11 cm H20/l/s (at 0.5 Us) and Vmaxp
of 0.15-0.70 I/s, allowing comparison of flows and RVs.
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Mean (SD): Vmaxp (I/s) 'maxc (I/s) R Vi(%) R V2(%)
Normals 0.49 (0.11) 1.86 (0.22)* 132 (8) 105 (1)*
Asthmatics 0.57 (0.09) 0.92 (0.13)* * 126 (7) 116 (3)**
'p 0.05 relative to Vmaxp or RV,; *p 0.02 relative to normals. RVI and
RV2 as ' of RV2 baseline.
For equivalent RL values, maximal flows were similar for
normals and asthmatics and both groups had a DI
bronchodilating effect. The amount of gas trapping was
also similar in the two groups. However, in normals this
was fully reversed by a DI, whereas in asthmatics the DI
had no significant effect. Our results suggest a relatively
smaller degree of reversibility of the peripheral airways in
response to a deep inspiration in asthmatics.
The role of the parasympathetic nervous system in
nocturnal asthma
JFJ MORRISON, SB PEARSON Pulmonary Function
Laboratory, Killingbeck Hospital, Leeds Increased vagal
tone at night has been implicated in the aetiology of
nocturnal asthma. In this study vagal activity was blocked
using intravenous (iv) atropine at the time of maximal
bronchoconstriction (4 a.m.) in 10 sleeping asthmatics
(diurnal variation in PEFR > 20%). A dose-response study
revealed the optimal dose of iv atropine to be 30 ug/kg.
Subjects were admitted for one day's acclimatisation, and
were studied at 4 a.m., immediately after being awoken,
and at 4 p.m. on two successive days being randomly given
atropine or placebo 30 minutes prior to PEFR
measurements. Inhaled beta-agonists or anticholinergic
drugs were omitted eight hours prior to the study. Plasma
adrenaline was sampled immediately before PEFR
measurement.
Mean (SEM) ADRENALINE (nmol/l) PEFR (l/min)
AM PM AM PM
PLACEBO 0.13 (0.02) 0.36 (0.08) 266 (44) 403 (42)
ATROPINE 0.14 (0.03) 0.37 (0.03) 393 (48) 438 (45)
There was a significant diurnal variation in PEFR (p<0.01)
and in plasma adrenaline (p = 0.02). Atropine did not alter
plasma adrenaline levels. Atropine reversed the fall in
PEFR at night (p<0.01) increasing it to PM placebo
values; however the PEFR after 4 p.m. atropine was higher
than after 4 p.m. placebo (p<0.05) and 4 a.m. atropine
(p<0.01), implying that other factors such as low
circulating adrenaline may also be important in the
nocturnal fall in PEFR. In conclusion increased vagal tone
appears to be an important aetiological factor in nocturnal
asthma.
Selective histamine blockade in childhood asthma: the
effect of terfenadine on resting bronchial tone and exercise
induced bronchospasm (EIB)
P1 MACFARLANE, DP HEAF The Respiratory Unit, Royal
Liverpool Children's Hospital, Alder Hey,
Liverpool Histamine is an important mediator of
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bronchoconstriction but conventional antihistamines only
weakly antagonize its effects at bronchial muscle H1
receptors; they are not therapeutically beneficial because of
side effects. Terfenadine is a non-sedative potent selective
H1 antagonist. We have investigated the effects of
terfenadine on resting bronchial tone and EIB in a
randomized double blind placebo controlled trial. Twenty
children (5.5-14.8 years) were studied on two days 48 hours
apart, by PEFR and FEVY measurements for three hours
after oral placebo or terfenadine 60 mg, followed by a free
running exercise test. Baseline values were the same on each
study day. Terfenadine induced significant
bronchodilatation within one hour of ingestion when
compared with placebo and a 32% improvement in FEVy
by three hours (p<0.00001), increasing FEVY from a
baseline mean % predicted 69% to 84% by three hours.
Bronchodilatation showed a significant inverse correlation
with baseline FEV1 (r = -0.81, p<0.00005). After exercise
challenge terfenadine significantly inhibited EIB
(terfenadine 21.5% fall PEFR, placebo 32% fall,
p = 0.037), but when the exercise test values were
normalised to the placebo baseline to eliminate the effect of
prior bronchodilatation, no such protective effect was
evident. Selective H1 blockade using terfenadine has an
acute bronchodilator effect, suggesting that asthmatic
children have significant resting "histamine tone". Partial
inhibition of EIB is a non-specific effect of
bronchodilatation rather than a- separate effect on
bronchial reactivity.
Mechanism of metabisulphite-induced bronchoconstriction
in atopic non-asthmatic subjects
ER CHILVERS, CMS DIXON, PW IND Department ofMedicine,
Royal Postgraduate Medical School, Hammersmith
Hospital, London Sodium metabisulphite (MBS) is a
widely used preservative which is increasingly recognised to
cause bronchocontstriction after ingestion. Inhaled MBS
has been the subject of few studies in asthmatics and none
in atopics. We have investigated the mechanism of MBS-
induced bronchoconstriction by examining the effect of (i)
nedocromil sodium, (N) and (ii) cholinergic receptor
blockade with oxitropium bromide (OB). In non-asthmatic
subjects inhaled MBS produced dose related
bronchoconstriction in 8/8 atopics but in 0/6 non-atopics.
We studied six atopic non-asthmatics pre-treated with
inhaled OB 200 ug, N 4 mg, or placebo (P), 30 minutes
before nebulisation of a previously determined dose of
MBS, in a randomised, double blind design. Specific
airways conductance (sGaw, mean of six readings)
determined by computerised body plethysmography was
recorded for 20 minutes after MBS inhalation. Baseline
sGaw did not differ significantly on the three study days.
sGaw increased after OB but this was not significant
compared to P or N. After MBS sGaw fell by 59% (9%)
and (47) (16%) (mean (SEM)) one and five minutes after P
and by 35% (20%7) and 27% (12%) after OB (p<0.05).
Nedocromil prevented any significant fall in sGaw
(p<0.05). Bronchoconstriction, measured by the area
under the curve of sGaw with time, was significantly
reduced by nedocromil (p<0.05). These results may be
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interpreted as suggesting that MBS induces
bronchoconstriction by mast cell degranulation but S02
liberation is not excluded.
Muscarinic autoreceptors inhibit cholinergic
neurotransmission in human airways in vivo and in vitro
PA MINETTE, PJ BARNES Department of Clinical
Pharmacology, Cardiothoracic Institute, London
Prejunctional muscarinic receptors which inhibit acetyl-
choline release from cholinergic nerves have been
demonstrated in intestine bladder and, recently in guinea-
pig airways in vivo (Faulkner et al, Br J Pharm
1986;88:181-7). We have investigated whether these
receptors exist in human airways, in vitro and in vivo.
Human bronchi obtained at surgical lobectomy were
mounted in an organ bath and stimulated by electric field
stimulation (EFS), that elicited a contractile response which
was inhibited by atropine and tetrodotoxin. Pilocarpine, a
selective agonist of presynaptic muscarinic receptors,
increased basal tone and reduced EFS contractile response
in a dose-dependent manner. This effect was inhibited by
gallamine. We have further investigated whether
pilocarpine inhibits cholinergic reflex bronchoconstriction
using sulphur dioxide (SO2) challenge in eight healthy
subjects (five atopics and three non-atopics). In a double
blind, randomized fashion, they were pretreated with
pilocarpine and histamine on separated days. The drugs
increased the airway resistance measured by a forced
oscillation technique (Rrs) by 24.60o 2.401o and 22.50/
(2.60/) (mean (SEM)) respectively. Then the subjects
inhaled a concentration of S02 which had been shown
previously to give a similar increase of Rrs (27.0 (7.0)).
After S02, Rrs further increased from 22.50/ to 31.80o
(6.0%o) after histamine, while it decreased from 25.20/o to
18.60/ (5.30/) after pilocarpine (paired t = 2.96). These
data support the idea that inhibitory muscarinic receptors
exist on cholinergic nerves in human airways.
Modulation of cholinergic neurotransmission In human
airways by A 2-receptors
KJ RHODEN, LA MELDRUM, PJ BARNES Department of
Clinical Pharmacology, Cardiothoracic Institute,
London Cholinergic neurotransmission in isolated canine
bronchial smooth muscle is inhibited by catecholamines,
probably via prejunctional /3-receptors (J Appl Physiol
1979;46:789-91). Human airway smooth muscle has no
functional adrenergic innervation but in asthmatics
/3-blockers induce a bronchoconstriction which is
prevented by anticholinergic drugs. We have examined the
effects of catecholamines on the responses of isolated
human bronchi to electrical field stimulation (EFS) and
exogenous acetylcholine (ACh). Bronchial rings were
obtained from patients undergoing lung resection for
carcinoma and were suspended in Krebs-Henseleit solution
at 37°C, bubbled with 95%02-5/ CO2. Contractile
responses to EFS (4-32 Hz, I ms, 40v) and to ACh (1pM-
1mM) were measured isometrically. Isoprenaline and
adrenaline inhibited responses to EFS with mean
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concentrations causing 50%/ inhibition (IC50) at 4Hz of 48
nM and 398 nM respectively. Both drugs had significantly
less effect on comparable responses to ACh, with IC50s of
4,M and 3pM respectively. Noradrenaline was less potent,
with an IC50 of 56pM on EFS. The effects of isoprenaline
on EFS were inhibited by 1pM propranolol and by 0.1pM
ICI118,551 (a /32-blocker) but not by 0.lpyM betaxolol (a
A 1-blocker). Thus, we conclude that catecholamines have
an inhibitory action on cholinergic neurotansmission in
human airways, probably via prejunctional / 2-receptors.
Adrenoceptors decrease during activation of protein kinase
C in airway smooth muscle
BM GRANDORDY, KJ RHODEN, PJ BARNES Department of
Clinical Pharmacology, Cardiothoracic Institute,
Brompton Hospital, London Carbachol stimulates
breakdown of phosphoinositides (PI) in airway smooth
muscle, leading to formation of diacylglycerol (DG), an
activator of protein kinase C. We have investigated whether
carbachol (CCh) and activation of protein kinase C by
phorbol esters (phorbol 12-myristate 13-acetate, PMA)
could affect A -receptor density and function. / -receptordensity was assessed by (1251) cyanopindolol (ICYP)
binding to membranes prepared from chopped bovine
airway smooth muscle pre-incubated with CCH (100 iM),
PMA (1 pM) or 4-phorbol 12,13-didecanoate (PD, an
inactive phorbol). There was a decrease in receptor density
after CCh and PMA vs control of 80 fmol/mg protein,
p<0.05). The displacement of ICYP specific binding by
isoprenaline (ISO) in control and PD-treated, but not in
PMA and CCh -treated membranes was sensitive to GTP,
indicating that coupling of A -receptors to adenylate cyclase(AC) was reduced by protein kinase C activation. ISO-
induced cyclic-AMP accumulation was decreased after
PMA and CCh treatment (EC50 = 56 pM and 73 pM
respectively vs 5.1 pM in control; p<0.05). After PMA
treatment and contraction by 30 mM KCI, the ISO
relaxation curve did not differ from that after KCI alone.
We conclude that CCh and PMA (probably via protein
kinase C activation) decrease A-receptor number and
coupling to AC, although this does not affect ISO-induced
smooth muscle relaxation. Combined or prolonged effect
of several inflammatory mediators could impair airway
,B-adrenergic function in asthma, however.
Evidence for a dual effect by beta-adrenoceptor antagonists
on post-exercise airway calibre
KE BERKIN, G WALKER, NC THOMSON Department of
Respiratory Medicine, Western Infirmary, Glasgow The
effect of selectivity of /3-adrenoceptor antagonists on
resting and post-exercise airway calibre in normal subjects
was examined using tests believed to distinguish between
effects on central and peripheral airways. Eight normal
subjects were given atenolol 50 mg, propranolol 80 mg and
placebo orally, in random order, double blind. Specific
airways conductance (sGaw) and flow at 257o of VC from
partial flow volume curves (V25(p)) were recorded before,
two hours after drug administration and after exercise.
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Neither drug had a measurable effect on sGaw or V25(p) at
rest. After exercise on placebo, V25(p) increased from 1.97
(0.11) to 2.38 (0.18) 1/s (mean(SEM)). This increase was
inhibited (p<0.01) by propranolol; V25(P) was 1.81(0.16)
before and 1.79(0.17) 1/s after exercise. The Al1- selective
atenolol allowed an increase in 425(P) from 1.87(0.14) to
2.24(0.26) I/s, comparable to that seen on placebo. After
exercise on placebo, sGaw increased slightly from
1.56(0.18) to 1.69(0.19) s-'kPa-', whereas on atenolol,
post-exercise sGaw fell from 1.49(0.20) to 1.23(0.11) and on
propranolol from 1.55(0.16) to 1.29(0.13) s-'kPa-1
(p<0.05). These results suggest that /3-adrenoceptor
antagonists may have a dual effect on airway calibre.
Firstly, a direct effect on the /2- receptors in airway
smooth muscle may occur. Secondly, in the central airways,
/
-adrenoceptor blockade may inhibit vagal pre-junctional
/31- receptors which normally inhibit acetylcholine release
at the nerve ending, thereby permitting vagally induced
airway narrowing.
/3-receptor stimulation does not inhibit human alveolar
macrophage activation
G O'MALLEY, AJ BAKER, J MACDERMOT, RW FULLER Clinical
Pharmacology, Royal Postgraduate Medical School,
London Alveolar macrophages (AM), the most numerous
airway cells, may contribute to airway inflammation by the
release of mediators following activation by phagocytosis
and IgE-dependent mechanisms. We have examined the
role of the /3-receptor agonist isoprenaline (ISO) and the
phosphodiesterase inhibitor R020-1724 (RO) on AM
release of thromboxane B2 (TXB2) and N-acetyl
glucosaminidase (NAG) following activation with both
opsonised zymosan (Z) and IgE/anti-IgE complexes (IgE).
Z increased TXB2 and NAG release by a mean (SD) of 63%
(59%) (n= 18) and 33% (48%) (n= 13). IgE increased
TXB2 and NAG release by 430% (729%) (n = 14) and 705%
(674%) (n = 11). ISO (10uM) plus RO (250uM) increased
adenylate cyclase activity by 96% and intracellular cyclic
AMP by 103%. Preincubation with ISO (lnM-10uM)
(n = 17) or RO (5OnM-50uM) (n = 9) or the combination of
RO (250pM) with ISO (lOnM-IpyM) (n = 10) had no effect
on AM release of TXB2 or NAG when stimulated with Z or
IgE. Alveolar macrophage activation is not inhibited by
/3-receptor agonists. This may explain the lack of anti-
inflammatory action of these drugs in the lung.
Investigation of the mechanism of methoxamine-induced
bronchoconstriction in asthmatic airways
A MATTHEWS, S COOPER, J BRITTON, A
TATTERSFIELD Respiratory Medicine Unit, City Hospital,
Nottingham Methoxamine, an alpha adrenoceptor
agonist with mild beta antagonist activity, causes
bronchoconstriction when inhaled by subjects with asthma.
Whether this action results from alpha agonism or beta
blockade, or alternatively from an unrecognised non-
specific irritant activity is not clear. We have determined
the relative importance of these effects by comparing
airway reactivity to methoxamine with reactivity to a beta
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adrenoceptor antagonist (propranolol) and to a non-
specific irritant (histamine), and by assessing the effect of
an alpha antagonist (prazosin) on methoxamine and
histamine reactivity in 20 subjects with mild asthma. On
five separate days in a randomised double blind design,
subjects took oral prazosin (1 mg) or placebo one hour
before inhaling either methoxamine or histamine, or
alternatively took placebo one hour before inhaling
propranolol. The inhaled drugs were given in doubling
concentrations by nebuliser at five minute intervals,
measuring the response as the PC35 for specific airways
conductance. Log PC35 values for methoxamine did not
correlate significantly with values for either histamine
(r= -0.097) or propranolol (r=0.416) when these drugs
were given after placebo. After prazosin, mean PC35 for
methoxamine was increased by 1.4 doubling doses relative
to placebo (p<0.01), whilst PC35 for histamine was
unchanged. These findings indicate that methoxamine-
induced bronchoconstriction is mediated by alpha
receptors.
Bronchial muscarinic receptor hypersensitivity after heart-
lung transplantation (HLT)
M JACKSON, T RASHDI, J WALLWORK, T
HIGENBOTTAM Papworth Hospital, Cambridge After
HLT, patients develop increased bronchial responsiveness
to inhaled methacholine (NR Banner et al, Thorax
1987;42:239). It is unclear whether this enhanced sensitivity
of muscarinic receptors results from vagal denervation or
mucosal inflammation secondary to infection or rejection
of the transplanted lung. To test for vagal reinnervation we
have studied reflexly induced cough using inhalation of
ultrasonically nebulized distilled water "fog" (Godden DG
et al, Clin Sci 1986;70:301-304) and the
bronchoconstriction response to "fog" (TW Higenbottam
et al, Br Med J 1983;286:1012-1014) and compared these
with the mechacholine response. All patients had
concurrent bronchial mucosal and transbronchial lung
biopsies. Six patients were studied (age range 21 to 47 years)
who had HLT three to 14 months earlier. No patient
coughed with "fog," supporting the idea of vagal
denervation, and no patient developed bronchoconstriction
after a cumulative exposure to "fog" of 30 minutes. The
provocative concentration of methacholine at which the
FEV1 fell by 20% (PC20M) ranged from 1.75 to 4 mg/ml.
Two patients had mucosal inflammation on biopsy and
their PC20M was 3 and 3.5 mg/ml respectively. These
observations support the view that vagal denervation is
responsible for muscarinic receptor hypersensitity
following HLT.
De novo beta-adrenoceptor synthesis in adult rat lung: an
in-vivo study
RJD WINTER, KEJ DICKINSON, RM RUDD, PS
SEVER, Hammersmith Hospital, St. Mary's Hospital, and
London Chest Hospital, London We sought to determine
the rate of synthesis of beta-adrenoceptors in adult rat lung.
Male Wistar rats were treated with either
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bromoacetylalprenololmenthane (BAAM) 25 mg/kg
intraperitoneally (n = 20) or ethanol/saline vehicle (n = 18).
BAAM links covalently with the beta-adrenoceptor
forming an irreversible bond (Biochem Pharmacol
1986;35:857-864). At intervals after injection (range 5-500
hours) animals were killed, lungs removed, and membranes
prepared as previously (Clin Sci 1986;70:159-165). Beta-
adrenoceptor density was determined by measuring the
binding of 1251-iodocyanopindolol (Radiochemical Centre,
Amersham) at six concentrations (range 10-500 pM).
Specific binding, defined using 200 umol/l isoprenaline,
was 850o. In the control group mean binding site maxima,
Bmax, was 346.9 SEM 37.7 fmol/mg protein; mean
dissociation constant, Kd, 24.7 SEM 4.1 pM. BAAM
caused significant reduction in receptor density at five and
15 hours (mean Bmax 155.5 SEM 44.8, n=4; 231.5 SEM
32.7 fmol/mg, n = 4, respectively; p < 0.05 both times)
without change in Kd. Recovery to control value, reflecting
de novo receptor synthesis, took about 300 hours. If airway
adrenoceptors do not differ in their pharmacological
properties from those at other sites in lung, these data
suggest that synthesis occurs slowly. This contrasts with the
rapid (30 minutes) in vivo alteration in cell surface receptor
density after agonist exposure (Endocrinology
1984;115:1392-1400).
Cimetidine prevents histamine tachyphylaxis in asthmatic
subjects
PJ MANNING, P JACKSON, PM O'BYRNE Department of
Medicine, McMaster University, Hamilton, Ontario,
Canada Histamine tachyphylaxis develops with repeat
inhalation of histamine in mild asthmatic subjects, due to
the release of prostaglandins. The purpose of this study was
to determine whether histamine tachyphylaxis occurs
through stimulation of H2 receptors in the airway. Seven
mild asthmatic subjects were studied on two days separated
by at least one week. On both days, three histamine
inhalation tests were performed, separated by one hour, as
described by Cockcroft et al (Clin Allergy 1977;7:235-43).
The response was expressed as the provocative
concentration of histamine causing a 20%7o fall i FEV1
(histamine PC20). Before each study day subjects were
pretreated with placebo or cimetidine (300 mg bid) for three
days, in a double blind randomized fashion. The baseline
FEVY was similar before each histamine test on each study
day. Cimetidine pretreatment had no effect on baseline
histamine PC20 (p>0.2). After pretreatment with placebo,
histamine tachyphylaxis occurred in all subjects; the PC20
increased from 3.01 mg/ml (%7oSD 1.44) to 4.88 (oSD 1.68)
and to 6.85 mg/ml %oSD 1.68). Cimetidine pretreatment
prevented histamine tachyphylaxis; the histamine PC20 was
2.72 mg/ml (%oSD 1.77), 3.02 mg/ml (oSD 1.73) and 3.56
mg/ml (oSD 1.59) with repeated tests, which differed
significantly from the placebo values (p<0.01 for the
second and p<0.0005 for the third histamine test). This
study demonstrated that cimetidine pretreatment prevents
histamine tachyphylaxis and suggests that the release of
inhibitory prostaglandins in response to histamine
inhalation occurs through stimulation of airway H2
receptors.
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Effector functions of bronchoalveolar leucocytes from rats
exposed to coalmine dust by inhalation
K DONALDSON, GM BROWN, MD ROBERTSON, J SLIGHT, A
SEATON Institute of Occupational Medicine,
Edinburgh Bronchoalveolar leucocytes are considered to
have a central role in tissue injury arising during long-term
inflammation and in subsequent fibrosis in the alveolar
region of the lung. We therefore assessed key effector
functions of bronchoalveolar leukocytes lavaged from
control rats and rats exposed for 45 days to airborne dust
(50 mg/m3) collected from a British colliery. The
bronchoalveolar population from dust-exposed rats
comprised (mean (SEM) x 106 per rat; n = 4) 15.6
(3.5)macrophages and 15.2 (2.4) neutrophils; control
bronchoalveolar cells were 8.0 (0.1) macrophages and 0 (0)
neutrophils. Control and dust-exposed bronchoalveolar cell
populations showed different activities in degrading
radiolabelled extracellular matrix components: figures for
fibronectin degradation (mean (SEM) cpm released; n = 4),
control cells 1308 (65), dust exposed cells 7010 (69)
(p<0.01). Cells from dust exposed rats also caused marked
detachment injury to cells of an alveolar epithelial cell line
in vitro while control cells were inactive: (mean (SEM) of
51Cr cpm in cells detached following co-culture with
bronchoalveolar cells; n = 4) medium 3722 (336), medium
+ control cells 3518 (441) (NS); medium 5047 (267),
medium + dust-exposed cells 11375 (154) (p<0.05). The
activated status of the coalmine dust-exposed
bronchoalveolar leucocytes was confirmed by their
increased microbicidal activity against spores of Aspergillus
fumigatus:- (mean (SEM) /o spores killed; n = 4), control
cells 11.85 (5.5), dust exposed cells 30.6 (2.3) (p<0.01).
Production of alveolar macrophage chemotaxins by the
action of pathogenic mineral dust on serum from control
rats and rats with inflammation
K DONALDSON, J SLIGHT, PP JOHNSTON, RE BOLTON, A
SEATON Institute of Occupational Medicine,
Edinburgh We have investigated the ability of the
pathogenic dusts chrysotile asbestos and quartz, and the
inert dust titanium dioxide (TiO2), to generate chemotaxins
for alveolar macrophages in HAN and PVG rat serum.
Both quartz and chrysotile asbestos, but not TiO2,
generated substantial amounts of migration-inducing
activity in the serum of both rat strains. By using a
modified "checkerboard" technique to assess chemokinesis
we calculated which proportion of the total cell movement
was due to chemotaxis in serum activated by the three
mineral dusts; this revealed that the percentage of cell
movement that was true chemotaxis varied depending on
the dust: asbestos 81.1%o; quartz 54.3%o; TiO2 23.3%o.
HAN serum yielded the following measures of chemotaxis
on treatment with S mg/ml of dust (given as mean (SD) cells
per high power field): TiO2 5.4 (1.5); quartz 15.9 (3.2);
chrysotile asbestos 25.1 (4.8). In the second part of the
study serum from control PVG rats and PVG rats with
inflammation caused by intrapertoneal injection of
Corynebacterium parvum were compared as to their ability
to be activated by the mineral dusts. Serum from
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"inflammatory" rats was much more amenable to
production of chemotactic factors (results given as mean
(SD) cells per high power field): (i) control rat serum -
chrysotile treatment 5.7 (3.4), quartz treatment 2.2 (1.3);
(ii) "inflammatory" rat serum - chrysotile treatment 13.3
(7.9), quartz treatment 8.1 (3.9).
Neutrophil chemotactic activity from cultured blood
mononuclear cells in acute severe asthma
DR BUCHANAN, P FITZHARRIS, 0 CROMWELL, AB
KAY Cardiothoracic Institute, Brompton Hospital,
London We previously reported that neutrophil
chemotactic activity (NCA) was elevated in serum from
patients with acute severe asthma (ASA) and that this
reverted to control/baseline values after treatment (J
Allergy Clin Immunol 1986;77:183). In the present study we
have attempted to determine the cell source of NCA by
culturing blood mononuclear cells (MNC) for varying
intervals of time. MNC from acute severe asthma (nine),
mild asthma (six) and normal controls (six) were cultured
for 24, 48 and 72 hours in the presence or absence of
phytohaemagglutinin (PHA). With PHA no differences
were observed in NCA when ASA was compared to mild
asthma (MA) and normal controls (N) at 24, 48 and 72
hours. In contrast baseline unstimulated NCA was
significantly raised in ASA compared with MA and N at 24
hours (p<0.02) and 48 hours (p<0.05). There was also a
significant decrease in NCA of ASA when day 0 (on
admission to hospital) was compared with seven days of
treatment (p<0.05). Preliminary experiments using fast
protein liquid chromatography gel filtration suggest that
the MNC-derived NCA of ASA is heterogeneous in respect
of molecular size. These experiments suggest that MNC
might be a source of the NCA of ASA.
Relationship of pathological changes to bronchial
hyperreactivity and bronchoalveolar lavage (BAL) fluid in
mild asthma
PK JEFFERY, AJ WARDLAW, FC NELSON, JV COLLINS, AB
KAY Departments of Lung Pathology and Allergy and
Clinical Immunology, Cardiothoracic Institute, Brompton
Hospital, London The pathological basis of asthma,
particularly in its early stages, is still poorly understood.
We have investigated bronchial biopsies and BAL in 11
non-smoking mild atopic asthmatics and 10 non-asthmatic
volunteers (five hay fever, five non-atopic). Seven of the
asthmatics had evidence of active disease with increased
bronchial hyperreactivity (PC20 <4 mg/ml methacholine).
Four of these were symptomatic requiring daily inhaled /2
agonists. We report here the histological changes measured
in semi- and ultra-thin plastic sections and the correlation
with symptoms and BAL data. Symptomatic asthmatics
had increased loss of epithelium (p <0.01) and an increased
proportion of irregular lymphocytes in their submucosa
(PX2<0.001). The degree of epithelial loss in all subjects
correlated with the degree of airway reactivity (r,- 0..60,
p<0.01). Hyperreactive asthmatics had a significantly
thickened basement membrane (p<0.01), which did not
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correlate significantly with PC20 (r,= -0.35, p=0.12).
There was no difference between groups in the numbers of
goblet cells, intraepithelial nerves, subepithelial
inflammatory cells, mast cells or platelets. Although there
were increased numbers of epithelial cells, eosinophils and
mast cells in the BAL fluid there was no significant
correlation with the findings in biopsy specimens. The
results indicate that epithelial fragility and basement
membrane thickening are early changes in asthma which
may contribute to the pathogenesis of bronchial
hyperreactivity.
Rapid cessation of neutrophil influx after intrapulmonary
instillation of the chemotaxin C5a des arg (C5a) in rabbits
C HASLETT, GS DOWNEY, HENSON PM Department of
Medicine, Royal Postgraduate Medical School,
Hammersmith Hospital and National Jewish Centre for
Immunology and Respiratory Medicine, Denver,
U.S.A. Differences in control of neutrophil (PMN) influx
may explain why a single intrabronchial dose of bleomycin
induces chronic inflammation and injury, while C5a results
in self-limited inflammation. 5 x 107 indium-Ill labelled
rabbit PMN (In.PMN) were given intravenously to 23
rabbits 0.5, 2, 6, and 12 hours after 20 ig C5a was instilled
into the right upper lobe (RUL) with left upper lobe (LUL)
as control. PMN influx was assessed 20 hours after PMN
injection by quantitative external y camera scintigraphy
("ext."), y count of bronchoalveolar lavage (BAL) and
tissue counts of dissected lungs ("tis.") and results
expressed as ten thousandths (mean (SEM)) of original
In.PMN infusate:
Hours 0.5(n=6) 2(n=5) 6(n=7) 12(n=5) LUL (control)
BAL 33 (8.1) 3.6 (0.6) 5.3 (1.5) 2.1 (0.2) 0.2 (0.08)
Tis. 218 (54) 16.6 (2) 20 (5) 5.7 (0.3) 4.7 (0.9)
Ext. 250 (28) 105 (8) 105 (7.3) 101 (10) 96 (8.6)
All three methods revealed a dramatic fall in PMN influx at
two hours after C5a, with low grade influx detectable at 12
hours by BAL and tissue counts, but not by the external '
camera, which may be less sensitive because of the
marginated PMN pool background. In summary, the bulk
of PMN influx had occurred within two hours after C5a, in
marked contrast to the effects of bleomycin, where influx
may persist for three weeeks.
Exposure to cigarette smoke does not enhance bleomycin
induced lung injury
JG HAY, TE BETTS, PL HASLAM, ME TURNER-WARWICK, GJ
LAURENT Department of Thoracic Medicine,
Cardiothoracic Institute, London and Department of
Thoracic Medicine, Fazakerley Hospital,
Liverpool Bleomycin is an important chemotherapeutic
agent which unpredictably causes acute severe lung injury.
An active species is formed when bleomycin complexes with
iron and oxygen and DNA is damaged by the release of free
radicals. Hydrogen peroxide is able to regenerate this active
species. Exposure to cigarette smoke has been shown to
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stimulate the production of hydrogen peroxide by
pulmonary cells (DB Drath et al, J Cell Physiol
1978;95:105-115), and might therefore be expected to
enhance the pulmonary toxicity of bleomycin. We have
previously shown that the administration of intravenous
bleomycin (5 mg) to male Lewis rats causes no evidence of
acute lung injury, yet when combined with hyperoxia or
excess iron, severe injury follows (JG Hay et al, Thorax in
press). In this study rats were exposed to the smoke of 10
cigarettes over a period of 200 minutes on four consecutive
days beginning two days prior to (Group 1) or simultaneous
with (Group 2) intravenous saline or bleomycin. The effect
of exposure to smoke on one session increased the
carboxyhaemoglobin concentration from < 1% to 9%.
Lung injury was measured as the total pulmonary
extravascular albumin space 72 hours following bleomycin;
this is the ratio of 1251 albumin in the lungs to that in 1 ml of
plasma 24 hours following an intravenous bolus injection
of 125I albumin.
Group I Group 2
Bleomycin 0.14 (0.03) NS 0.16 (0.04) NS
Saline 0.13 (0.01) 0.14 (0.01)
In conclusion, exposure to smoke in this manner does not
increase the pulmonary toxicity of intravenous bleomycin.
Serum human neutrophil elastase is increased in patients
with active Wegener's granuloma
CG WATHEN, D BELL, DJ HARRISON, M JACKSON, J
DAWES Departments of Medicine and Pathology and
Blood Transfusion Service, Royal Infirmary,
Edinburgh The neutrophil has been implicated in the
pathogenesis of vasculitis, including Wegener's granuloma
(Leavitt and Fauci, Am Rev Respir Dis 134:149-66).
Elevated levels of human neutrophil elastase (complexed to
ca1 antiprotease) are associated with neutrophil activation
and degranulation. We therefore measured human
neutrophil elastase by radioimmunoassay, in patients with
active Wegener's granuloma known to have neutrophil
anticytoplasmic antibodies present in their sera (de Woude
et al, Lancet 1985;i:425-9). Sera were studied from 10
patients (age 35-63 years, mean 46) with active Wegener's
granuloma and 20 control subjects (22-46 years) mean 31).
All patients with Wegener's granuloma had anticytoplasmic
antibodies present and detectable by immunofluorescence
at dilution of > 1:64. Serum human neutrophil elastase was
significantly increased in patients with active Wegener's
granuloma (894 (SD668)) ng/ml) compared with controls
(81 (50) ng/ml, p<0.001). In three patients the level fell
after the commencement of treatment of the condition.
These data support the view that neutrophil activation and
the release of neutrophil products may have a role in the
pathogenesis of Wegener's granuloma and that human
neutrophil elastase may provide the means of monitoring
disease activity and response to therapy.
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Human alveolar macrophages release more H202 in
response to increasing environmental hypoxia
AP GREENING, MH BAIN, W SCOTT, NJ DOUGLAS Rayne
Laboratory, Department of Respiratory Medicine,
Edinburgh Extracellular release of oxidants by
macrophages and neutrophils is thought to contribute to
acute and chronic lung injury. Alveolar macrophages (AM)
differentiate from their monocyte precursors in an aerobic
environment and display an active oxidative metabolism.
Since patients with chronic bronchitis and emphysema have
areas of relative pulmonary hypoxia, we questioned
whether the oxidative functions of AM from these areas
might be influenced by the "hypoxia". We have studied, in
vitro, the effects of different degrees of environmental
hypoxia on AM obtained from seven patients by
bronchoalveolar lavage. AM were purified by plastic
adherence and cultured overnight in sandwich boxes
"gassed" to give °2 concentrations of 21%, 10% and
2.50o. H202 release from the AM, following stimulation,
was assayed fluorometrically. Culture in hypoxic
environments resulted in enhanced release of H202 by the
AM.
Culture 02(H)H202 release (nmol/106 cells/h)
(mean (SEM))
21 12.75 (3.6) p<0 0S
10 18.6 (5.8)
P 002.5 21.2 (513) p00
We conclude that increasing environmental "hypoxia"
results in increasing extracellular H202 release by AM. This
may provide a mechanism for progressive oxidant mediated
tissue damage.
Transferrin accumulation in the lung and evidence of
neutrophil degranulation in the adult respiratory distress
syndrome (ARDS)
GM ROCKER, MS WISEMAN, D PEARSON, DJ SHALE Respiratory
Medicine Unit, University of Nottingham, and
Departments of Medical Physics, City Hospital,
Nottingham Neutrophil degranulation may be causally
linked to increased pulmonary vascular permeability in
ARDS. Of 27 patients with widespread pulmonary
infiltrates undergoing a double isotope determination of
transferrin accumulation in the lung 15 met the criteria of
ARDS (Petty et al, Chest 1982;82:98-103). Simultaneously
neutrophil degranulation was assessed as plasma beta-
glucuronidase (bG) activity and lactoferrin (Lf)
concentration. Nine healthy subjects were also assessed for
evidence of degranulation. Lf in ARDS (median 2.8 nM,
interquartile range 2.5-3.5) and non-ARDS (2.5, 2.2-3.2)
was greater than in controls (1.4, 1.3-1.4) p<0.01 (Kruskal-
Wallis test), but not significantly different from each other.
bG activity was not significantly different between groups.
The absolute neutrophil count was lower in ARDS
(8.3 x 109/l, 6.7-8.7) than non-ARDS patients (11.3,
11.2-14.4; p<0.01), but both were significantly greater
than the controls (3.1, 2.8-3.1). Transferrin accumulation
was significantly greater in ARDS than non-ARDS patients
(2.33x 10-3/min, 1.67-2.39 vs 0.55, 0.43-0.71; p<0.01).
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In established ARDS there was no relationship between
transferrin accumulation and neutrophil degranulation.
Degranulation occurred in non-ARDS subjects, who did
not develop ARDS, though at risk. These findings bring
into question the primary role of the neutrophil in ARDS.
A comparison of conventional chest radiography and a
double isotope method for lung accumulation of transferrin
in pulmonary oedema
GM ROCKER, DH ROSE, AR MANHIRE, D PEARSON, DJ
SHALE Respiratory Medicine Unit, University of
Nottingham, and Department of Radiology and Medical
Physics, City Hospital, Nottingham Conventional chest
radiography was reported to identify pulmonary oedema
associated with high and low capillary permeability states.
(Milne et al, Am J Roentgen 1985;144:879-94). Twenty-five
patients with radiographically detectable pulmonary
oedema were studied (seven non-cardiac (ARDS), 10 renal
and eight cardiac). Transferrin accumulation (PAI) in the
lung was determined using a double isotope method. Chest
radiographs were scored according to Milne's criteria with
weighting of the scores in favour of a high (HC) or low
(LC) capillary permeability cause. Two radiologists
unaware of the diagnosis carried out the scoring and agreed
a final category for each patient.
ARDS RENAL CARDIAC
PAI 2.52 0.72* 0.79*
(1.5-3.2) (-0.1-1.1) (0.5-1.9)
HC score 17 0' 15.
(12-22) (0-4.5) (0-15)
LC score 0.5 7.5' 7.5'
(0-4.5) (3.9-9.5) (0.8-11)
'Critical value < 0.05, Mann Whitney U test.
Results are median and (interquartile range).
Scores did not differentiate between cardiac and renal
pulmonary oedema, but capillary pulmonary oedema
(ARDS) was identified with certainty at a time when there
was evidence of increased pulmonary permeability to
proteins.
The effect of cigarette smoking on polymorphonuclear
leucocyte (PMN) retention in the lungs
W MACNEE, BA MARTIN, AS BELZBERG, BJ WIGGS, JC
HOGG UBC Pulmonary Research Laboratory, St. Paul's
Hospital, Vancouver, B.C., Canada Cigarette smoking is
thought to recruit PMNs into the lungs. To assess the effect
of smoking on the movement of PMNs through the
pulmonary vasculature, we have measured PMN retention
and subsequent washout from the lungs in healthy smokers
(n = 15, age 40 (SD 10) years) and non-smokers (n = 6, age
38 (7) years). We have related PMN retention in the lungs to
blood velocity as measured by red blood cell (RBC) transit
time (TT), following i.v. bolus injections of 99mTc labelled
RBCs and Indium-III labelled PMNs using a gamma
camera/computer system. The retention of PMNs in the
lungs at 10 minutes post-injection (but not the first pass
retention) correlated with RBC TT (r=0.83, p<0.005) in
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both non-smokers and smokers who were not smoking
during the study. PMN retention and washout from the
lungs was similar in these two groups. Inhalation of
cigarette smoke shortened RBC TT in the lungs of smokers
(FT = 6.1 +1 .6s) compared with non-smokers (TT = 8.9
(SD 1) s (1.0) s, p<0.001) but increased 10 minute
retention. Analysis of the PMN washout curves using the
equation y =A + Be - cx showed that this difference was due
to slower washout (c) (p<0.001) rather than the total
washout (B) or the concentrations of PMNs present at the
end of the experiment (A). We conclude that cigarette
smoking produces a transient delay in the passage of PMNs
through the lungs in spite of the decrease in RBC TT. Since
smoking activates PMNs and inactivates CVPi this delay in
PMN transit could result in focal areas of intravascular
protease/antiprotease imbalance which may be important
in the pathogenesis of emphysema.
Plasma elastin derived peptide levels in normal and
emphysematous subjects
G MCLENNAN, R WALSH, T DILLON, J MARTIN, R
ANTIC Departments of Thoracic Medicine, Royal
Adelaide Hospital, and the Adelaide Childrens Hospital
and Department of Clinical Chemistry, Institute ofMedical
and Veterinarary Science, Adelaide, South
Australia Pulmonary elastin breakdown results in
pulmonary emphysema. Elastin breakdown by elastases
results in soluble elastin fragments. One method of
assessing elastin breakdown is to measure these elastin
fragments which may be circulating in the plasma. Assays
for elastin derived peptides (EDP) have been performed on
human plasma using an Elisa assay. Assays were performed
in triplicate and results calculated using a standard curve.
The intra-batch coefficient of variation is 4.3%0 at 0.4
ng/ml and the inter-batch coefficient of variation is 5.2%o
at 0.4 ng/ml. EDP levels from disease free children (n = 24,
aged 1-14 years), disease free adult non-smokers (n = 24),
smokers (n = 10), reformed smokers (n = 14), (aged 20-50
years) and adults with established pulmonary emphysema
(n = 10) have been determined. The levels in children were
0.02-0.28 ng/ml (0.155 (SEM 0.017)); in non-smoking
adults 0.93-2.67 (1.967 (0.371)); in smoking adults
0.48-3.93 (1.924 (0.349)); in reformed smokers 0.58-5.13
(1.93 (0.318)); and in subjects with emphysema 21.3-90.8
(40.36 (6.35)). The levels in children were significantly
lower (p<0.001) than those from normal non-smoking
adults. The levels from adults with emphysema were
significantly higher (p<0.001) than those from the other
adult groups. We conclude that patients with established
emphysema have elevated levels of EDPs and that children
have low levels. This assay may be useful to evaluate
premature or rapid elastin breakdown.
Pleural complications of fatal acute pancreatitis: an
necropsy study
M WILKINSON, K ROBSON, GS BASRAN Departments of
Thoracic Medicine and Histopathology, City Hospital,
Nottingham Amylase-rich pleural effusions are
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recognised complications of pancreatitis; however, the
significant of their size and relationship to sub-
diaphragmatic pathology has not been highlighted.
Moreover the mechanism by which these exudative
effusions accumulate remain unexplained although direct
transdiaphragmatic communications have been postulated.
We have analysed the necropsy data on 19 patients who had
a clinical and pathological diagnosis of pancreatitis and in
whom adequate post-mortem histology was available. Eight
of these cases had encapsulated sub-diaphragmatic fluid
collections (pancreatic psuedocysts or abscesses) and seven
of these had large pleural effusions (volume 500-2000 ml).
The fluid was serous in four and blood stained in three. The
distribution was bilateral in five and right sided in two. Of
the remaining 11 cases only three had pleural effusions and
these were small (less than 200 ml; two bilateral, one right
sided). Contrary to findings in clinical studies none of our
patients had unilateral left sided effusions. Apart from one
patient with pleural fat necrosis and another with diffuse
alveolar damage no gross pleural or lung pathology was
seen. Thus all the patients with large pleural effusions had
encapsulated subdiaphragmatic fluid collections. However,
the postulated transdiaphragmatic communications which
could have explained the formation of the effusions were
not seen in any of our cases. The observed
subdiaphragmatic inflammatory pancreatic masses could
provide alternative explanations: impaired lymphatic
drainage through reduced diaphragmatic movement and
retrograde flow of fluid through trans diaphragmatic
lymphatics.
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Alveolar macrophage procoagulant activity is increased in
acute hyperoxic lung Injury
DA CAMPBELL, PG TIPPING, NW BOYCE, SR
HOLDSWORTH Queen Elizabeth Hospital, Adelaide, and
Monash University Department of Medicine; Prince
Henry's Hospital, Melbourne, Australia This study
demonstrates that alveolar macrophage (AM) procoagulant
activity (PCA) is increased in acute hyperoxic lung injury in
rats and indicates that AM are activated early in the
development of this disease. AM-PCA has been implicated
in fibrin deposition and subsequent fibrosis in chronic
interstitial lung disease (Chapman et al, Clin Invest
1985;75:2030). AM may also have a role in tissue injury in
adult respiratory distress syndrome and in pulmonary
oxygen toxicity in animal models (JD Crapo, Ann Rev
Physiol 1986;48:721). Hyperoxia-induced lung injury was
assessed at 24, 48 and 60 hours in rats exposed to > 95% 02,
and compared with controls. Lung injury was assessed
histologically (including fibrin deposition by
immunofluorescence) and functionally by the assessment of
pulmonary capillary permeability (1251-albumin lung
permeability index (LPI) and lung weight-body weight ratio
(LBW). Inflammatory cell accumulation and differential
cell count was assessed by bronchoalveolar lavage (BAL).
AM-PCA was measured by a one-stage clotting assay (SR
Holdsworth, PG Tipping J Clin Invest 1985;76:1367).
Pulmonary capillary permeability increased progressively
with increased hyperoxia exposure (p <0.01 at 24 hours);
however inflammatory cell accumulation in BAL fluid was
not seen until 60 hours (p<0.005), when the proportion of
neutrophils was increased (p<0.01). AM-PCA was
increased at all times in the hyperoxia-exposed groups
(p<0.01). AM-PCA was dependent upon coagulation
factors V and VII and largely independent of factors VIII
and XII; thus it has the characteristics of tissue factor. This
model provides insights into the contribution of AM-PCA
to fibrin deposition in interstitial lung diseases.
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